≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Vitamin B12 deficiency anaemia

DOID EFO Endpoint Browser PheWeb

D3_ANAEMIA_B12_DEF

vitamin B12 deficiency: A disease characterized by low serum levels of vitamin B12, either inherited or acquired.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D51
  • Hospital discharge: ICD-9 — 281[0-1]
  • Hospital discharge: ICD-8 — 281[0-1]
  • Cause of death: ICD-10 — D51
  • Cause of death: ICD-9 — 281[0-1]
  • Cause of death: ICD-8 — 281[0-1]
  • KELA reimbursements: KELA codes — 107

3 out of 7 registries used, show all original rules.

4818

4. Check minimum number of events

None

4818

5. Include endpoints

None

4818

6. Filter based on genotype QC (FinnGen only)

4660

Control definitions (FinnGen only)

Control exclude
D3_NUTRIANAEMIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D50-D53
Name in latin
Anaemia ex deficientia vitamini B12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 52228 29010 22438
Only index persons 35116 20477 14639
Unadjusted period prevalence (%)
Whole population 0.74 0.83 0.63
Only index persons 0.67 0.75 0.56
Median age at first event (years)
Whole population 69.57 69.67 69.40
Only index persons 67.32 66.96 67.81

-FinnGen-

Key figures

All Female Male
Number of individuals 4660 2371 2289
Unadjusted period prevalence (%) 0.94 0.84 1.05
Median age at first event (years) 62.44 58.30 66.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4817
Matched controls
48164
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A55
ICPC
General and Unspecified, Local injection/infiltration
20.0
320.4
249
131
-50
ICPC
Medication/prescr/renewal
6.4
309.0
548
944
B81
ICPC
Anaemia vit B12/folate deficiency
82.9
307.7
2639
694
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
172.5
307.7
307
19
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
39.0
307.7
411
115
WVA30, ,
SPAT
9.0
307.7
1095
1525
107
Kela drug reimbursment
Pernicious anaemia
+∞
307.7
3445
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
18.6
307.7
906
594
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
27.8
307.7
248
94
D51.8
ICD-10 Finland
Other vitamin B12deficiency anaemias
162.2
307.7
261
17
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
91.8
307.7
412
49
D51
ICD-10 Finland
Vitamin B12deficiency anaemia
45.0
307.7
292
69
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
768.8
307.7
880
14
K29.4
ICD-10 Finland
Chronic atrophic gastritis
44.5
307.7
1242
373
T91
ICPC
Vitamin/nutritional deficiency
34.1
307.7
387
123
B03BA03
ATC
hydroxocobalamin; parenteral
227.3
307.7
4123
1227
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
307.7
1111
3213
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.1
307.7
2639
9276
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
259.5
307.7
1414
77
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
16.2
269.0
231
149
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
20.7
268.9
205
103
B50
ICPC
Blood and Immunity, Medication/prescr/renewal
38.9
228.4
140
37
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.5
216.0
2476
14140
A50
ICPC
General and Unspecified, Medication/prescr/renewal
5.7
213.3
419
790
B03BA01
ATC
cyanocobalamin; nasal, systemic
+∞
207.8
198
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
12.5
198.8
198
165
D50.8
ICD-10 Finland
Other iron deficiency anaemias
17.8
196.0
160
93
K50.8
ICD-10 Finland
Other Crohn disease
12.6
191.7
190
157
8145/3-C16.9
ICD-O-3
Carcinoma, diffuse type of stomach, NOS
53.7
175.6
100
19
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
26.5
172.6
119
46
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
7.0
172.0
271
409
376
Kela drug reimbursment
Cyanocobalamin
+∞
171.9
164
*
B82
ICPC
Anaemia other/unspecified
5.9
170.9
322
582
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
64.0
159.4
88
14
WVA20, ,
SPAT
5.0
156.6
350
737
104
Kela drug reimbursment
Thyroid insufficiency
3.4
151.1
598
1914
B80
ICPC
Iron deficiency anaemia
6.8
145.6
233
357
H03AA01
ATC
levothyroxine sodium; systemic
2.3
139.9
1406
7257
C16.00
ICD-10 Finland
Cardia
23.2
138.1
100
44
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.7
133.4
887
3780
K50.9
ICD-10 Finland
Crohn disease, unspecified
9.0
129.3
161
184
S50
ICPC
Skin, Medication/prescr/renewal
12.7
128.5
126
102
UJF32
NOMESCO Finland
Coloscopy
2.2
126.5
1546
8584
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
33.7
114.4
73
22
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
25.9
113.8
79
31
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
10.5
113.6
126
123
ZX114, ,
SPAT
7.2
111.8
168
240
-55
ICPC
Local injection/infiltration
10.0
109.8
126
129
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
37.2
106.3
66
18
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
42.5
105.0
63
15
UJD02
NOMESCO Finland
Gastroscopy
3.4
102.2
387
1195
UJF92
NOMESCO Finland
Capsular endoscopy
8.0
100.5
137
175
S55
ICPC
Skin, Local injection/infiltration
23.6
100.1
72
31
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
16.5
98.6
83
51
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.1
98.5
280
710
K50.1
ICD-10 Finland
Crohn disease of large intestine
9.1
98.3
121
136
C16.24
ICD-10 Finland
Malignant tumor of the corpus ventriculi intestinal carcinoma
54.6
94.9
54
10
SPAT1254
SPAT
Administration of medicine
2.2
94.2
970
4953
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
92.4
591
2442
C10AC01
ATC
colestyramine; oral
4.4
90.2
231
541
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
32.6
90.0
58
18
A07EA06
ATC
budesonide; oral, local oral
4.1
89.5
256
652
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
22.7
89.1
65
29
L04AX01
ATC
azathioprine; systemic
3.8
85.0
272
750
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
15.8
84.6
73
47
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
83.1
1963
13235
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
25.5
83.0
58
23
2810X
ICD-9 Finland
Other deficiency anaemias, Pernicious anaemia[ANAEMIA PERNICIOSA SINE MYELOPATHIA SPINALI]
+∞
81.5
78
*
D50
ICPC
Digestive, Medication/prescr/renewal
33.7
78.3
50
15
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
33.7
78.3
50
15
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
26.8
77.2
53
20
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
31.6
76.8
50
16
JFB00
NOMESCO Finland
Partial resection of small intestine
5.0
72.5
157
320
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
69.6
1175
7067
A10AB05
ATC
insulin aspart; parenteral
2.5
68.6
469
1990
D50
ICD-10 Finland
Iron deficiency anaemia
5.6
66.1
126
229
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
64.2
250
782
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.6
64.0
217
621
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
9.9
63.4
73
75
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
62.1
710
3722
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
6.9
61.4
95
140
A10AE04
ATC
insulin glargine; parenteral
2.2
61.3
555
2657
C16.3
ICD-10 Finland
Malignant neoplasm: Pyloric antrum
21.6
60.4
45
21
JKA20
NOMESCO Finland
Cholecystectomy
3.3
59.4
228
707
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
3.8
57.9
181
490
E53.9
ICD-10 Finland
Vitamin B deficiency, unspecified
16.0
57.2
49
31
6322
FHL
Gastrectomy (including Roux-Y)
199.0
57.1
59
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
56.7
1649
11465
UJF02
NOMESCO Finland
Peroral enteroscopy
9.4
56.3
67
72
T89
ICPC
Diabetes insulin dependent
3.4
56.1
212
651
A07EC02
ATC
mesalazine; oral, rectal
2.9
55.8
278
1003
ZX120
NOMESCO Finland
Intravenous
2.2
55.0
506
2434
D52.9
ICD-10 Finland
Folate deficiency anaemia, unspecified
14.0
54.5
50
36
130
Kela drug reimbursment
Malignant tumour
2.1
54.2
555
2784
D74
ICPC
Malignant neoplasm stomach
18.8
51.8
41
22
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.6
51.5
122
268
K50
ICD-10 Finland
Crohn disease [regional enteritis]
17.6
51.5
42
24
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
21.3
50.6
38
18
D51.3
ICD-10 Finland
Other dietary vitamin B12deficiency anaemia
503.1
50.5
50
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.3
49.4
127
298
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
49.3
511
2571
R4190
NOMESCO Finland
Nutritional therapy
3.3
49.3
195
616
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.4
49.0
123
283
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
49.0
2350
18234
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.6
48.2
297
1194
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.9
47.9
235
840
T50
ICPC
Metabolic, Medication/prescr/renewal
10.7
47.0
51
48
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
14.0
46.8
43
31
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.9
46.7
140
368
RD210, ,
NOMESCO Finland
4.9
46.3
102
211
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
46.1
1091
7118
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
75.2
46.0
52
7
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
14.8
45.9
41
28
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
17.7
45.5
37
21
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.8
45.3
233
854
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.0
44.9
129
329
C16
ICD-10 Finland
Malignant neoplasm of stomach
151.4
42.8
45
*
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
12.9
42.6
41
32
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
42.5
1151
7753
L01BC06
ATC
capecitabine; oral
2.8
42.2
226
846
JAH00
NOMESCO Finland
Laparotomy
3.0
41.5
188
643
JF1BD
NOMESCO Finland
Very extensive small bowel CT
8.9
41.0
51
58
R11
ICD-10 Finland
Nausea and vomiting
2.0
40.6
467
2435
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
39.8
640
3725
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
4.3
39.1
101
238
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
13.9
39.1
36
26
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.1
38.5
162
531
C03CA01
ATC
furosemide; systemic
1.5
38.3
1946
15013
A02BC02
ATC
pantoprazole; systemic
1.5
37.9
3116
26450
3AC01, ,
NOMESCO Finland
6.8
37.7
59
88
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
37.6
655
3902
A10AE05
ATC
insulin detemir; parenteral
2.3
37.1
282
1248
JF1AD
NOMESCO Finland
Small bowel CT
7.0
36.8
56
81
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
100.9
36.7
40
*
J01MA02
ATC
ciprofloxacin; systemic
1.5
36.7
1896
14638
R50.9
ICD-10 Finland
Fever, unspecified
1.7
36.6
720
4439
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
36.4
1391
10085
JFB20
NOMESCO Finland
Ileocaecal resection
7.0
36.4
55
79
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
36.2
1106
7624
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
35.9
794
5051
J01MA12
ATC
levofloxacin; systemic
1.6
35.9
934
6194
5550A
ICD-9 Finland
Regional enteritis, Small intestine
80.7
35.8
40
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.0
35.8
166
575
B81
ICD-10 Finland
Other intestinal helminthiases, not elsewhere classified
59.0
35.2
41
7
JAH01
NOMESCO Finland
Laparoscopy
2.6
34.8
208
823
8145/3-C16.2
ICD-O-3
Carcinoma, diffuse type of body of stomach
95.8
34.7
38
*
A03FA02
ATC
cisapride; oral, rectal
1.9
34.6
444
2399
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
34.4
998
6788
JN4BD
NOMESCO Finland
Extensive body CT
1.8
34.0
522
2989
A10AB04
ATC
insulin lispro; parenteral
3.0
33.8
150
507
28109
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Perniciosa non definita
+∞
33.4
32
*
E61.1
ICD-10 Finland
Iron deficiency
3.9
33.3
97
250
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
33.3
427
2306
SPAT1262
SPAT
Handing over of treatment supplies
1.6
33.2
830
5438
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
33.0
848
5593
E10
ICD-10 Finland
Type 1 diabetes mellitus
4.3
33.0
84
196
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
44.8
32.8
40
9
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
32.7
1097
7700
28110
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Other vitamin B12 deficiency
+∞
32.3
31
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
32.0
563
3355
C16.21
ICD-10 Finland
Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma
88.2
31.7
35
*
A02BX02
ATC
sucralfate; oral
2.2
31.3
262
1206
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
5.9
31.3
56
96
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
31.2
1475
11102
A04
ICPC
Weakness/tiredness general
1.6
31.2
782
5122
R53
ICD-10 Finland
Malaise and fatigue
1.5
31.1
1204
8703
6402
FHL
Small bowel resection
10.1
30.9
35
35
E66.8
ICD-10 Finland
Other obesity
2.5
30.9
205
853
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
30.3
294
1436
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.5
30.1
73
164
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
30.0
749
4895
A10AC01
ATC
insulin (human); parenteral
1.9
30.0
424
2362
D64.8
ICD-10 Finland
Other specified anaemias
3.3
29.8
113
348
A28
ICPC
Limited function/disability NOS
1.5
29.4
1082
7722
C16.34
ICD-10 Finland
Malignant tumor of the antrum ventriculi intestinal carcinoma
37.3
29.3
37
10
XW000
NOMESCO Finland
Bone marrow biopsy
2.3
28.9
217
954
D51.1
ICD-10 Finland
Vitamin B12deficiency anaemia due to selective vitamin B12malabsorption with proteinuria
104.0
28.7
31
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
28.5
624
3942
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.4
28.4
101
299
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.9
28.2
130
449
6403
FHL
Ileocal resection
55.3
28.1
33
6
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
6.0
28.1
49
82
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.8
27.9
84
222
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
9.0
27.7
34
38
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
27.4
242
1139
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
4.1
27.2
74
182
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
38.0
27.1
34
9
H04AA01
ATC
glucagon; nasal, parenteral
3.7
26.7
84
229
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.6
26.7
152
588
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
140.8
26.6
28
*
B01AB05
ATC
enoxaparin; parenteral
1.4
26.6
1423
10893
K29.7
ICD-10 Finland
Gastritis, unspecified
2.4
26.3
186
797
C16.01
ICD-10 Finland
Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma
52.0
26.2
31
6
2809X
ICD-9 Finland
Iron deficiency anaemias, Iron deficiency anaemia, unspecified
+∞
26.1
25
*
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
60.3
26.0
30
5
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.6
25.6
60
131
SPAT1255
SPAT
Intravenous administration of medicine
1.9
25.6
331
1790
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.8
25.4
76
200
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
6.9
25.4
39
57
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
25.4
1244
9355
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.1
25.2
68
166
E87.6
ICD-10 Finland
Hypokalaemia
2.3
25.2
196
876
A41.9
ICD-10 Finland
Sepsis, unspecified
2.2
24.9
212
984
C16.4
ICD-10 Finland
Malignant neoplasm: Pylorus
26.3
24.8
34
13
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
10.1
24.7
28
28
A07DA03
ATC
loperamide; oral
2.3
24.6
194
872
JMA10
NOMESCO Finland
Transabdominal total splenectomy
5.5
24.6
47
86
K91.1
ICD-10 Finland
Postgastric surgery syndromes
24.4
24.3
34
14
D28
ICPC
Limited function/disability (D)
7.9
24.3
33
42
WW500
NOMESCO Finland
Blood transfusion
2.3
24.2
183
807
A10AA01, ,
ATC
2.8
24.2
118
421
28009
ICD-8 Finland
Iron deficiency anaemias, Unspecified
+∞
24.0
23
*
L04AC05
ATC
ustekinumab; parenteral
8.0
23.9
32
40
JN4AD
NOMESCO Finland
Body CT examination
1.6
23.8
536
3401
A10AE06
ATC
insulin degludec; parenteral
2.5
23.7
147
593
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
23.5
247
1243
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.8
23.3
72
194
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
6.1
23.3
40
66
A29
ICPC
General symptom/complaint other
1.6
23.2
651
4358
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
23.1
557
3594
C16.5
ICD-10 Finland
Malignant neoplasm: Lesser curvature of stomach, unspecified
45.2
22.3
27
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
22.3
802
5662
2811A
ICD-9 Finland
Other deficiency anaemias, Other vitamin B12 deficiency anaemia
+∞
21.9
21
*
SPAT1263
SPAT
Sampling
1.4
21.8
1721
13956
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
7.9
21.3
29
37
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
21.1
732
5121
N02BE01
ATC
paracetamol; systemic, rectal
1.5
20.9
3972
36781
JDD96
NOMESCO Finland
Total gastrectomy with other reconstruction
60.3
20.9
24
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
20.9
519
3372
C16.31
ICD-10 Finland
Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma
+∞
20.8
20
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
20.8
762
5391
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.8
20.7
103
372
K90.0
ICD-10 Finland
Coeliac disease
2.5
20.7
128
516
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
20.7
2761
24144
A10BH01
ATC
sitagliptin; oral
1.7
20.7
447
2805
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
6.2
20.6
35
57
N03AX16
ATC
[U] pregabalin
1.4
20.5
963
7146
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
20.5
380
2290
8480/3-C16.9
ICD-O-3
Mucinous adenocarcinoma of stomach, NOS
25.6
20.4
28
11
J01DB01
ATC
cefalexin; oral
1.4
20.2
3488
31638
A10BA02
ATC
metformin; oral
1.4
20.2
1335
10497
105
Kela drug reimbursment
Adrenal cortical hypofunction
8.4
20.1
26
31
N02AA05
ATC
oxycodone; systemic
1.4
20.1
960
7141
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.0
20.1
208
1041
WVA20
NOMESCO Finland
Medicine administration
2.5
20.1
130
536
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
20.0
1433
11411
ZXD05
NOMESCO Finland
Urgent procedure
1.4
20.0
1278
9993
AA1AD
NOMESCO Finland
CT of head and brain
1.4
20.0
1408
11183
EBA00
NOMESCO Finland
Extraction of tooth
1.4
19.9
1351
10665
WX002
NOMESCO Finland
Sedation and analgesia
1.5
19.9
831
6029
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
5.2
19.8
40
77
2800A
ICD-9 Finland
Iron deficiency anaemias, Secondary to blood loss (chronic)
+∞
19.8
19
*
2810A
ICD-9 Finland
Other deficiency anaemias, Pernicious anaemia[ANAEMIA PERNICIOSA CUM MYELOPATHIA SPINALI]
+∞
19.8
19
*
D51.2
ICD-10 Finland
Transcobalamin II deficiency
73.8
19.7
22
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.5
19.7
119
475
K56.7
ICD-10 Finland
Ileus, unspecified
2.7
19.7
108
411
QBJ30
NOMESCO Finland
Correction of abdominal apron
5.2
19.5
40
78
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
19.5
1220
9499
A11CC03
ATC
alfacalcidol; systemic
2.5
19.3
122
498
T90
ICPC
Diabetes non-insulin dependent
1.4
19.2
1074
8203
8144/3-C16.2
ICD-O-3
Adenocarcinoma, intestinal type of body of stomach
46.2
19.2
23
5
H3600, E103,
ICD-10 Finland
4.4
19.1
47
107
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
19.1
489
3197
E86
ICD-10 Finland
Volume depletion
2.2
19.1
159
732
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
55.2
18.9
22
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
18.9
445
2852
N02AX02
ATC
tramadol; systemic, rectal
1.3
18.8
1864
15540
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.2
18.8
155
710
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
18.8
161
750
8144/3-C16.9
ICD-O-3
Adenocarcinoma, intestinal type of stomach, NOS
27.9
18.7
25
9
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
4.9
18.7
41
85
P01AB01
ATC
metronidazole; oral, rectal
1.3
18.6
1545
12549
H02AB06
ATC
prednisolone; systemic
1.3
18.6
2066
17493
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.6
18.6
61
172
E03
ICD-10 Finland
Other hypothyroidism
1.9
18.6
256
1413
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
5.4
18.5
36
67
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
18.3
320
1896
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
18.2
311
1829
A10AB01
ATC
insulin (human); parenteral
2.2
18.2
150
687
E0000UV, ,
ATC
1.3
18.2
1697
14006
2449X
ICD-9 Finland
Acquired hypothyroidism, Unspecified hypothyroidism
7.5
18.2
26
35
H02AB09
ATC
hydrocortisone; systemic
2.6
18.2
102
393
Z93.2
ICD-10 Finland
Ileostomy status
6.1
18.1
31
51
R4110
NOMESCO Finland
Physiotherapy
1.4
18.1
1157
9024
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
18.1
1531
12463
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.1
18.0
164
782
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
18.0
269
1522
B03XA02
ATC
darbepoetin alfa; parenteral
2.5
18.0
109
436
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
17.9
694
4954
R06.0
ICD-10 Finland
Dyspnoea
1.4
17.9
1236
9753
N06AX11
ATC
mirtazapine; oral
1.3
17.9
1400
11261
H02AB07
ATC
prednisone; oral
1.5
17.8
615
4289
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
18.1
17.7
27
15
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.7
17.7
40
85
C16.22
ICD-10 Finland
Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma
66.8
17.7
20
*
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
17.6
446
2907
L80
ICD-10 Finland
Vitiligo
6.3
17.5
29
46
L01BB02
ATC
mercaptopurine; oral
4.4
17.5
43
98
A07AA02
ATC
nystatin; oral
1.8
17.5
286
1663
K02.1
ICD-10 Finland
Caries of dentine
1.3
17.4
2055
17491
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
17.2
206
1086
WX892
NOMESCO Finland
Monitored bed care
1.7
17.1
333
2030
J02AC01
ATC
fluconazole; systemic
1.3
17.1
1405
11362
Z2221
NOMESCO Finland
Medical doctor
1.4
17.0
1088
8470
T86
ICPC
Hypothyroidism/myxoedema
2.0
17.0
197
1026
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
7.5
17.0
24
32
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
5.5
16.9
32
58
E000001, ,
ATC
1.4
16.9
769
5654
H3603, E103,
ICD-10 Finland
4.8
16.8
37
77
D94
ICPC
Chronic enteritis/ulcerative colitis
4.6
16.8
39
85
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.0
16.7
74
251
Z3226
NOMESCO Finland
Physiotherapist
1.4
16.7
754
5533
B55
ICPC
Blood and Immunity, Local injection/infiltration
35.1
16.6
21
6
A10BB12
ATC
glimepiride; oral
1.6
16.6
384
2448
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
3.8
16.6
50
133
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
16.5
775
5725
JFF10
NOMESCO Finland
Loop enterostomy
4.6
16.5
39
86
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
16.5
302
1812
M05BA04
ATC
alendronic acid; oral
1.5
16.4
471
3156
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
4.3
16.4
42
99
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.8
16.4
238
1336
C07AB07
ATC
bisoprolol; oral
1.3
16.3
2384
20803
R42
ICD-10 Finland
Dizziness and giddiness
1.4
16.3
1095
8585
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
16.3
316
1927
K86.1
ICD-10 Finland
Other chronic pancreatitis
3.7
16.2
50
135
A10BH05
ATC
linagliptin; oral
1.8
16.2
262
1518
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
16.1
172
871
A04AA02
ATC
granisetron; systemic, transdermal
1.8
16.1
264
1536
K92.1
ICD-10 Finland
Melaena
1.8
16.0
264
1538
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
16.0
1503
12366
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
16.0
890
6770
JKB00
NOMESCO Finland
Incision of bile duct
6.2
15.9
27
44
A01AB09
ATC
miconazole; local oral
1.6
15.8
399
2596
K08.3
ICD-10 Finland
Retained dental root
1.7
15.8
328
2034
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
14.5
15.8
26
18
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
15.7
1639
13668
S97
ICPC
Chronic ulcer skin
1.7
15.6
313
1923
R13
ICD-10 Finland
Dysphagia
1.7
15.6
327
2033
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
15.6
244
1400
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
19.2
15.5
23
12
T55
ICPC
Metabolic, Local injection/infiltration
22.1
15.5
22
10
JFF00
NOMESCO Finland
Catheter enterostomy
22.1
15.5
22
10
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
15.5
284
1705
D11
ICPC
Diarrhoea
1.6
15.4
404
2652
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
15.4
1176
9388
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
15.4
526
3658
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.5
15.3
52
150
L01BC53
ATC
tegafur, combinations; systemic
14.8
15.3
25
17
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.9
15.3
185
979
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
6.7
15.3
24
36
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
3.2
15.3
59
185
256, ,
Kela drug reimbursment
16.1
15.2
24
15
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.3
15.2
113
497
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
15.1
364
2342
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
15.1
195
1054
L04AB04
ATC
adalimumab; parenteral
2.8
15.1
74
266
WX704
NOMESCO Finland
Intubation
1.7
15.1
313
1941
E66.9
ICD-10 Finland
Obesity, unspecified
2.2
15.1
127
588
L28
ICPC
Limited function/disability (L)
1.4
15.1
960
7452
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.8
15.1
224
1266
UJC12
NOMESCO Finland
Flexible oesophagoscopy
3.6
15.0
49
138
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.9
15.0
188
1007
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
14.9
1218
9807
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
14.9
1165
9322
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
3.3
14.9
54
163
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
4.0
14.8
42
107
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
14.8
293
1796
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
4.2
14.8
38
90
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
5.9
14.8
26
44
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
3.4
14.6
51
150
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
14.6
66
227
L95
ICPC
Osteoporosis
1.9
14.6
193
1052
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
14.5
985
7714
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
14.5
723
5388
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
3.4
14.5
52
156
C16.32
ICD-10 Finland
Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma
150.4
14.5
15
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.6
14.4
82
319
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.2
14.4
113
509
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.9
14.3
193
1058
E83.51
ICD-10 Finland
Hypocalcemia
4.0
14.3
40
101
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
14.3
433
2935
J01CA08
ATC
pivmecillinam; oral
1.3
14.2
1636
13774
JN4CD
NOMESCO Finland
Very extensive body CT
1.9
14.1
165
863
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
14.1
438
2986
J01FF01
ATC
clindamycin; systemic
1.3
14.1
1047
8311
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.2
14.0
121
566
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.7
13.9
258
1554
N18.8
ICD-10 Finland
Other chronic renal failure
2.2
13.9
122
575
H01CB02
ATC
octreotide; parenteral
6.0
13.8
24
40
A02BC03
ATC
lansoprazole; oral
1.3
13.8
1233
10034
8144/3-C16.3
ICD-O-3
Adenocarcinoma, intestinal type of gastric antrum
53.5
13.8
16
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
13.8
171
913
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
13.8
824
6324
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
3.3
13.8
50
151
WX402
NOMESCO Finland
General anaesthesia
1.4
13.7
766
5817
N30.0
ICD-10 Finland
Acute cystitis
1.4
13.7
733
5527
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
13.7
100
437
A04AA01
ATC
ondansetron; systemic, rectal
1.6
13.7
326
2093
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
13.6
353
2312
Z71.8
ICD-10 Finland
Other specified counselling
1.3
13.6
1230
10027
D50.1
ICD-10 Finland
Sideropenic dysphagia
+∞
13.5
13
*
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
5.4
13.5
26
48
8145/3-C16.0
ICD-O-3
Carcinoma, diffuse type of cardia, NOS
34.1
13.5
17
5
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
13.5
1476
12329
C16.13
ICD-10 Finland
Malignant tumor of the fundus ventriculi diffuse carcinoma
140.4
13.4
14
*
B78
ICPC
Hereditary haemolytic anaemia
16.2
13.4
21
13
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
13.4
1945
16809
L04AX03
ATC
methotrexate; systemic
1.6
13.3
341
2227
M05BX04
ATC
denosumab; parenteral
1.6
13.2
300
1903
Z3231
NOMESCO Finland
Registered nurse
1.3
13.2
1120
9044
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.2
13.1
34
81
D06
ICPC
Abdominal pain localized other
1.6
13.1
327
2122
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
5.5
13.0
25
46
A01AB04
ATC
amphotericin B; local oral
1.7
13.0
232
1384
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.9
12.9
174
955
C03DA01
ATC
spironolactone; oral
1.4
12.9
596
4380
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
12.9
223
1319
TPH04, ,
SPAT
2.9
12.8
58
200
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
12.8
191
1081
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
3.9
12.8
37
96
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
12.7
1208
9893
B28
ICPC
Limited function/disability (B)
4.2
12.7
33
79
TK800
NOMESCO Finland
Hemodialysis
2.4
12.7
85
358
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
4.4
12.6
31
71
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
5.5
12.6
24
44
SPAT1325
SPAT
Vaccination
1.3
12.6
1446
12131
SPAT1088
SPAT
Blood transfusion
4.1
12.5
33
80
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
12.5
328
2155
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
12.4
713
5430
ZXC86
NOMESCO Finland
Use of endoscopic device
4.3
12.4
31
72
A02BA02
ATC
ranitidine; systemic
1.3
12.4
893
7042
N19
ICD-10 Finland
Unspecified kidney failure
1.8
12.4
199
1153
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
12.3
287
1833
A01
ICPC
Pain general/multiple sites
1.5
12.3
418
2900
SPAT1310
SPAT
Counselling related to known health issue
1.3
12.3
1204
9894
JDC10
NOMESCO Finland
Partial gastrectomy and gastrojejunostomy
11.6
12.3
22
19
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
12.2
405
2795
SFA10
NOMESCO Finland
One-surface restoration
1.2
12.2
1917
16663
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.0
12.2
124
619
L01BA01
ATC
methotrexate; systemic
1.9
12.2
146
772
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
12.1
598
4442
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
12.1
824
6438
JKB20
NOMESCO Finland
Intraoperative cholangioscopy
6.0
12.1
21
35
SFA30
NOMESCO Finland
Three-surface restoration
1.3
12.1
1483
12526
E03.8
ICD-10 Finland
Other specified hypothyroidism
5.2
12.0
24
46
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.1
12.0
118
582
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.2
12.0
98
450
H02AA02
ATC
fludrocortisone; oral
2.9
11.9
55
192
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
11.9
326
2160
L17
ICPC
Foot/toe symptom/complaint
1.3
11.9
1200
9892
6321
FHL
Subtotal gastrectomy (also includes oment and spleen removal)
46.8
11.9
14
*
SPAT1301
SPAT
No procedures
1.3
11.8
1305
10875
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.5
11.8
73
296
R55
ICD-10 Finland
Syncope and collapse
1.4
11.8
533
3900
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
11.8
313
2062
6318
FHL
Resection (2/3) and gastrojejunostomy (including Roux-Y)
10.5
11.7
22
21
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
11.7
1899
16541
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
11.7
1220
10095
8145/3-C16.3
ICD-O-3
Carcinoma, diffuse type of gastric antrum
30.1
11.6
15
5
1514C
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]
65.1
11.6
13
*
A10BG03
ATC
pioglitazone; oral
2.1
11.6
104
496
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
11.6
1692
14566
E87.5
ICD-10 Finland
Hyperkalaemia
2.1
11.6
102
483
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
11.5
586
4373
A06AD11
ATC
lactulose; oral
1.3
11.5
801
6276
-1, ,
ICPC
1.9
11.5
148
802
K55.8
ICD-10 Finland
Other vascular disorders of intestine
9.2
11.5
23
25
A10AA02, ,
ATC
1.8
11.4
158
875
T28
ICPC
Limited function/disability (T)
2.9
11.4
51
175
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
11.4
965
7770
K22.2
ICD-10 Finland
Oesophageal obstruction
2.9
11.3
53
187
SPAT1260
SPAT
Consultation of another employee
1.4
11.3
677
5188
5559X
ICD-9 Finland
Regional enteritis, Unspecified site
35.1
11.3
14
*
C16.02
ICD-10 Finland
Malignant tumor of cardiac early intestinal gastric carcinoma
35.1
11.3
14
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
11.2
462
3323
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.6
11.2
63
244
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
9.6
11.2
22
23
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
11.2
297
1956
384
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
25.1
11.1
15
6
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
11.1
1550
13257
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
11.1
234
1459
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.7
11.1
58
217
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
11.1
374
2591
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
11.0
199
1191
K56.0
ICD-10 Finland
Paralytic ileus
2.8
11.0
52
184
253, ,
Kela drug reimbursment
10.0
11.0
21
21
3042, ,
Kela drug reimbursment
10.0
11.0
21
21
ZXE00
NOMESCO Finland
One hour or less
1.2
11.0
1507
12863
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
4.5
10.9
26
58
1370
FHL
Colonoscopy, whole colon
3.7
10.9
34
93
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.4
10.9
71
296
N05CF01
ATC
zopiclone; oral
1.3
10.8
1451
12349
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
10.8
800
6322
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.6
10.8
252
1612
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
10.8
181
1063
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.0
10.7
30
76
D55
ICPC
Digestive, Local injection/infiltration
28.1
10.7
14
5
C16.10
ICD-10 Finland
Malignant tumor of the fundus ventriculi without histology
28.1
10.7
14
5
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
28.1
10.7
14
5
5551A
ICD-9 Finland
Regional enteritis, Large intestine
21.5
10.7
15
7
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1.8
10.7
164
939
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
10.6
155
873
R10.0
ICD-10 Finland
Acute abdomen
1.9
10.6
126
665
Z51.5
ICD-10 Finland
Palliative care
1.4
10.6
441
3178
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
10.6
296
1972
56096
ICD-8 Finland
Intestinal obstruction without mention of hernia, Ileus propter adhaesionem (functione laesa circulationis intestinalis non indicata)
5.3
10.6
21
40
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
3.4
10.5
36
105
S22
ICPC
Nail symptom/complaint
1.6
10.5
260
1684
K29.6
ICD-10 Finland
Other gastritis
2.6
10.5
58
223
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
10.5
412
2939
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
1.9
10.5
127
675
A07EA02
ATC
hydrocortisone; rectal
2.2
10.5
81
364
UKC02
NOMESCO Finland
Cystoscopy
1.3
10.5
761
5995
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
4.6
10.5
24
52
N06AX03
ATC
mianserin; oral
1.7
10.4
192
1156
UJD10, ,
SPAT
2.1
10.4
98
476
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
10.4
972
7915
15199
ICD-8 Finland
Malignant neoplasm of stomach, Part unspecified
110.3
10.4
11
*
28000
ICD-8 Finland
Iron deficiency anaemias, Posthaemorrhagica
+∞
10.4
10
*
L04AD02
ATC
tacrolimus; systemic
3.7
10.4
32
87
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.4
10.4
67
278
A03
ICPC
Fever
1.4
10.3
505
3742
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.9
10.3
46
158
P03
ICPC
Feeling depressed
1.6
10.3
251
1621
A11CC02
ATC
dihydrotachysterol; oral
5.1
10.3
21
41
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
2.6
10.3
58
226
Z02.7
ICD-10 Finland
Issue of medical certificate
1.5
10.2
295
1978
A12AA04
ATC
calcium carbonate; oral
2.4
10.2
68
286
N06AX21
ATC
duloxetine; oral
1.4
10.2
407
2910
R4120
NOMESCO Finland
Occupational therapy
1.6
10.2
243
1561
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.6
10.2
56
215
P01BA02
ATC
hydroxychloroquine; oral
1.5
10.2
291
1949
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.5
10.1
61
245
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
10.1
315
2146
E34.0
ICD-10 Finland
Carcinoid syndrome
5.3
10.1
20
38
K65.0
ICD-10 Finland
Acute peritonitis
2.5
10.1
60
240
J01DA01
ATC
[U] cefalexin
1.2
10.0
2558
23213
H02AB04
ATC
methylprednisolone; systemic
1.4
10.0
563
4269
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
10.0
1788
15661
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
40.1
10.0
12
*
RD250, ,
NOMESCO Finland
40.1
10.0
12
*
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.5
10.0
313
2138
H02AB02
ATC
dexamethasone; systemic
1.4
9.9
445
3250
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.6
9.9
32
90
R60.0
ICD-10 Finland
Localized oedema
1.4
9.9
559
4240
SPAT1216
SPAT
Assessment of functional ability
1.3
9.9
734
5796
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
4.1
9.9
26
63
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.0
9.9
43
146
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.7
9.8
30
81
OAB50, ,
SPAT
1.5
9.8
303
2061
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
12.2
9.8
17
14
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
5.1
9.8
20
39
R52.2
ICD-10 Finland
Other chronic pain
1.8
9.8
139
777
S72.1
ICD-10 Finland
Pertrochanteric fracture
1.8
9.8
142
799
RD160, ,
NOMESCO Finland
8.1
9.8
21
26
T44
ICPC
Metabolic, Preventive immunization/medic
26.1
9.8
13
5
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.0
9.8
105
536
ZXA05
NOMESCO Finland
Left side
1.3
9.8
1057
8758
2859X
ICD-9 Finland
Other and unspecified anaemias, Anaemia, unspecified[ANAEMIA NUD]
4.5
9.8
23
51
N03AX12
ATC
[U] gabapentin; oral
1.3
9.8
605
4655
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.2
9.7
78
356
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
9.7
919
7492
J01EA01
ATC
trimethoprim; systemic
1.3
9.7
1135
9490
ZY010
NOMESCO Finland
Hospital outpatient
1.8
9.7
141
795
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.9
9.7
116
615
D99
ICPC
Disease digestive system other
2.8
9.7
46
164
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
9.6
239
1551
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
9.6
210
1322
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
9.6
221
1409
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.9
9.6
126
688
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
9.6
483
3597
TPX15
NOMESCO Finland
Removal of vascular injection port
4.3
9.6
24
56
JAD10
NOMESCO Finland
Repair of incisional hernia
3.0
9.6
41
138
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
9.5
734
5825
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
2.5
9.5
58
235
UJK02
NOMESCO Finland
ERCP
1.8
9.4
127
699
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.0
9.4
103
529
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
9.4
150
868
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
3.3
9.4
34
103
C16.14
ICD-10 Finland
Malignant tumor of the fundus ventriculi intestinal carcinoma
100.2
9.4
10
*
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
30.1
9.4
12
*
8140/3-C16.3
ICD-O-3
Adenocarcinoma, NOS, of gastric antrum
30.1
9.4
12
*
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.6
9.4
193
1197
28008
ICD-8 Finland
Iron deficiency anaemias, Alia definita
+∞
9.4
9
*
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
4.2
9.4
24
57
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.7
9.3
149
864
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
4.0
9.3
26
66
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.3
9.3
71
318
K85
ICD-10 Finland
Acute pancreatitis
2.2
9.3
73
331
5609X
ICD-9 Finland
Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction
4.7
9.3
21
45
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
8.7
9.3
19
22
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
9.3
114
610
S29
ICPC
Skin symptom/complaint other
1.3
9.3
794
6388
R33
ICD-10 Finland
Retention of urine
1.4
9.2
402
2920
S72.0
ICD-10 Finland
Fracture of neck of femur
1.5
9.2
247
1630
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.6
9.2
29
80
K80.8
ICD-10 Finland
Other cholelithiasis
2.2
9.2
77
358
S72.2
ICD-10 Finland
Subtrochanteric fracture
2.6
9.2
52
203
B04AD01, ,
ATC
7.3
9.2
21
29
N18.0
ICD-10 Finland
End-stage renal disease
2.6
9.2
53
209
H05AA02
ATC
teriparatide; parenteral
3.7
9.1
28
76
D07AC01
ATC
betamethasone; topical
1.2
9.1
1426
12291
A03DA02
ATC
pitofenone and analgesics; systemic
1.9
9.1
103
536
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
9.1
457
3404
E66.01
ICD-10 Finland
Obesity due to excess calories
1.5
9.1
249
1654
JLC10
NOMESCO Finland
Distal pancreatectomy
4.8
9.0
20
42
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
9.0
286
1957
WX290
NOMESCO Finland
Other blockage of nerve
1.2
9.0
1410
12149
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
10.0
9.0
17
17
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
9.0
731
5840
K51.8
ICD-10 Finland
Other ulcerative colitis
2.6
9.0
51
200
R02
ICPC
Shortness of breath/dyspnoea
1.3
8.9
548
4207
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
8.9
67
298
R4180, ,
SPAT
2.5
8.9
54
218
205
Kela drug reimbursment
Chronic hypertension
1.2
8.9
1400
12067
5351A
ICD-9 Finland
Gastritis and duodenitis, Atrophic gastritis[GASTRITIS ATROPHICANS CORPORIS (TYPUS A)]
24.0
8.9
12
5
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.3
8.9
630
4941
D87
ICPC
Stomach function disorder
4.3
8.9
22
51
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.3
8.8
559
4311
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.8
2533
23120
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
8.8
194
1224
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.9
8.8
101
528
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
1.7
8.8
140
811
E87.2
ICD-10 Finland
Acidosis
3.5
8.8
29
83
M13.9
ICD-10 Finland
Arthritis, unspecified
1.5
8.8
258
1739
J01MA14
ATC
moxifloxacin; systemic
1.4
8.8
347
2479
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
8.8
696
5541
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
8.7
889
7301
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.7
729
5841
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.7
2888
26699
JFB30
NOMESCO Finland
Right hemicolectomy
2.2
8.7
69
314
2662A
ICD-9 Finland
Deficiency of B-complex components, Other B-complex deficiencies[HYPOVITAMINOSIS B12]
50.1
8.7
10
*
N06AA09
ATC
amitriptyline; systemic
1.4
8.6
380
2767
Z01.2
ICD-10 Finland
Dental examination
1.2
8.6
1520
13245
N20.1
ICD-10 Finland
Calculus of ureter
1.7
8.6
139
809
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.6
8.6
206
1327
M10.9
ICD-10 Finland
Gout, unspecified
1.5
8.6
302
2110
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.7
8.6
159
961
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.6
8.6
174
1077
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
8.2
8.6
18
22
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.4
8.5
395
2900
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
8.5
110
598
WZC30
NOMESCO Finland
Teaching
1.3
8.5
602
4716
N06AB04
ATC
citalopram; systemic
1.3
8.5
803
6535
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
1.9
8.5
95
493
SFA20
NOMESCO Finland
Two-surface restoration
1.2
8.5
1947
17391
TJF00
NOMESCO Finland
Insertion of jejunal tube
20.0
8.5
12
6
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.1
8.4
77
371
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
8.4
1144
9700
M04AA01
ATC
allopurinol; systemic
1.3
8.4
630
4973
L03AA02
ATC
filgrastim; parenteral
1.8
8.4
110
601
1512C
ICD-9 Finland
Malignant neoplasm of stomach, Pyloric antrum[MAHASYÖPÄ, ANTRI PYLORI DIFFUUSI KARSINOOMA]
90.2
8.4
9
*
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.4
8.4
402
2968
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.5
8.4
283
1961
A10BD03
ATC
metformin and rosiglitazone; systemic
2.2
8.4
69
319
R06AE07
ATC
cetirizine; oral
1.2
8.4
1561
13665
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.7
8.4
164
1006
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
8.4
173
1076
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.9
8.4
108
588
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
3.4
8.3
29
86
D77
ICPC
Malignant digestive neopl other/NOS
3.4
8.3
29
86
K83.0
ICD-10 Finland
Cholangitis
2.2
8.3
69
321
ZXA10
NOMESCO Finland
Bilateral
1.3
8.3
759
6154
S19
ICPC
Skin injury other
1.7
8.3
157
956
WX610
NOMESCO Finland
Patient controlled analgesia
3.5
8.2
27
77
K81.0
ICD-10 Finland
Acute cholecystitis
1.9
8.2
97
513
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
14.5
8.2
13
9
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
8.2
1068
9018
-1, ,
NOMESCO Finland
1.2
8.2
1036
8720
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
3.1
8.1
33
108
U07
ICPC
Urine symptom/complaint other
1.4
8.1
350
2540
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.8
8.1
122
697
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.4
8.1
383
2824
L04AG05
ATC
vedolizumab; parenteral
8.1
8.1
17
21
5608A
ICD-9 Finland
Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]
3.8
8.1
24
64
WYA10
NOMESCO Finland
Emergency care or similar visit
1.5
8.0
222
1477
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
2.8
8.0
39
141
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
8.0
553
6995
K30
ICD-10 Finland
Functional dyspepsia
1.4
8.0
392
2905
JCC30
NOMESCO Finland
Transthoracic partial oesophagectomy with interposition of intestine
22.0
8.0
11
5
UKB02
NOMESCO Finland
Retrograde ureteroscopy
2.6
8.0
44
170
SPAT1284
SPAT
Extensive health certificate
1.9
8.0
91
476
Y0599
ICD-8 Finland
Investigation of digestive system
2.0
8.0
80
400
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.4
8.0
393
2917
KMAK, ,
NOMESCO Finland
1.2
7.9
1691
14973
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.8
7.9
39
142
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
7.9
1511
13241
N17.8
ICD-10 Finland
Other acute renal failure
2.3
7.9
57
250
SPAT1104
SPAT
Monitoring of emergency patient
1.5
7.9
253
1737
A10BG02
ATC
rosiglitazone; oral
2.2
7.9
66
308
L04AA33
ATC
[U] vedolizumab
13.0
7.9
13
10
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
4.6
7.9
18
39
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
7.9
174
1101
A10BX04
ATC
[U] exenatide
2.7
7.8
39
143
ZX120, ,
SPAT
2.2
7.8
59
264
K50
ICPC
Cardiovascular, Medication/prescr/renewal
3.4
7.8
27
80
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.8
2250
20461
D07AD01
ATC
clobetasol; topical
1.3
7.8
595
4712
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.3
7.8
465
3558
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
7.7
122
706
B01AB10
ATC
tinzaparin; parenteral
1.4
7.7
397
2965
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.7
479
3683
A99
ICPC
Disease/condition unspecnature/site
1.4
7.7
398
2975
6561
FHL
Removal of fasteners and related measures
4.2
7.7
20
48
C16.6
ICD-10 Finland
Malignant neoplasm: Greater curvature of stomach, unspecified
15.0
7.7
12
8
Z51.88
ICD-10 Finland
Other specified medical care
1.9
7.7
88
461
D07AC13
ATC
mometasone; topical
1.2
7.7
1071
9097
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.8
7.7
105
583
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.7
1254
10824
M05BA07
ATC
risedronic acid; oral
1.7
7.7
147
898
U02
ICPC
Urinary frequency/urgency
1.3
7.6
560
4408
L29.9
ICD-10 Finland
Pruritus, unspecified
1.8
7.6
106
591
SGA04
NOMESCO Finland
Opening and preparing the root canals, extremely complicated
1.4
7.6
286
2024
N05AH04
ATC
quetiapine; oral
1.3
7.6
585
4634
EBA30
NOMESCO Finland
Extraction of root of tooth
1.5
7.6
220
1479
L13.0
ICD-10 Finland
Dermatitis herpetiformis
3.7
7.6
23
62
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
1.9
7.6
87
456
8140/3-C16.2
ICD-O-3
Adenocarcinoma, NOS, of body of stomach
18.4
7.6
11
6
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.4
7.6
285
2019
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.8
7.6
98
535
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
7.5
373
2770
L12
ICPC
Hand/finger symptom/complaint
1.3
7.5
580
4595
D10
ICPC
Vomiting
1.7
7.5
135
810
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
7.5
691
5599
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
7.5
469
3610
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.0
7.5
32
108
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.2
7.5
19
45
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.0
7.5
74
369
A46
ICD-10 Finland
Erysipelas
1.3
7.4
616
4926
D52.8
ICD-10 Finland
Other folate deficiency anaemias
80.2
7.4
8
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
2.1
7.4
66
316
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
7.4
1425
12483
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
3.5
7.4
24
68
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
7.4
302
2172
318
Kela drug reimbursment
Teriparatide
3.2
7.4
28
88
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
7.3
683
5544
BEF00, ,
SPAT
2.8
7.3
35
126
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.3
7.3
51
221
5793A
ICD-9 Finland
Intestinal malabsorption, Other and unspecified postsurgical nonabsorption[SHORT BOWEL SYNDROME]
+∞
7.3
7
*
28199
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Other and unspecified deficiency anaemia
+∞
7.3
7
*
JD003
NOMESCO Finland
Adjuvant radiotherapy of gastric or duodenal tumor
+∞
7.3
7
*
6101
FHL
Exploratory laparotomy, includes possible biopases
3.6
7.3
23
64
W19
ICD-10 Finland
Unspecified fall
1.4
7.2
395
2979
N03AX09
ATC
lamotrigine; oral
1.8
7.2
111
638
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
2.5
7.2
42
167
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
4.3
7.2
18
42
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.8
7.2
35
127
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
2.2
7.2
60
280
D01
ICPC
Abdominal pain/cramps general
1.4
7.2
392
2956
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.3
7.2
49
210
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
7.2
263
1855
UJF34
NOMESCO Finland
Left colonoscopy
2.9
7.1
32
111
D53.9
ICD-10 Finland
Nutritional anaemia, unspecified
30.0
7.1
9
*
L88
ICPC
Rheumatoid/seropositive arthritis
1.6
7.1
139
853
D09
ICPC
Nausea
1.7
7.1
136
830
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.9
7.1
84
445
T87
ICPC
Hypoglycaemia
3.6
7.1
23
65
J01DA09
ATC
[U] cefadroxil
1.2
7.1
951
8034
XF402
NOMESCO Finland
ECG with work load test
1.3
7.1
407
3092
K55.2
ICD-10 Finland
Angiodysplasia of colon
3.3
7.1
25
75
K07
ICPC
Swollen ankles/oedema
1.5
7.1
224
1535
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
2.5
7.1
41
163
A05AA02
ATC
ursodeoxycholic acid; oral
2.3
7.1
50
218
N04BC05
ATC
pramipexole; oral
1.4
7.1
303
2198
Z50.1
ICD-10 Finland
Other physical therapy
1.5
7.1
199
1332
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
8.8
7.0
14
16
SFA00
NOMESCO Finland
Small restoration
1.3
7.0
449
3467
N06AX16
ATC
venlafaxine; oral
1.3
7.0
403
3063
J01MA06
ATC
norfloxacin; oral
1.3
7.0
533
4214
SPAT1229
SPAT
Assessment of need for aid
1.4
7.0
334
2466
N29
ICPC
Neurological sympt/complt other
1.9
7.0
77
399
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
7.0
7.0
16
23
K83.1
ICD-10 Finland
Obstruction of bile duct
2.1
7.0
62
297
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
7.0
463
3595
EBA10
NOMESCO Finland
Operative extraction of tooth
1.4
7.0
313
2289
N28
ICPC
Limited function/disability (N)
2.0
6.9
73
372
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
3.0
6.9
29
97
C08CA01
ATC
amlodipine; oral
1.2
6.9
1742
15608
TQW11
NOMESCO Finland
Vacuum treatment of wound
1.9
6.9
77
401
A02BB01
ATC
misoprostol; oral
2.8
6.9
33
119
A10BD11
ATC
metformin and linagliptin; oral
4.0
6.9
19
48
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.6
6.9
148
932
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
2.9
6.8
30
103
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
6.8
110
642
K61.0
ICD-10 Finland
Anal abscess
2.4
6.8
43
178
NHQ40
NOMESCO Finland
Amputation of toe
1.9
6.8
75
389
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
6.8
165
1069
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
3.8
6.8
20
53
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.3
6.8
50
222
JFA96
NOMESCO Finland
Other local operation on intestine
10.9
6.8
12
11
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
6.8
140
873
L04AA06
ATC
mycophenolic acid; systemic
2.2
6.8
54
248
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
6.8
81
432
K60.3
ICD-10 Finland
Anal fistula
2.2
6.7
51
229
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.3
6.7
48
210
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.4
6.7
42
173
D64
ICD-10 Finland
Other anaemias
5.6
6.7
18
32
E16.19
ICD-10 Finland
Other specified hypoglycaemia
3.6
6.7
21
58
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.6
6.7
156
1000
Z49.2
ICD-10 Finland
Other dialysis
3.1
6.7
27
88
H3601, E103,
ICD-10 Finland
3.1
6.7
27
88
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.8
6.7
92
512
T99
ICPC
Endocr/metab/nutrit disease other
2.1
6.7
61
295
JFC00
NOMESCO Finland
Entero-enterostomy
6.4
6.6
16
25
H26.9
ICD-10 Finland
Cataract, unspecified
2.0
6.6
69
351
K02.2
ICD-10 Finland
Caries of cementum
1.5
6.6
171
1124
WX419
NOMESCO Finland
Other general anesthesy
2.6
6.6
36
139
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
7.8
6.6
14
18
K29
ICPC
Cardiovascular sympt/complt other
1.5
6.6
187
1255
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
6.6
703
5796
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
2.8
6.6
31
111
R51.80
ICD-10 Finland
Headache
1.3
6.6
478
3759
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
3.3
6.5
23
69
SPAT1240
SPAT
Therapeutic discussion
1.4
6.5
253
1804
SGC10
NOMESCO Finland
Pulp capping
1.5
6.5
202
1380
SPAT1281
SPAT
Other administrative function
1.4
6.5
265
1906
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.4
6.5
284
2068
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.7
6.5
102
592
C09AA05
ATC
ramipril; oral
1.2
6.5
1146
9942
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
6.5
422
3270
160
Kela drug reimbursment
exenatide
2.0
6.5
64
320
Z2446
NOMESCO Finland
Social worker
1.5
6.4
206
1416
A02BC01
ATC
omeprazole; systemic
1.2
6.4
1138
9870
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.1
6.4
55
260
K56.2
ICD-10 Finland
Volvulus
2.6
6.4
36
141
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
3.9
6.4
18
46
SPAT1238
SPAT
Brief therapy
2.5
6.4
39
159
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.8
6.4
98
564
4222
FHL
Endonasal etmoidectomy
2.8
6.4
30
107
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
2.8
6.4
30
107
5790A
ICD-9 Finland
Intestinal malabsorption, Coeliac disease
7.4
6.4
14
19
A97
ICPC
No disease
1.2
6.4
731
6070
8144/3-C16.0
ICD-O-3
Adenocarcinoma, intestinal type of cardia, NOS
14.3
6.4
10
7
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
6.4
248
1769
A91
ICPC
Abnormal result investigation NOS
1.5
6.4
201
1378
SPAT1312
SPAT
General health counselling
1.2
6.4
1089
9416
SPAT1252
SPAT
Overall medication plan or its review
1.4
6.3
283
2070
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
1.6
6.3
153
992
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.6
6.3
141
897
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
6.3
207
1431
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.5
6.3
192
1308
T29
ICPC
Endocr/metab/nutr sympt/compl other
1.9
6.3
75
400
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
2.6
6.3
34
131
R52.9
ICD-10 Finland
Pain, unspecified
1.3
6.3
353
2677
JDC11
NOMESCO Finland
Laparoscopic partial gastrectomy and gastrojejunostomy
18.0
6.3
9
5
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.3
6.3
396
3055
28100
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Perniciosa cum myelopathia spinali
+∞
6.2
6
*
15181
ICD-8 Finland
Malignant neoplasm of stomach, Fundi sive corporis ventriculi
+∞
6.2
6
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.3
6.2
44
192
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
6.2
229
1617
AN1
HP
Coronary angiography
1.3
6.2
492
3910
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
3.0
6.2
26
87
CL2S4, ,
SPAT
1.9
6.2
75
402
C01DA14
ATC
isosorbide mononitrate; oral
1.2
6.2
896
7623
E66.0
ICD-10 Finland
Obesity due to excess calories
2.4
6.2
40
168
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
6.2
130
816
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
4.0
6.2
17
43
ZX114
NOMESCO Finland
Intramuscular
2.2
6.2
46
206
E06.3
ICD-10 Finland
Autoimmune thyroiditis
3.2
6.1
23
72
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.3
6.1
366
2800
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
7.7
6.1
13
17
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
6.1
71
376
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.7
6.1
102
603
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.8
6.1
91
521
M79.6
ICD-10 Finland
Pain in limb
1.2
6.1
1616
14502
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
4.1
6.1
16
39
6531B
ICD-9 Finland
Disproportion, Generally contracted pelvis[PELVIS ANGUSTA,SYNNYTYKSEN AIKANA]
4.1
6.1
16
39
C16.1
ICD-10 Finland
Malignant neoplasm: Fundus of stomach
12.5
6.1
10
8
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.7
6.1
106
634
A10BX02
ATC
repaglinide; oral
2.1
6.1
53
253
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
6.1
166
1106
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.0
6.1
57
280
I95.1
ICD-10 Finland
Orthostatic hypotension
1.5
6.0
198
1369
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.4
6.0
39
164
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.6
6.0
119
735

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
hydroxocobalamin
V03AB33 [21605256]
2.8e+00
3.6e+00
4.9e+00
—
5.3e+00
5.6e+00
5.9e+00
cases:9.30%
controls:0.62%
cases:17.06%
controls:0.58%
cases:9.30%
controls:0.08%
—
—
cases:13.44%
controls:0.08%
cases:63.57%
controls:0.65%
cases:76.41%
controls:0.91%
436
291
4254
46444
800
272
3890
46463
436
36
4254
46699
—
628
36
4045
46631
2874
297
1647
45501
2989
371
923
40393
hydroxocobalamin; parenteral
B03BA03 [21601123]
2.8e+00
3.6e+00
4.9e+00
—
5.3e+00
5.6e+00
5.9e+00
cases:9.30%
controls:0.62%
cases:17.06%
controls:0.58%
cases:9.30%
controls:0.08%
—
—
cases:13.44%
controls:0.08%
cases:63.57%
controls:0.65%
cases:76.41%
controls:0.91%
436
291
4254
46444
800
272
3890
46463
436
36
4254
46699
—
628
36
4045
46631
2874
297
1647
45501
2989
371
923
40393
Anaemia vit B12/folate deficiency
B81 [2002000292]
2.8e+00
3.4e+00
4.0e+00
—
4.8e+00
4.2e+00
4.3e+00
cases:4.69%
controls:0.30%
cases:6.40%
controls:0.23%
cases:3.05%
controls:0.06%
—
—
cases:5.97%
controls:0.05%
cases:15.64%
controls:0.27%
cases:24.08%
controls:0.41%
220
138
4470
46597
300
106
4390
46629
143
27
4547
46708
—
279
24
4394
46643
707
125
3814
45673
942
168
2970
40596
Iron deficiency anaemia, unspecified
D50.9 [45605373]
3.5e+00
4.7e+00
4.6e+00
1.0e+50
—
4.4e+00
3.2e+00
cases:2.39%
controls:0.07%
cases:3.16%
controls:0.03%
cases:1.09%
controls:0.01%
cases:2.43%
controls:0.00%
—
—
cases:2.70%
controls:0.03%
cases:4.42%
controls:0.20%
112
35
4578
46700
148
14
4542
46721
51
5
4639
46730
114
0
4576
46735
—
122
15
4399
45783
173
80
3739
40684
Vitamin B12deficiency anaemia, unspecified
D51.9 [45532988]
3.6e+00
4.4e+00
—
1.0e+50
1.0e+50
6.2e+00
5.1e+00
cases:1.07%
controls:0.03%
cases:1.41%
controls:0.02%
—
—
cases:23.20%
controls:0.00%
cases:5.54%
controls:0.00%
cases:8.05%
controls:0.02%
cases:5.57%
controls:0.04%
50
14
4640
46721
66
8
4624
46727
—
1088
0
3602
46735
259
0
4414
46667
364
8
4157
45790
218
15
3694
40749
Other Crohn disease
K50.8 [45533599]
2.7e+00
2.9e+00
3.8e+00
—
2.9e+00
2.9e+00
3.0e+00
cases:1.32%
controls:0.09%
cases:1.13%
controls:0.06%
cases:0.60%
controls:0.01%
—
—
cases:0.49%
controls:0.03%
cases:1.33%
controls:0.07%
cases:2.35%
controls:0.12%
62
41
4628
46694
53
29
4637
46706
28
6
4662
46729
—
23
13
4650
46654
60
34
4461
45764
92
48
3820
40716
Gastroenterology
10 [38004455]
9.7e-01
2.1e+00
3.1e+00
5.7e+00
2.8e+00
2.2e+00
1.4e+00
cases:7.65%
controls:3.05%
cases:9.62%
controls:1.26%
cases:4.69%
controls:0.22%
cases:4.41%
controls:0.01%
cases:3.53%
controls:0.23%
cases:9.98%
controls:1.27%
cases:14.80%
controls:4.09%
359
1426
4331
45309
451
590
4239
46145
220
101
4470
46634
207
7
4483
46728
165
108
4508
46559
451
583
4070
45215
579
1668
3333
39096
Crohn disease of small intestine
K50.0 [45596324]
2.9e+00
3.3e+00
—
1.0e+50
3.5e+00
3.6e+00
3.4e+00
cases:1.22%
controls:0.07%
cases:1.28%
controls:0.05%
—
—
cases:0.30%
controls:0.00%
cases:0.49%
controls:0.01%
cases:1.46%
controls:0.04%
cases:2.22%
controls:0.08%
57
32
4633
46703
60
23
4630
46712
—
14
0
4676
46735
23
7
4650
46660
66
18
4455
45780
87
32
3825
40732
Chronic atrophic gastritis
K29.4 [45567297]
2.9e+00
4.5e+00
—
1.0e+50
—
4.7e+00
4.1e+00
cases:1.83%
controls:0.10%
cases:4.14%
controls:0.05%
—
—
cases:2.26%
controls:0.00%
—
—
cases:4.80%
controls:0.05%
cases:8.23%
controls:0.15%
86
46
4604
46689
194
22
4496
46713
—
106
0
4584
46735
—
217
21
4304
45777
322
62
3590
40702
cyanocobalamin, combinations
B03BA51 [21601126]
1.7e+00
3.4e+00
—
—
—
5.7e+00
5.2e+00
cases:0.32%
controls:0.06%
cases:0.32%
controls:0.01%
—
—
—
—
—
—
cases:4.31%
controls:0.02%
cases:6.57%
controls:0.04%
15
28
4675
46707
15
5
4675
46730
—
—
—
195
7
4326
45791
257
16
3655
40748
cyanocobalamin; nasal, oral, parenteral
B03BA01 [21601121]
1.6e+00
2.3e+00
2.5e+00
—
2.7e+00
3.6e+00
3.0e+00
cases:1.28%
controls:0.26%
cases:2.17%
controls:0.21%
cases:1.17%
controls:0.10%
—
—
cases:1.60%
controls:0.11%
cases:8.23%
controls:0.25%
cases:9.76%
controls:0.54%
60
120
4630
46615
102
99
4588
46636
55
46
4635
46689
—
75
51
4598
46616
372
116
4149
45682
382
219
3530
40545
Anaemia, unspecified
D64.9 [45600610]
1.4e+00
2.6e+00
3.7e+00
—
3.8e+00
2.3e+00
1.3e+00
cases:2.79%
controls:0.69%
cases:4.22%
controls:0.32%
cases:2.15%
controls:0.06%
—
—
cases:1.71%
controls:0.04%
cases:3.41%
controls:0.34%
cases:4.42%
controls:1.24%
131
324
4559
46411
198
151
4492
46584
101
26
4589
46709
—
80
19
4593
46648
154
154
4367
45644
173
505
3739
40259
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
5.9e-01
1.6e+00
3.2e+00
4.1e+00
3.0e+00
1.6e+00
8.6e-01
cases:7.93%
controls:4.54%
cases:10.85%
controls:2.43%
cases:5.82%
controls:0.25%
cases:0.85%
controls:0.01%
cases:4.67%
controls:0.25%
cases:11.97%
controls:2.55%
cases:19.02%
controls:9.08%
372
2124
4318
44611
509
1134
4181
45601
273
118
4417
46617
40
7
4650
46728
218
119
4455
46548
541
1168
3980
44630
744
3700
3168
37064
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.1e+00
2.7e+00
3.7e+00
—
3.5e+00
2.2e+00
1.5e+00
cases:8.10%
controls:2.97%
cases:12.37%
controls:0.92%
cases:4.01%
controls:0.10%
—
—
cases:2.74%
controls:0.09%
cases:7.65%
controls:0.88%
cases:13.32%
controls:3.26%
380
1389
4310
45346
580
428
4110
46307
188
48
4502
46687
—
128
40
4545
46627
346
402
4175
45396
521
1330
3391
39434
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
7.1e-01
1.6e+00
3.0e+00
4.1e+00
3.1e+00
1.3e+00
6.6e-01
cases:3.11%
controls:1.55%
cases:4.88%
controls:1.03%
cases:2.43%
controls:0.13%
cases:0.66%
controls:0.01%
cases:2.44%
controls:0.12%
cases:4.60%
controls:1.29%
cases:9.05%
controls:4.89%
146
725
4544
46010
229
481
4461
46254
114
59
4576
46676
31
5
4659
46730
114
55
4559
46612
208
589
4313
45209
354
1995
3558
38769
Vitamin/nutritional deficiency
T91 [2002001132]
2.6e+00
3.3e+00
1.0e+50
—
1.0e+50
4.3e+00
4.1e+00
cases:0.38%
controls:0.03%
cases:0.41%
controls:0.01%
cases:0.21%
controls:0.00%
—
—
cases:0.28%
controls:0.00%
cases:0.77%
controls:0.01%
cases:1.92%
controls:0.03%
18
13
4672
46722
19
7
4671
46728
10
0
4680
46735
—
13
0
4660
46667
35
5
4486
45793
75
13
3837
40751
Upper gastrointestinal surgery
106 [44777669]
6.5e-01
1.6e+00
3.0e+00
4.0e+00
2.5e+00
1.6e+00
9.5e-01
cases:11.41%
controls:6.28%
cases:12.15%
controls:2.60%
cases:7.36%
controls:0.41%
cases:1.00%
controls:0.02%
cases:5.11%
controls:0.43%
cases:11.37%
controls:2.52%
cases:18.35%
controls:7.99%
535
2935
4155
43800
570
1215
4120
45520
345
193
4345
46542
47
9
4643
46726
239
200
4434
46467
514
1156
4007
44642
718
3258
3194
37506
Other obesity
E66.8 [45533036]
1.8e+00
2.3e+00
3.1e+00
—
2.9e+00
2.3e+00
1.6e+00
cases:1.98%
controls:0.33%
cases:1.75%
controls:0.17%
cases:1.11%
controls:0.05%
—
—
cases:0.51%
controls:0.03%
cases:1.86%
controls:0.19%
cases:2.12%
controls:0.42%
93
153
4597
46582
82
81
4608
46654
52
23
4638
46712
—
24
13
4649
46654
84
86
4437
45712
83
172
3829
40592
Internal Medicine
11 [38004456]
5.9e-01
1.2e+00
2.3e+00
5.6e+00
2.3e+00
1.3e+00
8.0e-01
cases:32.99%
controls:21.45%
cases:24.82%
controls:8.83%
cases:12.28%
controls:1.41%
cases:16.55%
controls:0.07%
cases:12.65%
controls:1.45%
cases:26.61%
controls:9.21%
cases:40.77%
controls:23.63%
1547
10026
3143
36709
1164
4129
3526
42606
576
659
4114
46076
776
34
3914
46701
591
678
4082
45989
1203
4220
3318
41578
1595
9634
2317
31130
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.1e+00
2.0e+00
4.1e+00
1.0e+50
3.8e+00
1.8e+00
1.2e+00
cases:0.98%
controls:0.34%
cases:1.28%
controls:0.17%
cases:0.94%
controls:0.01%
cases:0.36%
controls:0.00%
cases:0.86%
controls:0.02%
cases:0.95%
controls:0.17%
cases:2.20%
controls:0.68%
46
157
4644
46578
60
78
4630
46657
44
7
4646
46728
17
0
4673
46735
40
9
4633
46658
43
76
4478
45722
86
277
3826
40487
Hematology
82 [38004501]
8.6e-01
1.2e+00
1.9e+00
5.3e+00
2.1e+00
1.7e+00
1.0e+00
cases:1.77%
controls:0.76%
cases:1.77%
controls:0.55%
cases:1.17%
controls:0.19%
cases:2.03%
controls:0.01%
cases:1.56%
controls:0.19%
cases:2.81%
controls:0.53%
cases:2.79%
controls:1.02%
83
355
4607
46380
83
259
4607
46476
55
87
4635
46648
95
5
4595
46730
73
90
4600
46577
127
243
4394
45555
109
415
3803
40349
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
9.2e-01
2.5e+00
3.6e+00
—
3.1e+00
2.3e+00
1.5e+00
cases:0.72%
controls:0.29%
cases:1.81%
controls:0.16%
cases:1.13%
controls:0.03%
—
—
cases:0.92%
controls:0.04%
cases:1.73%
controls:0.18%
cases:2.12%
controls:0.47%
34
136
4656
46599
85
73
4605
46662
53
15
4637
46720
—
43
20
4630
46647
78
81
4443
45717
83
192
3829
40572
Dietary counselling and surveillance
Z71.3 [45552101]
1.1e+00
1.8e+00
3.5e+00
—
3.4e+00
2.6e+00
1.4e+00
cases:0.77%
controls:0.26%
cases:0.62%
controls:0.10%
cases:0.64%
controls:0.02%
—
—
cases:0.64%
controls:0.02%
cases:1.42%
controls:0.11%
cases:1.15%
controls:0.28%
36
123
4654
46612
29
48
4661
46687
30
9
4660
46726
—
30
10
4643
46657
64
51
4457
45747
45
115
3867
40649
Stomach Pathology biopsy report
66114-0 [40768797]
9.6e-01
2.6e+00
3.8e+00
1.0e+50
3.2e+00
2.0e+00
1.0e+00
cases:2.88%
controls:1.12%
cases:5.01%
controls:0.40%
cases:0.98%
controls:0.02%
cases:1.60%
controls:0.00%
cases:0.43%
controls:0.02%
cases:2.72%
controls:0.36%
cases:4.17%
controls:1.56%
135
522
4555
46213
235
187
4455
46548
46
10
4644
46725
75
0
4615
46735
20
8
4653
46659
123
166
4398
45632
163
635
3749
40129
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
7.3e-01
2.0e+00
3.5e+00
—
3.6e+00
2.2e+00
1.5e+00
cases:1.41%
controls:0.68%
cases:2.77%
controls:0.38%
cases:2.11%
controls:0.06%
—
—
cases:1.50%
controls:0.04%
cases:2.83%
controls:0.32%
cases:4.42%
controls:1.04%
66
319
4624
46416
130
176
4560
46559
99
29
4591
46706
—
70
19
4603
46648
128
148
4393
45650
173
425
3739
40339
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
6.6e-01
1.4e+00
2.5e+00
4.2e+00
2.2e+00
1.5e+00
9.2e-01
cases:6.82%
controls:3.65%
cases:8.64%
controls:2.31%
cases:3.58%
controls:0.30%
cases:0.72%
controls:0.01%
cases:3.08%
controls:0.36%
cases:9.71%
controls:2.35%
cases:16.87%
controls:7.45%
320
1704
4370
45031
405
1079
4285
45656
168
138
4522
46597
34
5
4656
46730
144
166
4529
46501
439
1078
4082
44720
660
3037
3252
37727
Vitamin B12deficiency anaemia
D51 [45571630]
3.6e+00
—
—
1.0e+50
1.0e+50
5.7e+00
3.9e+00
cases:0.68%
controls:0.02%
—
—
—
—
cases:27.65%
controls:0.00%
cases:2.31%
controls:0.00%
cases:3.05%
controls:0.01%
cases:1.97%
controls:0.04%
32
9
4658
46726
—
—
1297
0
3393
46735
108
0
4565
46667
138
5
4383
45793
77
16
3835
40748
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.5e-01
1.4e+00
3.1e+00
3.1e+00
2.3e+00
1.5e+00
1.0e+00
cases:2.20%
controls:1.27%
cases:2.77%
controls:0.68%
cases:1.75%
controls:0.08%
cases:0.23%
controls:0.01%
cases:1.37%
controls:0.13%
cases:2.99%
controls:0.68%
cases:6.13%
controls:2.24%
103
595
4587
46140
130
320
4560
46415
82
39
4608
46696
11
5
4679
46730
64
62
4609
46605
135
312
4386
45486
240
913
3672
39851
capecitabine
L01BC06 [21601440]
7.7e-01
2.9e+00
2.6e+00
—
3.4e+00
2.8e+00
1.0e+00
cases:0.34%
controls:0.16%
cases:1.56%
controls:0.09%
cases:0.15%
controls:0.01%
—
—
cases:0.92%
controls:0.03%
cases:1.79%
controls:0.11%
cases:0.69%
controls:0.24%
16
74
4674
46661
73
42
4617
46693
7
5
4683
46730
—
43
14
4630
46653
81
50
4440
45748
27
99
3885
40665
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.4e-01
1.5e+00
2.9e+00
4.0e+00
2.1e+00
1.3e+00
5.9e-01
cases:1.41%
controls:1.01%
cases:2.37%
controls:0.54%
cases:1.51%
controls:0.08%
cases:0.58%
controls:0.01%
cases:0.79%
controls:0.10%
cases:2.08%
controls:0.57%
cases:4.14%
controls:2.33%
66
472
4624
46263
111
253
4579
46482
71
39
4619
46696
27
5
4663
46730
37
47
4636
46620
94
260
4427
45538
162
949
3750
39815
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.4e-01
1.2e+00
2.5e+00
3.6e+00
2.3e+00
1.3e+00
7.1e-01
cases:7.31%
controls:4.84%
cases:8.72%
controls:2.74%
cases:5.54%
controls:0.49%
cases:0.92%
controls:0.03%
cases:4.58%
controls:0.48%
cases:10.02%
controls:2.98%
cases:15.95%
controls:8.53%
343
2260
4347
44475
409
1280
4281
45455
260
230
4430
46505
43
12
4647
46723
214
224
4459
46443
453
1365
4068
44433
624
3476
3288
37288
Endocrinology
46 [38004485]
9.4e-01
1.3e+00
1.9e+00
4.1e+00
1.4e+00
1.4e+00
9.2e-01
cases:4.58%
controls:1.85%
cases:3.73%
controls:1.09%
cases:1.71%
controls:0.25%
cases:0.90%
controls:0.01%
cases:0.94%
controls:0.22%
cases:4.34%
controls:1.10%
cases:5.90%
controls:2.43%
215
865
4475
45870
175
508
4515
46227
80
116
4610
46619
42
7
4648
46728
44
105
4629
46562
196
503
4325
45295
231
991
3681
39773
lidocaine, combinations
N01BB52 [21604241]
4.9e-01
1.1e+00
1.9e+00
—
2.7e+00
3.4e+00
2.8e+00
cases:0.81%
controls:0.50%
cases:0.53%
controls:0.18%
cases:0.15%
controls:0.02%
—
—
cases:0.49%
controls:0.03%
cases:4.51%
controls:0.16%
cases:7.03%
controls:0.48%
38
232
4652
46503
25
83
4665
46652
7
10
4683
46725
—
23
15
4650
46652
204
74
4317
45724
275
194
3637
40570
Crohn disease, unspecified
K50.9 [45562490]
2.7e+00
2.9e+00
—
—
—
3.3e+00
2.9e+00
cases:0.85%
controls:0.06%
cases:0.58%
controls:0.03%
—
—
—
—
—
—
cases:0.69%
controls:0.03%
cases:1.20%
controls:0.07%
40
27
4650
46708
27
15
4663
46720
—
—
—
31
12
4490
45786
47
27
3865
40737
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
7.1e-01
1.7e+00
3.5e+00
1.0e+50
3.5e+00
1.7e+00
1.4e+00
cases:0.38%
controls:0.19%
cases:0.49%
controls:0.09%
cases:0.34%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.43%
controls:0.01%
cases:0.42%
controls:0.08%
cases:1.05%
controls:0.26%
18
88
4672
46647
23
44
4667
46691
16
5
4674
46730
6
0
4684
46735
20
6
4653
46661
19
35
4502
45763
41
104
3871
40660
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
6.4e-01
1.7e+00
3.3e+00
—
3.6e+00
1.6e+00
9.4e-01
cases:1.26%
controls:0.67%
cases:1.86%
controls:0.36%
cases:1.28%
controls:0.05%
—
—
cases:1.63%
controls:0.05%
cases:1.90%
controls:0.37%
cases:3.53%
controls:1.41%
59
311
4631
46424
87
169
4603
46566
60
22
4630
46713
—
76
22
4597
46645
86
171
4435
45627
138
575
3774
40189
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
7.9e-01
1.7e+00
3.2e+00
—
3.4e+00
1.6e+00
9.5e-01
cases:2.26%
controls:1.04%
cases:2.88%
controls:0.54%
cases:1.81%
controls:0.07%
—
—
cases:2.08%
controls:0.07%
cases:2.63%
controls:0.55%
cases:5.01%
controls:2.00%
106
486
4584
46249
135
252
4555
46483
85
34
4605
46701
—
97
34
4576
46633
119
253
4402
45545
196
815
3716
39949
Anaemia other/unspecified
B82 [2002000293]
1.7e+00
2.4e+00
2.5e+00
—
—
2.9e+00
2.0e+00
cases:0.68%
controls:0.13%
cases:0.51%
controls:0.04%
cases:0.13%
controls:0.01%
—
—
—
—
cases:0.69%
controls:0.04%
cases:1.35%
controls:0.18%
32
59
4658
46676
24
21
4666
46714
6
5
4684
46730
—
—
31
18
4490
45780
53
73
3859
40691
Medication/prescr/renewal
-50 [2002000121]
1.2e+00
2.1e+00
—
—
3.0e+00
2.8e+00
2.5e+00
cases:0.75%
controls:0.23%
cases:0.43%
controls:0.05%
—
—
—
—
cases:0.21%
controls:0.01%
cases:1.02%
controls:0.06%
cases:2.97%
controls:0.26%
35
107
4655
46628
20
25
4670
46710
—
—
10
5
4663
46662
46
29
4475
45769
116
106
3796
40658
azathioprine; oral, parenteral
L04AX01 [21603927]
1.5e+00
1.6e+00
2.7e+00
—
1.9e+00
2.0e+00
1.9e+00
cases:1.60%
controls:0.38%
cases:1.30%
controls:0.26%
cases:0.62%
controls:0.04%
—
—
cases:0.53%
controls:0.08%
cases:1.75%
controls:0.25%
cases:2.71%
controls:0.40%
75
177
4615
46558
61
121
4629
46614
29
20
4661
46715
—
25
39
4648
46628
79
115
4442
45683
106
163
3806
40601
Office Visit
OMOP4822458 [581477]
4.0e-01
1.1e+00
2.4e+00
3.6e+00
2.3e+00
1.2e+00
5.6e-01
cases:9.96%
controls:6.92%
cases:6.33%
controls:2.11%
cases:2.77%
controls:0.26%
cases:0.60%
controls:0.02%
cases:2.74%
controls:0.30%
cases:6.50%
controls:2.14%
cases:12.17%
controls:7.35%
467
3235
4223
43500
297
988
4393
45747
130
121
4560
46614
28
8
4662
46727
128
138
4545
46529
294
981
4227
44817
476
2996
3436
37768
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
8.9e-01
1.7e+00
3.1e+00
—
2.9e+00
1.7e+00
1.1e+00
cases:5.37%
controls:2.29%
cases:6.61%
controls:1.26%
cases:2.32%
controls:0.11%
—
—
cases:2.93%
controls:0.17%
cases:6.57%
controls:1.27%
cases:12.93%
controls:4.53%
252
1070
4438
45665
310
590
4380
46145
109
50
4581
46685
—
137
78
4536
46589
297
581
4224
45217
506
1848
3406
38916
Bacteria identified in Blood by Culture
600-7 [3023368]
4.1e-01
9.2e-01
2.3e+00
4.4e+00
1.9e+00
9.4e-01
5.5e-01
cases:3.80%
controls:2.56%
cases:3.18%
controls:1.29%
cases:1.88%
controls:0.18%
cases:0.83%
controls:0.01%
cases:1.41%
controls:0.22%
cases:3.61%
controls:1.43%
cases:8.46%
controls:5.06%
178
1196
4512
45539
149
603
4541
46132
88
86
4602
46649
39
5
4651
46730
66
102
4607
46565
163
657
4358
45141
331
2063
3581
38701
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.0e-01
1.1e+00
2.1e+00
4.0e+00
2.0e+00
1.1e+00
6.1e-01
cases:7.95%
controls:5.47%
cases:9.25%
controls:3.28%
cases:5.05%
controls:0.65%
cases:1.30%
controls:0.02%
cases:4.94%
controls:0.70%
cases:9.71%
controls:3.43%
cases:16.44%
controls:9.66%
373
2558
4317
44177
434
1531
4256
45204
237
304
4453
46431
61
11
4629
46724
231
327
4442
46340
439
1569
4082
44229
643
3936
3269
36828
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.5e-01
1.1e+00
2.5e+00
3.5e+00
2.2e+00
9.5e-01
6.9e-01
cases:3.88%
controls:2.52%
cases:3.90%
controls:1.35%
cases:2.30%
controls:0.20%
cases:0.55%
controls:0.02%
cases:1.43%
controls:0.16%
cases:3.36%
controls:1.33%
cases:7.21%
controls:3.76%
182
1178
4508
45557
183
633
4507
46102
108
92
4582
46643
26
8
4664
46727
67
77
4606
46590
152
609
4369
45189
282
1534
3630
39230
colestyramine; oral
C10AC01 [21601876]
1.4e+00
2.3e+00
—
—
2.4e+00
2.8e+00
2.2e+00
cases:0.68%
controls:0.16%
cases:0.79%
controls:0.08%
—
—
—
—
cases:0.26%
controls:0.02%
cases:1.17%
controls:0.07%
cases:2.02%
controls:0.23%
32
76
4658
46659
37
36
4653
46699
—
—
12
11
4661
46656
53
33
4468
45765
79
94
3833
40670
Inpatient Visit
IP [9201]
2.9e-01
8.3e-01
2.1e+00
5.1e+00
1.7e+00
7.3e-01
4.8e-01
cases:11.58%
controls:8.91%
cases:6.72%
controls:3.04%
cases:2.88%
controls:0.37%
cases:2.62%
controls:0.02%
cases:1.84%
controls:0.36%
cases:5.51%
controls:2.73%
cases:12.12%
controls:7.83%
543
4164
4147
42571
315
1421
4375
45314
135
171
4555
46564
123
8
4567
46727
86
166
4587
46501
249
1250
4272
44548
474
3193
3438
37571
Multiple adjuvant cytostatic therapy
WB113 [2001310629]
7.3e-01
2.0e+00
2.4e+00
—
3.7e+00
3.0e+00
5.1e-01
cases:0.47%
controls:0.23%
cases:0.68%
controls:0.09%
cases:0.19%
controls:0.02%
—
—
cases:0.68%
controls:0.02%
cases:1.50%
controls:0.07%
cases:0.28%
controls:0.17%
22
106
4668
46629
32
44
4658
46691
9
8
4681
46727
—
32
8
4641
46659
68
34
4453
45764
11
69
3901
40695
Thorax X-ray examination
GD1AA [2001303617]
4.6e-01
1.0e+00
2.1e+00
4.7e+00
1.3e+00
9.1e-01
6.3e-01
cases:8.96%
controls:5.87%
cases:6.18%
controls:2.34%
cases:2.32%
controls:0.30%
cases:1.79%
controls:0.02%
cases:1.20%
controls:0.32%
cases:5.68%
controls:2.36%
cases:13.22%
controls:7.49%
420
2744
4270
43991
290
1093
4400
45642
109
141
4581
46594
84
8
4606
46727
56
150
4617
46517
257
1081
4264
44717
517
3053
3395
37711
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
1.7e-01
2.4e+00
2.0e+00
—
3.2e+00
2.6e+00
8.8e-01
cases:0.36%
controls:0.31%
cases:1.54%
controls:0.15%
cases:0.26%
controls:0.03%
—
—
cases:0.53%
controls:0.02%
cases:1.70%
controls:0.13%
cases:0.92%
controls:0.39%
17
143
4673
46592
72
69
4618
46666
12
16
4678
46719
—
25
10
4648
46657
77
60
4444
45738
36
157
3876
40607
Gastroscopy
UJD02 [2001304787]
1.1e+00
2.7e+00
—
1.0e+50
3.5e+00
2.1e+00
1.6e+00
cases:0.83%
controls:0.27%
cases:1.51%
controls:0.10%
—
—
cases:0.19%
controls:0.00%
cases:0.36%
controls:0.01%
cases:0.73%
controls:0.09%
cases:1.48%
controls:0.31%
39
125
4651
46610
71
48
4619
46687
—
9
0
4681
46735
17
5
4656
46662
33
42
4488
45756
58
127
3854
40637
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
9.0e-01
1.5e+00
2.9e+00
—
2.8e+00
1.7e+00
1.2e+00
cases:2.94%
controls:1.21%
cases:3.39%
controls:0.79%
cases:1.86%
controls:0.11%
—
—
cases:2.01%
controls:0.12%
cases:4.16%
controls:0.78%
cases:8.00%
controls:2.59%
138
567
4552
46168
159
371
4531
46364
87
51
4603
46684
—
94
57
4579
46610
188
358
4333
45440
313
1056
3599
39708
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
5.7e-01
1.4e+00
2.7e+00
2.3e+00
1.7e+00
1.4e+00
9.5e-01
cases:2.11%
controls:1.20%
cases:2.86%
controls:0.75%
cases:2.09%
controls:0.15%
cases:0.15%
controls:0.01%
cases:1.11%
controls:0.20%
cases:3.07%
controls:0.80%
cases:5.24%
controls:2.09%
99
563
4591
46172
134
352
4556
46383
98
70
4592
46665
7
7
4683
46728
52
93
4621
46574
139
368
4382
45430
205
852
3707
39912
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
8.6e-01
1.4e+00
2.8e+00
—
2.8e+00
1.7e+00
1.2e+00
cases:2.39%
controls:1.02%
cases:2.77%
controls:0.68%
cases:1.60%
controls:0.10%
—
—
cases:1.73%
controls:0.10%
cases:3.47%
controls:0.66%
cases:7.06%
controls:2.16%
112
477
4578
46258
130
319
4560
46416
75
47
4615
46688
—
81
48
4592
46619
157
302
4364
45496
276
880
3636
39884
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
2.4e-01
1.3e+00
2.6e+00
3.1e+00
1.9e+00
1.2e+00
7.7e-01
cases:3.41%
controls:2.71%
cases:3.77%
controls:1.07%
cases:1.58%
controls:0.12%
cases:0.23%
controls:0.01%
cases:1.01%
controls:0.15%
cases:4.03%
controls:1.29%
cases:9.15%
controls:4.46%
160
1266
4530
45469
177
500
4513
46235
74
54
4616
46681
11
5
4679
46730
47
72
4626
46595
182
590
4339
45208
358
1818
3554
38946
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.9e-01
9.7e-01
2.5e+00
4.2e+00
1.8e+00
9.0e-01
5.0e-01
cases:5.42%
controls:4.50%
cases:5.18%
controls:2.02%
cases:3.52%
controls:0.30%
cases:1.09%
controls:0.02%
cases:1.69%
controls:0.29%
cases:4.62%
controls:1.93%
cases:10.71%
controls:6.80%
254
2105
4436
44630
243
944
4447
45791
165
140
4525
46595
51
8
4639
46727
79
134
4594
46533
209
885
4312
44913
419
2772
3493
37992
Thoracal epidural anesthesia
WX302 [2001310795]
9.0e-01
2.4e+00
4.5e+00
—
—
2.1e+00
8.9e-01
cases:0.75%
controls:0.31%
cases:1.15%
controls:0.10%
cases:1.17%
controls:0.01%
—
—
—
—
cases:0.51%
controls:0.07%
cases:0.66%
controls:0.27%
35
143
4655
46592
54
47
4636
46688
55
6
4635
46729
—
—
23
30
4498
45768
26
112
3886
40652
Intramuscular and subcutaneous injection
SPAT1256 [2001700357]
3.0e-01
8.7e-01
1.7e+00
2.5e+00
2.4e+00
1.7e+00
1.2e+00
cases:7.29%
controls:5.51%
cases:6.89%
controls:3.00%
cases:2.60%
controls:0.49%
cases:0.49%
controls:0.04%
cases:5.48%
controls:0.51%
cases:14.09%
controls:3.00%
cases:22.39%
controls:7.64%
342
2573
4348
44162
323
1404
4367
45331
122
231
4568
46504
23
18
4667
46717
256
239
4417
46428
637
1376
3884
44422
876
3115
3036
37649
Medical doctor
Z2221 [2001311556]
4.5e-01
1.2e+00
2.0e+00
4.1e+00
1.2e+00
9.8e-01
8.2e-01
cases:5.93%
controls:3.88%
cases:4.07%
controls:1.26%
cases:1.26%
controls:0.17%
cases:0.62%
controls:0.01%
cases:0.71%
controls:0.21%
cases:3.01%
controls:1.15%
cases:6.16%
controls:2.82%
278
1812
4412
44923
191
590
4499
46145
59
81
4631
46654
29
5
4661
46730
33
99
4640
46568
136
527
4385
45271
241
1151
3671
39613
Physiotherapy
R4110 [2001310233]
4.2e-01
9.6e-01
1.9e+00
4.3e+00
1.5e+00
9.1e-01
6.7e-01
cases:4.93%
controls:3.29%
cases:3.16%
controls:1.23%
cases:1.36%
controls:0.20%
cases:0.94%
controls:0.01%
cases:0.66%
controls:0.15%
cases:2.50%
controls:1.02%
cases:6.19%
controls:3.26%
231
1536
4459
45199
148
575
4542
46160
64
95
4626
46640
44
6
4646
46729
31
69
4642
46598
113
466
4408
45332
242
1329
3670
39435
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.2e-01
9.6e-01
2.1e+00
4.0e+00
1.9e+00
9.5e-01
5.4e-01
cases:7.36%
controls:5.47%
cases:7.93%
controls:3.19%
cases:3.86%
controls:0.50%
cases:1.11%
controls:0.02%
cases:3.49%
controls:0.55%
cases:8.34%
controls:3.39%
cases:16.39%
controls:10.26%
345
2556
4345
44179
372
1491
4318
45244
181
233
4509
46502
52
10
4638
46725
163
257
4510
46410
377
1554
4144
44244
641
4183
3271
36581
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
8.6e-01
1.5e+00
2.7e+00
—
2.8e+00
1.6e+00
1.2e+00
cases:2.58%
controls:1.11%
cases:3.03%
controls:0.72%
cases:1.62%
controls:0.11%
—
—
cases:1.93%
controls:0.11%
cases:3.65%
controls:0.74%
cases:7.41%
controls:2.37%
121
518
4569
46217
142
338
4548
46397
76
52
4614
46683
—
90
53
4583
46614
165
337
4356
45461
290
967
3622
39797
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
6.3e-01
1.7e+00
3.2e+00
—
2.7e+00
1.5e+00
9.5e-01
cases:1.45%
controls:0.78%
cases:1.86%
controls:0.36%
cases:1.19%
controls:0.05%
—
—
cases:0.75%
controls:0.05%
cases:1.61%
controls:0.36%
cases:3.25%
controls:1.28%
68
364
4622
46371
87
168
4603
46567
56
23
4634
46712
—
35
23
4638
46644
73
166
4448
45632
127
521
3785
40243
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.8e-01
9.9e-01
2.0e+00
3.9e+00
1.8e+00
9.9e-01
6.0e-01
cases:6.93%
controls:4.87%
cases:7.12%
controls:2.77%
cases:3.20%
controls:0.44%
cases:0.92%
controls:0.02%
cases:2.91%
controls:0.49%
cases:7.52%
controls:2.92%
cases:14.67%
controls:8.59%
325
2274
4365
44461
334
1293
4356
45442
150
206
4540
46529
43
9
4647
46726
136
227
4537
46440
340
1339
4181
44459
574
3501
3338
37263
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
4.3e-01
1.7e+00
3.1e+00
—
2.7e+00
1.7e+00
9.7e-01
cases:1.56%
controls:1.01%
cases:2.22%
controls:0.42%
cases:1.51%
controls:0.07%
—
—
cases:0.96%
controls:0.06%
cases:2.15%
controls:0.41%
cases:4.19%
controls:1.63%
73
474
4617
46261
104
196
4586
46539
71
32
4619
46703
—
45
29
4628
46638
97
190
4424
45608
164
663
3748
40101
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
5.4e-01
1.7e+00
3.4e+00
—
2.7e+00
1.3e+00
8.7e-01
cases:4.56%
controls:2.71%
cases:4.65%
controls:0.90%
cases:2.03%
controls:0.07%
—
—
cases:1.63%
controls:0.11%
cases:3.52%
controls:0.94%
cases:7.64%
controls:3.35%
214
1266
4476
45469
218
422
4472
46313
95
31
4595
46704
—
76
53
4597
46614
159
430
4362
45368
299
1366
3613
39398
Capsular endoscopy
UJF92 [2001305032]
1.8e+00
2.3e+00
—
—
—
3.5e+00
2.8e+00
cases:0.32%
controls:0.05%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.62%
controls:0.02%
cases:0.66%
controls:0.04%
15
24
4675
46711
10
10
4680
46725
—
—
—
28
9
4493
45789
26
16
3886
40748
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
3.9e-01
9.9e-01
2.3e+00
4.1e+00
1.7e+00
7.8e-01
6.0e-01
cases:1.58%
controls:1.07%
cases:1.68%
controls:0.63%
cases:0.75%
controls:0.08%
cases:0.62%
controls:0.01%
cases:0.47%
controls:0.08%
cases:1.66%
controls:0.77%
cases:4.81%
controls:2.69%
74
501
4616
46234
79
296
4611
46439
35
37
4655
46698
29
5
4661
46730
22
39
4651
46628
75
351
4446
45447
188
1098
3724
39666
Inpatient Hospital
21 [8717]
3.1e-01
9.0e-01
1.7e+00
4.6e+00
1.6e+00
7.6e-01
4.6e-01
cases:38.44%
controls:31.35%
cases:24.73%
controls:11.78%
cases:9.59%
controls:1.83%
cases:9.98%
controls:0.11%
cases:8.13%
controls:1.81%
cases:22.19%
controls:11.80%
cases:41.95%
controls:31.25%
1803
14651
2887
32084
1160
5505
3530
41230
450
855
4240
45880
468
50
4222
46685
380
846
4293
45821
1003
5403
3518
40395
1641
12740
2271
28024
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
7.7e-01
2.1e+00
3.0e+00
—
2.8e+00
1.7e+00
2.4e-01
cases:0.62%
controls:0.29%
cases:0.77%
controls:0.09%
cases:0.34%
controls:0.02%
—
—
cases:0.21%
controls:0.01%
cases:0.35%
controls:0.07%
cases:0.59%
controls:0.46%
29
134
4661
46601
36
44
4654
46691
16
8
4674
46727
—
10
6
4663
46661
16
31
4505
45767
23
188
3889
40576
Chronic kidney disease, unspecified
N18.9 [45553438]
6.9e-01
8.5e-01
1.6e+00
4.3e+00
1.1e+00
1.1e+00
7.0e-01
cases:1.04%
controls:0.53%
cases:0.83%
controls:0.36%
cases:0.43%
controls:0.09%
cases:0.77%
controls:0.01%
cases:0.30%
controls:0.10%
cases:1.37%
controls:0.44%
cases:2.15%
controls:1.08%
49
246
4641
46489
39
167
4651
46568
20
41
4670
46694
36
5
4654
46730
14
47
4659
46620
62
203
4459
45595
84
439
3828
40325
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
6.5e-01
7.9e-01
1.6e+00
4.7e+00
1.4e+00
7.7e-01
4.4e-01
cases:8.55%
controls:4.66%
cases:5.44%
controls:2.55%
cases:1.88%
controls:0.39%
cases:3.09%
controls:0.03%
cases:1.71%
controls:0.42%
cases:5.62%
controls:2.69%
cases:10.05%
controls:6.68%
401
2177
4289
44558
255
1192
4435
45543
88
182
4602
46553
145
14
4545
46721
80
195
4593
46472
254
1231
4267
44567
393
2724
3519
38040
Extensive abdominal CT
JN3BD [2001305556]
6.4e-01
1.5e+00
2.9e+00
1.0e+50
2.3e+00
1.8e+00
1.2e+00
cases:1.49%
controls:0.79%
cases:1.13%
controls:0.25%
cases:0.30%
controls:0.02%
cases:0.11%
controls:0.00%
cases:0.21%
controls:0.02%
cases:1.13%
controls:0.19%
cases:2.07%
controls:0.64%
70
371
4620
46364
53
118
4637
46617
14
8
4676
46727
5
0
4685
46735
10
10
4663
46657
51
86
4470
45712
81
260
3831
40504
pH of Serum or Plasma
2753-2 [3018418]
4.1e-01
9.6e-01
1.7e+00
3.7e+00
1.9e+00
1.0e+00
5.7e-01
cases:4.56%
controls:3.07%
cases:4.56%
controls:1.80%
cases:1.66%
controls:0.30%
cases:0.43%
controls:0.01%
cases:2.14%
controls:0.32%
cases:4.98%
controls:1.84%
cases:9.66%
controls:5.69%
214
1436
4476
45299
214
842
4476
45893
78
139
4612
46596
20
5
4670
46730
100
151
4573
46516
225
843
4296
44955
378
2321
3534
38443
Severe malabsorption of nutrients, mainly fats
601 [2001600366]
3.5e+00
—
1.0e+50
1.0e+50
—
3.6e+00
3.2e+00
cases:0.49%
controls:0.01%
—
—
cases:0.19%
controls:0.00%
cases:5.14%
controls:0.00%
—
—
cases:0.62%
controls:0.02%
cases:0.66%
controls:0.03%
23
7
4667
46728
—
9
0
4681
46735
241
0
4449
46735
—
28
8
4493
45790
26
11
3886
40753
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
4.5e-01
1.7e+00
2.8e+00
—
2.5e+00
1.7e+00
1.1e+00
cases:1.56%
controls:0.99%
cases:3.41%
controls:0.61%
cases:1.77%
controls:0.11%
—
—
cases:1.67%
controls:0.14%
cases:3.63%
controls:0.70%
cases:4.63%
controls:1.62%
73
465
4617
46270
160
287
4530
46448
83
52
4607
46683
—
78
64
4595
46603
164
322
4357
45476
181
659
3731
40105
loperamide; oral
A07DA03 [21600646]
8.9e-01
1.8e+00
2.3e+00
—
2.1e+00
1.9e+00
1.2e+00
cases:1.86%
controls:0.77%
cases:2.24%
controls:0.39%
cases:0.70%
controls:0.07%
—
—
cases:0.73%
controls:0.09%
cases:2.68%
controls:0.41%
cases:3.55%
controls:1.11%
87
359
4603
46376
105
184
4585
46551
33
33
4657
46702
—
34
41
4639
46626
121
186
4400
45612
139
452
3773
40312
loperamide oxide; oral
A07DA05 [21600648]
8.9e-01
1.8e+00
2.3e+00
—
2.1e+00
1.9e+00
1.2e+00
cases:1.86%
controls:0.77%
cases:2.24%
controls:0.39%
cases:0.70%
controls:0.07%
—
—
cases:0.73%
controls:0.09%
cases:2.68%
controls:0.41%
cases:3.55%
controls:1.11%
87
359
4603
46376
105
184
4585
46551
33
33
4657
46702
—
34
41
4639
46626
121
186
4400
45612
139
452
3773
40312
Benign neoplasm: Stomach
D13.1 [45586087]
1.8e+00
3.4e+00
—
1.0e+50
1.0e+50
2.8e+00
2.1e+00
cases:0.64%
controls:0.10%
cases:0.96%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
cases:0.30%
controls:0.00%
cases:0.66%
controls:0.04%
cases:1.30%
controls:0.16%
30
49
4660
46686
45
15
4645
46720
—
8
0
4682
46735
14
0
4659
46667
30
19
4491
45779
51
65
3861
40699
dihydrotachysterol; oral
A11CC02 [21600817]
2.1e+00
2.4e+00
—
—
—
2.9e+00
2.6e+00
cases:0.23%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
—
—
—
—
cases:0.20%
controls:0.01%
cases:0.26%
controls:0.02%
11
13
4679
46722
8
7
4682
46728
—
—
—
9
5
4512
45793
10
8
3902
40756
ferrous glycine sulfate; oral
B03AA01 [21601080]
1.1e+00
1.7e+00
1.9e+00
—
2.3e+00
1.9e+00
1.1e+00
cases:1.28%
controls:0.42%
cases:1.22%
controls:0.22%
cases:0.34%
controls:0.05%
—
—
cases:0.51%
controls:0.05%
cases:1.59%
controls:0.24%
cases:2.61%
controls:0.87%
60
198
4630
46537
57
104
4633
46631
16
24
4674
46711
—
24
24
4649
46643
72
112
4449
45686
102
355
3810
40409
Emergency Room Visit
ER [9203]
2.9e-01
7.9e-01
1.7e+00
4.8e+00
1.3e+00
6.8e-01
4.9e-01
cases:32.94%
controls:26.95%
cases:20.04%
controls:10.26%
cases:6.97%
controls:1.41%
cases:6.31%
controls:0.06%
cases:4.90%
controls:1.35%
cases:18.67%
controls:10.46%
cases:40.82%
controls:29.81%
1545
12596
3145
34139
940
4793
3750
41942
327
660
4363
46075
296
27
4394
46708
229
629
4444
46038
844
4790
3677
41008
1597
12152
2315
28612
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
7.6e-01
1.5e+00
2.3e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:0.53%
controls:0.25%
cases:0.47%
controls:0.11%
cases:0.17%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.69%
controls:0.10%
cases:1.20%
controls:0.41%
25
117
4665
46618
22
51
4668
46684
8
8
4682
46727
—
8
7
4665
46660
31
48
4490
45750
47
168
3865
40596
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
8.3e-01
1.4e+00
2.2e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:0.53%
controls:0.23%
cases:0.43%
controls:0.10%
cases:0.15%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.66%
controls:0.10%
cases:1.15%
controls:0.38%
25
109
4665
46626
20
47
4670
46688
7
8
4683
46727
—
8
7
4665
46660
30
45
4491
45753
45
155
3867
40609
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
8.1e-01
1.3e+00
2.4e+00
—
2.5e+00
1.8e+00
1.0e+00
cases:0.72%
controls:0.33%
cases:0.53%
controls:0.14%
cases:0.23%
controls:0.02%
—
—
cases:0.24%
controls:0.02%
cases:0.77%
controls:0.13%
cases:1.51%
controls:0.55%
34
152
4656
46583
25
66
4665
46669
11
10
4679
46725
—
11
9
4662
46658
35
58
4486
45740
59
223
3853
40541
Extensive body CT
JN4BD [2001310899]
7.4e-01
1.6e+00
2.2e+00
—
2.2e+00
1.9e+00
1.2e+00
cases:1.79%
controls:0.86%
cases:1.92%
controls:0.40%
cases:0.51%
controls:0.06%
—
—
cases:0.36%
controls:0.04%
cases:2.19%
controls:0.33%
cases:2.48%
controls:0.79%
84
403
4606
46332
90
187
4600
46548
24
26
4666
46709
—
17
18
4656
46649
99
152
4422
45646
97
321
3815
40443
Outpatient Hospital
22 [8756]
3.1e-01
9.1e-01
1.9e+00
4.0e+00
1.6e+00
8.0e-01
4.3e-01
cases:29.40%
controls:23.43%
cases:16.80%
controls:7.55%
cases:6.29%
controls:1.02%
cases:2.88%
controls:0.06%
cases:4.49%
controls:0.96%
cases:14.64%
controls:7.19%
cases:30.90%
controls:22.61%
1379
10950
3311
35785
788
3527
3902
43208
295
476
4395
46259
135
26
4555
46709
210
449
4463
46218
662
3292
3859
42506
1209
9216
2703
31548
Partial resection of small intestine
JFB00 [2001304885]
2.2e+00
3.2e+00
1.0e+50
—
—
2.7e+00
1.7e+00
cases:0.64%
controls:0.07%
cases:0.49%
controls:0.02%
cases:0.17%
controls:0.00%
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.41%
controls:0.08%
30
32
4660
46703
23
9
4667
46726
8
0
4682
46735
—
—
13
9
4508
45789
16
32
3896
40732
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
8.2e-01
1.4e+00
2.2e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:0.53%
controls:0.24%
cases:0.43%
controls:0.11%
cases:0.15%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.66%
controls:0.10%
cases:1.20%
controls:0.40%
25
110
4665
46625
20
50
4670
46685
7
8
4683
46727
—
8
7
4665
46660
30
46
4491
45752
47
164
3865
40600
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.7e-01
8.7e-01
1.7e+00
3.8e+00
1.6e+00
8.1e-01
5.9e-01
cases:7.14%
controls:5.05%
cases:7.27%
controls:3.19%
cases:3.50%
controls:0.63%
cases:0.83%
controls:0.02%
cases:3.40%
controls:0.68%
cases:7.21%
controls:3.35%
cases:14.21%
controls:8.38%
335
2362
4355
44373
341
1493
4349
45242
164
294
4526
46441
39
9
4651
46726
159
316
4514
46351
326
1533
4195
44265
556
3414
3356
37350
Deficiency of other specified B group vitamins
E53.8 [45533035]
2.6e+00
—
1.0e+50
1.0e+50
1.0e+50
4.2e+00
3.0e+00
cases:0.43%
controls:0.03%
—
—
cases:1.17%
controls:0.00%
cases:7.83%
controls:0.00%
cases:0.66%
controls:0.00%
cases:0.97%
controls:0.02%
cases:0.77%
controls:0.04%
20
15
4670
46720
—
55
0
4635
46735
367
0
4323
46735
31
0
4642
46667
44
7
4477
45791
30
16
3882
40748
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.7e-01
8.6e-01
1.7e+00
3.7e+00
1.6e+00
8.1e-01
5.9e-01
cases:7.12%
controls:5.05%
cases:7.21%
controls:3.19%
cases:3.41%
controls:0.64%
cases:0.81%
controls:0.02%
cases:3.36%
controls:0.67%
cases:7.23%
controls:3.34%
cases:14.16%
controls:8.35%
334
2360
4356
44375
338
1493
4352
45242
160
298
4530
46437
38
9
4652
46726
157
312
4516
46355
327
1531
4194
44267
554
3403
3358
37361
Pure hypercholesterolaemia
E78.01 [2000501514]
1.8e-01
4.1e-01
1.3e+00
5.2e+00
1.8e+00
7.0e-01
2.8e-01
cases:2.73%
controls:2.30%
cases:1.73%
controls:1.16%
cases:0.64%
controls:0.17%
cases:2.17%
controls:0.01%
cases:0.96%
controls:0.16%
cases:2.65%
controls:1.33%
cases:5.37%
controls:4.09%
128
1074
4562
45661
81
541
4609
46194
30
78
4660
46657
102
6
4588
46729
45
73
4628
46594
120
610
4401
45188
210
1669
3702
39095
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.7e-01
8.5e-01
1.7e+00
3.8e+00
1.7e+00
7.9e-01
5.5e-01
cases:7.21%
controls:5.10%
cases:7.16%
controls:3.20%
cases:3.33%
controls:0.63%
cases:0.77%
controls:0.02%
cases:3.34%
controls:0.66%
cases:7.28%
controls:3.43%
cases:13.83%
controls:8.48%
338
2382
4352
44353
336
1494
4354
45241
156
294
4534
46441
36
8
4654
46727
156
307
4517
46360
329
1570
4192
44228
541
3456
3371
37308
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.6e-01
8.6e-01
1.7e+00
3.7e+00
1.7e+00
8.1e-01
5.9e-01
cases:7.08%
controls:5.03%
cases:7.19%
controls:3.18%
cases:3.45%
controls:0.64%
cases:0.79%
controls:0.02%
cases:3.40%
controls:0.67%
cases:7.23%
controls:3.34%
cases:14.03%
controls:8.33%
332
2350
4358
44385
337
1486
4353
45249
162
299
4528
46436
37
9
4653
46726
159
313
4514
46354
327
1530
4194
44268
549
3397
3363
37367
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.7e-01
8.6e-01
1.7e+00
3.8e+00
1.6e+00
7.8e-01
5.5e-01
cases:7.36%
controls:5.22%
cases:7.42%
controls:3.29%
cases:3.50%
controls:0.64%
cases:0.83%
controls:0.02%
cases:3.40%
controls:0.69%
cases:7.32%
controls:3.48%
cases:14.19%
controls:8.72%
345
2440
4345
44295
348
1538
4342
45197
164
298
4526
46437
39
9
4651
46726
159
322
4514
46345
331
1593
4190
44205
555
3553
3357
37211
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
7.4e-01
1.4e+00
2.3e+00
—
2.4e+00
1.8e+00
9.6e-01
cases:0.72%
controls:0.35%
cases:0.60%
controls:0.14%
cases:0.23%
controls:0.02%
—
—
cases:0.24%
controls:0.02%
cases:0.84%
controls:0.14%
cases:1.58%
controls:0.61%
34
163
4656
46572
28
66
4662
46669
11
11
4679
46724
—
11
10
4662
46657
38
65
4483
45733
62
250
3850
40514
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
7.2e-01
1.4e+00
2.3e+00
—
2.4e+00
1.8e+00
9.6e-01
cases:0.72%
controls:0.35%
cases:0.60%
controls:0.14%
cases:0.23%
controls:0.02%
—
—
cases:0.24%
controls:0.02%
cases:0.84%
controls:0.14%
cases:1.58%
controls:0.61%
34
165
4656
46570
28
66
4662
46669
11
11
4679
46724
—
11
10
4662
46657
38
65
4483
45733
62
250
3850
40514
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
7.4e-01
1.4e+00
2.3e+00
—
2.4e+00
1.8e+00
9.6e-01
cases:0.72%
controls:0.35%
cases:0.60%
controls:0.14%
cases:0.23%
controls:0.02%
—
—
cases:0.24%
controls:0.02%
cases:0.84%
controls:0.14%
cases:1.58%
controls:0.62%
34
163
4656
46572
28
67
4662
46668
11
11
4679
46724
—
11
10
4662
46657
38
65
4483
45733
62
251
3850
40513
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
9.1e-01
1.6e+00
2.2e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:0.60%
controls:0.24%
cases:0.55%
controls:0.12%
cases:0.28%
controls:0.03%
—
—
cases:0.28%
controls:0.03%
cases:0.82%
controls:0.15%
cases:1.64%
controls:0.54%
28
113
4662
46622
26
55
4664
46680
13
15
4677
46720
—
13
15
4660
46652
37
69
4484
45729
64
221
3848
40543
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
9.1e-01
1.5e+00
2.2e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:0.60%
controls:0.24%
cases:0.55%
controls:0.12%
cases:0.28%
controls:0.03%
—
—
cases:0.28%
controls:0.03%
cases:0.82%
controls:0.15%
cases:1.64%
controls:0.54%
28
113
4662
46622
26
57
4664
46678
13
15
4677
46720
—
13
15
4660
46652
37
69
4484
45729
64
222
3848
40542
budesonide; oral, sublingual
A07EA06 [21600658]
1.4e+00
1.9e+00
1.4e+00
—
2.5e+00
2.0e+00
1.8e+00
cases:1.00%
controls:0.26%
cases:0.90%
controls:0.13%
cases:0.15%
controls:0.04%
—
—
cases:0.26%
controls:0.02%
cases:0.75%
controls:0.11%
cases:1.89%
controls:0.32%
47
121
4643
46614
42
61
4648
46674
7
17
4683
46718
—
12
10
4661
46657
34
49
4487
45749
74
132
3838
40632
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
1.4e+00
1.8e+00
2.5e+00
—
2.4e+00
1.5e+00
7.4e-01
cases:0.32%
controls:0.08%
cases:0.38%
controls:0.07%
cases:0.13%
controls:0.01%
—
—
cases:0.19%
controls:0.02%
cases:0.29%
controls:0.07%
cases:0.36%
controls:0.17%
15
38
4675
46697
18
31
4672
46704
6
5
4684
46730
—
9
8
4664
46659
13
30
4508
45768
14
70
3898
40694
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
1.7e-01
7.6e-01
2.1e+00
3.9e+00
1.7e+00
7.5e-01
4.0e-01
cases:8.17%
controls:6.96%
cases:7.78%
controls:3.78%
cases:3.97%
controls:0.53%
cases:1.54%
controls:0.03%
cases:2.59%
controls:0.50%
cases:7.85%
controls:3.85%
cases:16.87%
controls:11.97%
383
3251
4307
43484
365
1768
4325
44967
186
247
4504
46488
72
15
4618
46720
121
235
4552
46432
355
1764
4166
44034
660
4878
3252
35886
Coeliac disease
K90.0 [45586745]
6.0e-01
1.1e+00
2.7e+00
1.0e+50
2.2e+00
1.9e+00
1.5e+00
cases:0.45%
controls:0.25%
cases:0.36%
controls:0.12%
cases:0.19%
controls:0.01%
cases:0.36%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.75%
controls:0.11%
cases:1.30%
controls:0.29%
21
115
4669
46620
17
54
4673
46681
9
6
4681
46729
17
0
4673
46735
10
11
4663
46656
34
52
4487
45746
51
120
3861
40644
Bacteria [Presence] in Urine
87829-8 [36304419]
2.9e-01
7.0e-01
1.6e+00
4.1e+00
1.6e+00
6.4e-01
5.2e-01
cases:3.69%
controls:2.79%
cases:3.24%
controls:1.64%
cases:1.13%
controls:0.23%
cases:0.79%
controls:0.01%
cases:1.13%
controls:0.24%
cases:3.12%
controls:1.67%
cases:7.85%
controls:4.80%
173
1303
4517
45432
152
768
4538
45967
53
108
4637
46627
37
6
4653
46729
53
111
4620
46556
141
765
4380
45033
307
1957
3605
38807
Iron deficiency anaemia
B80 [2002000291]
1.7e+00
2.6e+00
—
—
—
2.7e+00
2.4e+00
cases:0.41%
controls:0.08%
cases:0.32%
controls:0.02%
—
—
—
—
—
—
cases:0.44%
controls:0.03%
cases:1.10%
controls:0.10%
19
36
4671
46699
15
11
4675
46724
—
—
—
20
13
4501
45785
43
42
3869
40722
Intubation
WX704 [2001310820]
6.3e-01
1.7e+00
3.4e+00
—
2.1e+00
1.5e+00
1.1e-01
cases:0.92%
controls:0.49%
cases:0.96%
controls:0.18%
cases:0.53%
controls:0.02%
—
—
cases:0.13%
controls:0.01%
cases:0.66%
controls:0.16%
cases:0.92%
controls:0.83%
43
229
4647
46506
45
82
4645
46653
25
8
4665
46727
—
6
7
4667
46660
30
71
4491
45727
36
338
3876
40426
Neoplasm of uncertain or unknown behaviour: Stomach
D37.1 [45591003]
2.3e+00
4.5e+00
—
—
1.0e+50
—
2.5e+00
cases:0.17%
controls:0.02%
cases:1.19%
controls:0.01%
—
—
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.46%
controls:0.04%
8
8
4682
46727
56
6
4634
46729
—
—
16
0
4657
46667
—
18
15
3894
40749
Intravenous
ZX120 [2001311495]
8.5e-01
1.5e+00
1.5e+00
—
2.3e+00
2.0e+00
1.2e+00
cases:1.41%
controls:0.61%
cases:1.22%
controls:0.27%
cases:0.30%
controls:0.07%
—
—
cases:0.62%
controls:0.06%
cases:1.55%
controls:0.22%
cases:2.58%
controls:0.77%
66
284
4624
46451
57
124
4633
46611
14
31
4676
46704
—
29
30
4644
46637
70
99
4451
45699
101
313
3811
40451
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
8.2e-01
2.0e+00
—
—
3.1e+00
2.4e+00
1.8e+00
cases:0.28%
controls:0.12%
cases:0.79%
controls:0.10%
—
—
—
—
cases:0.39%
controls:0.02%
cases:1.02%
controls:0.09%
cases:1.38%
controls:0.23%
13
57
4677
46678
37
49
4653
46686
—
—
18
8
4655
46659
46
42
4475
45756
54
93
3858
40671
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
9.0e-01
1.5e+00
2.1e+00
—
2.1e+00
1.7e+00
1.1e+00
cases:0.58%
controls:0.24%
cases:0.53%
controls:0.12%
cases:0.26%
controls:0.03%
—
—
cases:0.24%
controls:0.03%
cases:0.73%
controls:0.14%
cases:1.43%
controls:0.51%
27
110
4663
46625
25
54
4665
46681
12
14
4678
46721
—
11
14
4662
46653
33
64
4488
45734
56
206
3856
40558
Basophils [#/volume] in Blood
26444-0 [3006315]
3.2e-01
8.1e-01
1.7e+00
3.6e+00
1.6e+00
7.8e-01
5.1e-01
cases:7.21%
controls:5.34%
cases:7.25%
controls:3.37%
cases:3.67%
controls:0.66%
cases:0.75%
controls:0.02%
cases:3.36%
controls:0.69%
cases:7.50%
controls:3.60%
cases:14.34%
controls:9.12%
338
2496
4352
44239
340
1576
4350
45159
172
309
4518
46426
35
10
4655
46725
157
320
4516
46347
339
1648
4182
44150
561
3716
3351
37048
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
6.2e-01
1.1e+00
2.7e+00
—
2.8e+00
1.3e+00
7.1e-01
cases:1.04%
controls:0.56%
cases:1.00%
controls:0.32%
cases:0.53%
controls:0.04%
—
—
cases:0.53%
controls:0.03%
cases:1.13%
controls:0.30%
cases:2.25%
controls:1.11%
49
264
4641
46471
47
150
4643
46585
25
17
4665
46718
—
25
15
4648
46652
51
137
4470
45661
88
454
3824
40310
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
7.9e-01
1.7e+00
3.2e+00
1.0e+50
2.1e+00
1.4e+00
4.0e-01
cases:0.90%
controls:0.41%
cases:1.11%
controls:0.20%
cases:0.90%
controls:0.04%
cases:0.19%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.82%
controls:0.19%
cases:1.28%
controls:0.86%
42
191
4648
46544
52
92
4638
46643
42
17
4648
46718
9
0
4681
46735
11
13
4662
46654
37
89
4484
45709
50
350
3862
40414
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.1e-01
8.0e-01
1.7e+00
3.6e+00
1.6e+00
7.8e-01
5.1e-01
cases:7.14%
controls:5.32%
cases:7.21%
controls:3.37%
cases:3.65%
controls:0.65%
cases:0.75%
controls:0.02%
cases:3.32%
controls:0.68%
cases:7.45%
controls:3.58%
cases:14.29%
controls:9.07%
335
2487
4355
44248
338
1573
4352
45162
171
306
4519
46429
35
10
4655
46725
155
319
4518
46348
337
1638
4184
44160
559
3696
3353
37068
Ileoscopy through colon
UJF30 [2001305028]
1.1e+00
1.7e+00
—
1.0e+50
3.1e+00
2.1e+00
1.3e+00
cases:1.51%
controls:0.53%
cases:0.98%
controls:0.18%
—
—
cases:0.19%
controls:0.00%
cases:0.24%
controls:0.01%
cases:1.24%
controls:0.15%
cases:2.61%
controls:0.72%
71
246
4619
46489
46
83
4644
46652
—
9
0
4681
46735
11
5
4662
46662
56
68
4465
45730
102
294
3810
40470
Crohn disease of large intestine
K50.1 [45601173]
1.9e+00
2.4e+00
—
—
—
2.6e+00
2.4e+00
cases:0.34%
controls:0.05%
cases:0.32%
controls:0.03%
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:0.79%
controls:0.07%
16
25
4674
46710
15
13
4675
46722
—
—
—
17
13
4504
45785
31
29
3881
40735
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
7.9e-01
1.4e+00
2.2e+00
—
2.2e+00
1.8e+00
9.1e-01
cases:0.72%
controls:0.33%
cases:0.53%
controls:0.13%
cases:0.19%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.82%
controls:0.13%
cases:1.41%
controls:0.57%
34
155
4656
46580
25
63
4665
46672
9
10
4681
46725
—
9
10
4664
46657
37
61
4484
45737
55
233
3857
40531
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.6e-01
7.0e-01
1.4e+00
4.4e+00
1.6e+00
6.0e-01
4.0e-01
cases:4.73%
controls:3.69%
cases:4.61%
controls:2.33%
cases:1.49%
controls:0.38%
cases:1.00%
controls:0.01%
cases:1.63%
controls:0.34%
cases:4.53%
controls:2.54%
cases:10.33%
controls:7.19%
222
1723
4468
45012
216
1089
4474
45646
70
177
4620
46558
47
6
4643
46729
76
161
4597
46506
205
1164
4316
44634
404
2932
3508
37832
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.0e-01
8.8e-01
1.6e+00
3.4e+00
1.6e+00
9.2e-01
5.4e-01
cases:8.46%
controls:6.39%
cases:9.64%
controls:4.24%
cases:5.03%
controls:1.02%
cases:1.11%
controls:0.04%
cases:5.14%
controls:1.06%
cases:10.60%
controls:4.51%
cases:16.95%
controls:10.63%
397
2985
4293
43750
452
1982
4238
44753
236
476
4454
46259
52
18
4638
46717
240
494
4433
46173
479
2067
4042
43731
663
4332
3249
36432
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
3.5e-01
9.2e-01
2.2e+00
2.3e+00
2.0e+00
9.4e-01
6.0e-01
cases:5.74%
controls:4.13%
cases:5.50%
controls:2.27%
cases:2.37%
controls:0.27%
cases:0.19%
controls:0.02%
cases:2.10%
controls:0.30%
cases:6.33%
controls:2.57%
cases:13.78%
controls:8.09%
269
1928
4421
44807
258
1061
4432
45674
111
124
4579
46611
9
9
4681
46726
98
140
4575
46527
286
1179
4235
44619
539
3298
3373
37466
General Practice
1 [38004446]
2.2e-01
6.2e-01
1.3e+00
4.5e+00
1.5e+00
6.7e-01
4.0e-01
cases:14.12%
controls:11.63%
cases:9.36%
controls:5.29%
cases:2.96%
controls:0.82%
cases:4.35%
controls:0.05%
cases:3.64%
controls:0.82%
cases:10.84%
controls:5.84%
cases:23.13%
controls:16.76%
662
5435
4028
41300
439
2470
4251
44265
139
383
4551
46352
204
23
4486
46712
170
385
4503
46282
490
2674
4031
43124
905
6833
3007
33931
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.1e-01
8.0e-01
1.7e+00
3.6e+00
1.6e+00
7.6e-01
5.1e-01
cases:7.53%
controls:5.64%
cases:7.57%
controls:3.55%
cases:3.69%
controls:0.70%
cases:0.79%
controls:0.02%
cases:3.38%
controls:0.72%
cases:7.68%
controls:3.75%
cases:14.80%
controls:9.49%
353
2635
4337
44100
355
1659
4335
45076
173
326
4517
46409
37
10
4653
46725
158
338
4515
46329
347
1718
4174
44080
579
3868
3333
36896
Abdominal ultrasound examination
JN3AE [2001305555]
7.8e-01
1.5e+00
2.5e+00
—
2.1e+00
1.2e+00
1.1e+00
cases:2.13%
controls:0.99%
cases:1.41%
controls:0.30%
cases:0.36%
controls:0.03%
—
—
cases:0.26%
controls:0.03%
cases:1.11%
controls:0.34%
cases:3.14%
controls:1.09%
100
463
4590
46272
66
142
4624
46593
17
14
4673
46721
—
12
14
4661
46653
50
155
4471
45643
123
445
3789
40319
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.1e-01
8.0e-01
1.7e+00
3.6e+00
1.6e+00
7.5e-01
4.9e-01
cases:7.55%
controls:5.63%
cases:7.53%
controls:3.52%
cases:3.65%
controls:0.68%
cases:0.75%
controls:0.02%
cases:3.47%
controls:0.72%
cases:7.63%
controls:3.75%
cases:14.62%
controls:9.47%
354
2631
4336
44104
353
1644
4337
45091
171
318
4519
46417
35
10
4655
46725
162
335
4511
46332
345
1719
4176
44079
572
3859
3340
36905
Celiac disease serology panel - Serum
94494-2 [36660697]
6.1e-01
1.5e+00
2.7e+00
—
2.8e+00
9.5e-01
6.1e-01
cases:0.98%
controls:0.53%
cases:0.98%
controls:0.22%
cases:0.32%
controls:0.02%
—
—
cases:0.43%
controls:0.03%
cases:0.51%
controls:0.20%
cases:1.76%
controls:0.97%
46
249
4644
46486
46
102
4644
46633
15
10
4675
46725
—
20
12
4653
46655
23
90
4498
45708
69
395
3843
40369
More than three and less than five hours
ZXE20 [2001311408]
3.3e-01
1.6e+00
3.4e+00
—
2.0e+00
1.2e+00
9.2e-01
cases:1.77%
controls:1.28%
cases:1.62%
controls:0.32%
cases:0.90%
controls:0.03%
—
—
cases:0.26%
controls:0.03%
cases:0.93%
controls:0.28%
cases:2.38%
controls:0.96%
83
599
4607
46136
76
148
4614
46587
42
14
4648
46721
—
12
16
4661
46651
42
129
4479
45669
93
390
3819
40374
sucralfate; oral
A02BX02 [21600111]
6.7e-01
1.6e+00
2.9e+00
—
1.5e+00
2.1e+00
1.9e+00
cases:0.68%
controls:0.35%
cases:0.62%
controls:0.12%
cases:0.23%
controls:0.01%
—
—
cases:0.15%
controls:0.03%
cases:0.80%
controls:0.10%
cases:1.89%
controls:0.30%
32
163
4658
46572
29
56
4661
46679
11
6
4679
46729
—
7
15
4666
46652
36
46
4485
45752
74
121
3838
40643
Hypothyroidism, unspecified
E03.9 [45537945]
8.5e-01
1.3e+00
2.3e+00
—
2.4e+00
1.3e+00
1.0e+00
cases:2.81%
controls:1.22%
cases:1.92%
controls:0.55%
cases:0.94%
controls:0.09%
—
—
cases:0.94%
controls:0.09%
cases:2.34%
controls:0.66%
cases:5.14%
controls:1.88%
132
571
4558
46164
90
256
4600
46479
44
44
4646
46691
—
44
40
4629
46627
106
300
4415
45498
201
767
3711
39997
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.0e-01
9.8e-01
2.0e+00
2.8e+00
1.6e+00
9.2e-01
4.3e-01
cases:4.97%
controls:3.38%
cases:4.35%
controls:1.67%
cases:1.81%
controls:0.25%
cases:0.21%
controls:0.01%
cases:1.43%
controls:0.29%
cases:4.11%
controls:1.67%
cases:8.41%
controls:5.66%
233
1581
4457
45154
204
782
4486
45953
85
116
4605
46619
10
6
4680
46729
67
136
4606
46531
186
767
4335
45031
329
2306
3583
38458
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.6e-01
6.8e-01
1.4e+00
4.3e+00
1.5e+00
5.7e-01
4.1e-01
cases:4.31%
controls:3.36%
cases:3.92%
controls:2.03%
cases:1.32%
controls:0.33%
cases:0.94%
controls:0.01%
cases:1.46%
controls:0.31%
cases:3.85%
controls:2.21%
cases:9.23%
controls:6.35%
202
1572
4488
45163
184
950
4506
45785
62
156
4628
46579
44
6
4646
46729
68
146
4605
46521
174
1014
4347
44784
361
2587
3551
38177
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
5.8e-01
1.3e+00
2.3e+00
—
2.4e+00
1.6e+00
8.7e-01
cases:1.09%
controls:0.61%
cases:0.94%
controls:0.26%
cases:0.47%
controls:0.05%
—
—
cases:0.39%
controls:0.03%
cases:1.28%
controls:0.26%
cases:2.40%
controls:1.02%
51
287
4639
46448
44
120
4646
46615
22
22
4668
46713
—
18
16
4655
46651
58
119
4463
45679
94
416
3818
40348
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
6.1e-01
1.3e+00
2.3e+00
—
2.5e+00
1.4e+00
9.1e-01
cases:1.83%
controls:1.00%
cases:2.28%
controls:0.65%
cases:1.28%
controls:0.12%
—
—
cases:1.58%
controls:0.13%
cases:2.59%
controls:0.65%
cases:4.47%
controls:1.85%
86
468
4604
46267
107
306
4583
46429
60
58
4630
46677
—
74
60
4599
46607
117
296
4404
45502
175
755
3737
40009
Emergency Medicine
93 [38004510]
1.3e-01
5.3e-01
1.7e+00
4.7e+00
1.2e+00
5.7e-01
3.2e-01
cases:8.55%
controls:7.60%
cases:7.44%
controls:4.50%
cases:3.33%
controls:0.63%
cases:3.26%
controls:0.03%
cases:2.18%
controls:0.65%
cases:8.16%
controls:4.80%
cases:18.20%
controls:13.93%
401
3552
4289
43183
349
2103
4341
44632
156
295
4534
46440
153
14
4537
46721
102
304
4571
46363
369
2197
4152
43601
712
5680
3200
35084
Heart failure, unspecified
I50.9 [45576879]
3.6e-01
6.2e-01
1.5e+00
4.2e+00
1.3e+00
7.6e-01
3.5e-01
cases:2.26%
controls:1.58%
cases:1.81%
controls:0.98%
cases:0.79%
controls:0.19%
cases:1.13%
controls:0.02%
cases:0.75%
controls:0.21%
cases:2.54%
controls:1.21%
cases:4.55%
controls:3.25%
106
740
4584
45995
85
459
4605
46276
37
87
4653
46648
53
8
4637
46727
35
100
4638
46567
115
552
4406
45246
178
1324
3734
39440
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
6.9e-01
1.4e+00
2.3e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:0.58%
controls:0.29%
cases:0.51%
controls:0.13%
cases:0.21%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.77%
controls:0.12%
cases:1.41%
controls:0.49%
27
136
4663
46599
24
62
4666
46673
10
10
4680
46725
—
9
8
4664
46659
35
56
4486
45742
55
201
3857
40563
Body CT examination
JN4AD [2001310897]
6.6e-01
1.6e+00
2.6e+00
1.0e+50
1.6e+00
1.4e+00
1.1e+00
cases:0.79%
controls:0.41%
cases:1.22%
controls:0.24%
cases:0.47%
controls:0.04%
cases:0.28%
controls:0.00%
cases:0.21%
controls:0.04%
cases:1.33%
controls:0.33%
cases:2.86%
controls:0.96%
37
191
4653
46544
57
112
4633
46623
22
17
4668
46718
13
0
4677
46735
10
20
4663
46647
60
151
4461
45647
112
392
3800
40372
Outpatient Visit
OP [9202]
3.3e-01
7.1e-01
1.4e+00
3.9e+00
1.3e+00
8.8e-01
5.4e-01
cases:66.59%
controls:58.84%
cases:58.00%
controls:40.48%
cases:27.21%
controls:8.78%
cases:17.04%
controls:0.42%
cases:25.44%
controls:8.73%
cases:62.49%
controls:40.88%
cases:79.32%
controls:69.18%
3123
27498
1567
19237
2720
18920
1970
27815
1276
4104
3414
42631
799
195
3891
46540
1189
4075
3484
42592
2825
18721
1696
27077
3103
28201
809
12563
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
2.4e-01
6.8e-01
1.5e+00
4.2e+00
1.6e+00
5.6e-01
4.6e-01
cases:3.62%
controls:2.87%
cases:3.33%
controls:1.71%
cases:1.22%
controls:0.27%
cases:0.83%
controls:0.01%
cases:1.16%
controls:0.24%
cases:3.14%
controls:1.82%
cases:8.05%
controls:5.26%
170
1340
4520
45395
156
799
4534
45936
57
125
4633
46610
39
6
4651
46729
54
113
4619
46554
142
833
4379
44965
315
2145
3597
38619
Chronic superficial gastritis
K29.3 [45596316]
9.8e-01
2.3e+00
3.0e+00
—
2.6e+00
1.3e+00
4.0e-01
cases:0.51%
controls:0.19%
cases:0.47%
controls:0.04%
cases:0.21%
controls:0.01%
—
—
cases:0.15%
controls:0.01%
cases:0.20%
controls:0.06%
cases:0.31%
controls:0.21%
24
90
4666
46645
22
21
4668
46714
10
5
4680
46730
—
7
5
4666
46662
9
26
4512
45772
12
84
3900
40680
Lactate [Moles/volume] in Blood
32693-4 [3047181]
7.8e-01
1.8e+00
3.0e+00
—
1.9e+00
1.4e+00
5.0e-01
cases:0.60%
controls:0.27%
cases:0.72%
controls:0.12%
cases:0.38%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.51%
controls:0.12%
cases:0.89%
controls:0.54%
28
128
4662
46607
34
55
4656
46680
18
9
4672
46726
—
7
10
4666
46657
23
57
4498
45741
35
221
3877
40543
Malignant neoplasm: Small intestine, unspecified
C17.9 [45561788]
2.0e+00
2.4e+00
—
1.0e+50
—
2.6e+00
1.9e+00
cases:0.15%
controls:0.02%
cases:0.19%
controls:0.02%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.27%
controls:0.02%
cases:0.20%
controls:0.03%
7
9
4683
46726
9
8
4681
46727
—
5
0
4685
46735
—
12
9
4509
45789
8
13
3904
40751
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.8e-01
8.2e-01
1.7e+00
3.2e+00
1.7e+00
7.8e-01
4.6e-01
cases:13.45%
controls:10.51%
cases:13.94%
controls:6.69%
cases:6.91%
controls:1.31%
cases:1.45%
controls:0.06%
cases:6.87%
controls:1.35%
cases:14.44%
controls:7.18%
cases:24.46%
controls:17.00%
631
4913
4059
41822
654
3125
4036
43610
324
613
4366
46122
68
29
4622
46706
321
632
4352
46035
653
3288
3868
42510
957
6931
2955
33833
Cathetrisation of vein
TPH04 [2001309597]
6.5e-01
1.3e+00
2.6e+00
—
2.2e+00
1.2e+00
8.8e-01
cases:3.48%
controls:1.84%
cases:2.56%
controls:0.69%
cases:1.15%
controls:0.08%
—
—
cases:0.60%
controls:0.07%
cases:2.39%
controls:0.72%
cases:5.83%
controls:2.50%
163
859
4527
45876
120
322
4570
46413
54
39
4636
46696
—
28
32
4645
46635
108
332
4413
45466
228
1021
3684
39743
folic acid; oral, parenteral
B03BB01 [21601129]
9.9e-01
1.4e+00
1.4e+00
—
2.1e+00
1.8e+00
1.2e+00
cases:1.60%
controls:0.60%
cases:2.20%
controls:0.57%
cases:0.87%
controls:0.21%
—
—
cases:1.69%
controls:0.21%
cases:4.03%
controls:0.69%
cases:4.75%
controls:1.54%
75
280
4615
46455
103
266
4587
46469
41
97
4649
46638
—
79
99
4594
46568
182
314
4339
45484
186
626
3726
40138
folic acid
V04CX02 [715877]
9.9e-01
1.4e+00
1.4e+00
—
2.1e+00
1.8e+00
1.2e+00
cases:1.60%
controls:0.60%
cases:2.20%
controls:0.57%
cases:0.87%
controls:0.21%
—
—
cases:1.69%
controls:0.21%
cases:4.03%
controls:0.69%
cases:4.75%
controls:1.54%
75
280
4615
46455
103
266
4587
46469
41
97
4649
46638
—
79
99
4594
46568
182
314
4339
45484
186
626
3726
40138
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
1.6e-01
6.6e-01
1.3e+00
4.2e+00
1.6e+00
5.9e-01
4.1e-01
cases:4.67%
controls:4.01%
cases:4.22%
controls:2.23%
cases:1.34%
controls:0.35%
cases:0.87%
controls:0.01%
cases:1.54%
controls:0.33%
cases:4.25%
controls:2.39%
cases:10.25%
controls:7.07%
219
1874
4471
44861
198
1042
4492
45693
63
165
4627
46570
41
6
4649
46729
72
154
4601
46513
192
1096
4329
44702
401
2882
3511
37882
Medical Oncology
90 [38004507]
7.6e-02
9.9e-01
1.3e+00
2.8e+00
1.8e+00
1.3e+00
5.0e-01
cases:3.16%
controls:2.93%
cases:5.25%
controls:2.02%
cases:2.60%
controls:0.70%
cases:1.07%
controls:0.07%
cases:4.43%
controls:0.73%
cases:8.01%
controls:2.24%
cases:6.77%
controls:4.24%
148
1370
4542
45365
246
946
4444
45789
122
327
4568
46408
50
31
4640
46704
207
340
4466
46327
362
1024
4159
44774
265
1727
3647
39037
mesalazine; oral, rectal
A07EC02 [21600664]
1.3e+00
1.3e+00
1.5e+00
—
1.6e+00
1.5e+00
1.5e+00
cases:2.35%
controls:0.67%
cases:1.90%
controls:0.52%
cases:0.81%
controls:0.18%
—
—
cases:0.86%
controls:0.17%
cases:2.23%
controls:0.50%
cases:3.22%
controls:0.71%
110
314
4580
46421
89
241
4601
46494
38
83
4652
46652
—
40
81
4633
46586
101
231
4420
45567
126
288
3786
40476
Nausea and vomiting
R11 [45539317]
4.7e-01
1.6e+00
2.9e+00
1.0e+50
2.5e+00
1.1e+00
6.2e-01
cases:1.00%
controls:0.63%
cases:1.11%
controls:0.22%
cases:0.23%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.71%
controls:0.24%
cases:1.71%
controls:0.92%
47
295
4643
46440
52
103
4638
46632
11
6
4679
46729
5
0
4685
46735
13
11
4660
46656
32
110
4489
45688
67
377
3845
40387
Neurology
13 [38004458]
2.4e-01
6.6e-01
1.2e+00
4.2e+00
1.2e+00
7.3e-01
4.4e-01
cases:11.07%
controls:8.91%
cases:6.87%
controls:3.68%
cases:2.07%
controls:0.62%
cases:1.30%
controls:0.02%
cases:1.88%
controls:0.59%
cases:7.68%
controls:3.83%
cases:15.57%
controls:10.66%
519
4164
4171
42571
322
1721
4368
45014
97
291
4593
46444
61
9
4629
46726
88
275
4585
46392
347
1756
4174
44042
609
4346
3303
36418
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
7.1e-01
1.8e+00
4.3e+00
—
-1.0e+50
1.0e+00
8.5e-01
cases:0.85%
controls:0.42%
cases:0.85%
controls:0.14%
cases:0.75%
controls:0.01%
—
—
cases:0.00%
controls:0.02%
cases:0.35%
controls:0.12%
cases:0.97%
controls:0.42%
40
197
4650
46538
40
66
4650
46669
35
5
4655
46730
—
0
8
4673
46659
16
57
4505
45741
38
170
3874
40594
Other transluminal endoscopic operation on stomach or duodenum
JDW98 [2001304774]
1.6e+00
2.8e+00
1.0e+50
—
—
2.6e+00
1.6e+00
cases:0.43%
controls:0.09%
cases:0.58%
controls:0.03%
cases:0.15%
controls:0.00%
—
—
—
—
cases:0.42%
controls:0.03%
cases:0.38%
controls:0.08%
20
41
4670
46694
27
16
4663
46719
7
0
4683
46735
—
—
19
14
4502
45784
15
32
3897
40732
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
5.6e-01
1.8e+00
2.2e+00
—
2.8e+00
1.3e+00
7.4e-02
cases:1.09%
controls:0.62%
cases:1.07%
controls:0.19%
cases:0.30%
controls:0.03%
—
—
cases:0.28%
controls:0.02%
cases:0.71%
controls:0.20%
cases:0.89%
controls:0.83%
51
291
4639
46444
50
87
4640
46648
14
15
4676
46720
—
13
8
4660
46659
32
90
4489
45708
35
339
3877
40425
Essential (primary) hypertension
I10 [45591453]
3.0e-01
5.3e-01
1.0e+00
4.8e+00
1.3e+00
4.9e-01
1.9e-01
cases:19.36%
controls:15.05%
cases:12.13%
controls:7.48%
cases:3.43%
controls:1.26%
cases:7.61%
controls:0.07%
cases:4.22%
controls:1.24%
cases:12.72%
controls:8.18%
cases:24.49%
controls:21.08%
908
7033
3782
39702
569
3497
4121
43238
161
588
4529
46147
357
31
4333
46704
197
581
4476
46086
575
3746
3946
42052
958
8592
2954
32172
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
7.1e-01
1.1e+00
2.2e+00
—
2.2e+00
1.5e+00
8.5e-01
cases:1.43%
controls:0.71%
cases:1.04%
controls:0.35%
cases:0.64%
controls:0.07%
—
—
cases:0.53%
controls:0.06%
cases:1.46%
controls:0.33%
cases:2.91%
controls:1.27%
67
332
4623
46403
49
163
4641
46572
30
33
4660
46702
—
25
28
4648
46639
66
149
4455
45649
114
518
3798
40246
Coloscopy
UJF32 [2001305029]
6.6e-01
1.4e+00
2.0e+00
—
2.3e+00
1.4e+00
8.7e-01
cases:5.48%
controls:2.90%
cases:3.41%
controls:0.88%
cases:0.66%
controls:0.09%
—
—
cases:0.81%
controls:0.08%
cases:3.03%
controls:0.80%
cases:7.92%
controls:3.47%
257
1355
4433
45380
160
410
4530
46325
31
44
4659
46691
—
38
39
4635
46628
137
365
4384
45433
310
1414
3602
39350
Oxygen saturation in Arterial blood
2708-6 [3016502]
5.6e-01
1.3e+00
3.1e+00
—
2.3e+00
9.1e-01
4.1e-01
cases:1.32%
controls:0.76%
cases:1.39%
controls:0.39%
cases:0.94%
controls:0.04%
—
—
cases:0.45%
controls:0.05%
cases:1.04%
controls:0.42%
cases:2.61%
controls:1.75%
62
356
4628
46379
65
182
4625
46553
44
20
4646
46715
—
21
22
4652
46645
47
192
4474
45606
102
712
3810
40052
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
6.7e-01
1.7e+00
3.4e+00
1.0e+50
2.0e+00
1.4e+00
2.6e-01
cases:0.62%
controls:0.32%
cases:0.85%
controls:0.16%
cases:0.64%
controls:0.02%
cases:0.15%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.64%
controls:0.15%
cases:1.10%
controls:0.85%
29
149
4661
46586
40
76
4650
46659
30
10
4660
46725
7
0
4683
46735
8
11
4665
46656
29
70
4492
45728
43
348
3869
40416
Polyneuropathy, unspecified
G62.9 [45566898]
5.9e-01
1.6e+00
2.5e+00
—
2.2e+00
1.3e+00
9.8e-01
cases:0.49%
controls:0.27%
cases:0.58%
controls:0.12%
cases:0.21%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.55%
controls:0.16%
cases:1.18%
controls:0.45%
23
127
4667
46608
27
57
4663
46678
10
8
4680
46727
—
7
8
4666
46659
25
72
4496
45726
46
182
3866
40582
Abdominal CT examination
JN3AD [2001305554]
7.1e-01
1.4e+00
2.6e+00
1.0e+50
1.7e+00
1.3e+00
7.8e-01
cases:0.87%
controls:0.43%
cases:1.00%
controls:0.24%
cases:0.45%
controls:0.03%
cases:0.23%
controls:0.00%
cases:0.24%
controls:0.04%
cases:1.02%
controls:0.28%
cases:2.63%
controls:1.22%
41
202
4649
46533
47
112
4643
46623
21
16
4669
46719
11
0
4679
46735
11
21
4662
46646
46
126
4475
45672
103
498
3809
40266
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
5.8e-01
1.4e+00
3.1e+00
—
2.3e+00
1.1e+00
3.6e-01
cases:1.24%
controls:0.70%
cases:1.36%
controls:0.34%
cases:1.02%
controls:0.04%
—
—
cases:0.41%
controls:0.04%
cases:1.08%
controls:0.36%
cases:2.33%
controls:1.63%
58
325
4632
46410
64
159
4626
46576
48
21
4642
46714
—
19
20
4654
46647
49
167
4472
45631
91
666
3821
40098
Other autoimmune haemolytic anaemias
D59.1 [45566703]
2.5e+00
3.3e+00
—
—
—
—
2.6e+00
cases:0.26%
controls:0.02%
cases:0.36%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.02%
12
10
4678
46725
17
6
4673
46729
—
—
—
—
12
9
3900
40755
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
6.8e-01
1.6e+00
1.6e+00
—
2.5e+00
1.5e+00
6.4e-01
cases:4.12%
controls:2.12%
cases:4.46%
controls:0.95%
cases:0.68%
controls:0.15%
—
—
cases:1.63%
controls:0.13%
cases:4.09%
controls:0.95%
cases:5.50%
controls:2.96%
193
992
4497
45743
209
445
4481
46290
32
68
4658
46667
—
76
63
4597
46604
185
437
4336
45361
215
1208
3697
39556
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
6.9e-01
1.9e+00
—
—
2.7e+00
2.6e+00
1.2e+00
cases:0.45%
controls:0.22%
cases:0.68%
controls:0.10%
—
—
—
—
cases:0.34%
controls:0.02%
cases:1.17%
controls:0.09%
cases:1.61%
controls:0.48%
21
105
4669
46630
32
46
4658
46689
—
—
16
11
4657
46656
53
41
4468
45757
63
194
3849
40570
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
3.8e-01
9.5e-01
2.7e+00
—
2.4e+00
1.4e+00
9.2e-01
cases:0.55%
controls:0.38%
cases:0.55%
controls:0.22%
cases:0.55%
controls:0.04%
—
—
cases:0.21%
controls:0.02%
cases:0.75%
controls:0.19%
cases:1.92%
controls:0.78%
26
177
4664
46558
26
101
4664
46634
26
17
4664
46718
—
10
9
4663
46658
34
86
4487
45712
75
316
3837
40448
Nephrology
39 [38004479]
8.1e-01
8.6e-01
1.0e+00
2.5e+00
9.5e-01
1.1e+00
1.1e+00
cases:1.24%
controls:0.55%
cases:1.02%
controls:0.43%
cases:0.55%
controls:0.20%
cases:0.38%
controls:0.03%
cases:0.53%
controls:0.21%
cases:1.55%
controls:0.50%
cases:2.53%
controls:0.87%
58
258
4632
46477
48
203
4642
46532
26
92
4664
46643
18
15
4672
46720
25
97
4648
46570
70
228
4451
45570
99
354
3813
40410
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.4e-01
6.2e-01
1.6e+00
3.6e+00
1.5e+00
5.6e-01
2.2e-01
cases:17.91%
controls:15.97%
cases:18.81%
controls:11.09%
cases:10.90%
controls:2.30%
cases:5.99%
controls:0.17%
cases:9.99%
controls:2.31%
cases:19.02%
controls:11.79%
cases:30.50%
controls:26.09%
840
7465
3850
39270
882
5185
3808
41550
511
1073
4179
45662
281
78
4409
46657
467
1076
4206
45591
860
5398
3661
40400
1193
10634
2719
30130
Obesity, unspecified
E66.9 [45576460]
1.3e+00
1.9e+00
2.3e+00
1.0e+50
—
1.8e+00
1.1e+00
cases:0.70%
controls:0.20%
cases:0.38%
controls:0.06%
cases:0.13%
controls:0.01%
cases:0.13%
controls:0.00%
—
—
cases:0.42%
controls:0.07%
cases:0.69%
controls:0.23%
33
94
4657
46641
18
28
4672
46707
6
6
4684
46729
6
0
4684
46735
—
19
32
4502
45766
27
94
3885
40670
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.5e-02
5.1e-01
1.5e+00
4.5e+00
1.3e+00
4.0e-01
1.4e-01
cases:4.67%
controls:4.47%
cases:3.73%
controls:2.27%
cases:1.34%
controls:0.29%
cases:0.96%
controls:0.01%
cases:1.13%
controls:0.31%
cases:3.69%
controls:2.50%
cases:9.48%
controls:8.33%
219
2090
4471
44645
175
1059
4515
45676
63
137
4627
46598
45
5
4645
46730
53
144
4620
46523
167
1143
4354
44655
371
3396
3541
37368
Nutritional therapy
R4190 [2001310243]
1.2e+00
2.5e+00
—
—
—
2.7e+00
1.8e+00
cases:0.38%
controls:0.11%
cases:0.53%
controls:0.04%
—
—
—
—
—
—
cases:0.82%
controls:0.05%
cases:0.97%
controls:0.16%
18
52
4672
46683
25
21
4665
46714
—
—
—
37
25
4484
45773
38
66
3874
40698
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
4.5e-01
1.6e+00
2.3e+00
1.0e+50
2.5e+00
7.7e-01
5.7e-01
cases:2.69%
controls:1.74%
cases:3.11%
controls:0.64%
cases:0.96%
controls:0.10%
cases:0.11%
controls:0.00%
cases:0.92%
controls:0.07%
cases:1.39%
controls:0.65%
cases:4.96%
controls:2.86%
126
811
4564
45924
146
300
4544
46435
45
45
4645
46690
5
0
4685
46735
43
35
4630
46632
63
299
4458
45499
194
1167
3718
39597
pH of Arterial blood
2744-1 [3019977]
5.1e-01
1.2e+00
2.9e+00
—
2.1e+00
9.7e-01
4.3e-01
cases:1.49%
controls:0.91%
cases:1.56%
controls:0.46%
cases:1.07%
controls:0.06%
—
—
cases:0.45%
controls:0.05%
cases:1.24%
controls:0.47%
cases:2.99%
controls:1.96%
70
423
4620
46312
73
213
4617
46522
50
27
4640
46708
—
21
25
4652
46642
56
217
4465
45581
117
800
3795
39964
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
6.5e-01
1.7e+00
3.3e+00
1.0e+50
1.9e+00
1.3e+00
3.5e-01
cases:0.62%
controls:0.32%
cases:0.90%
controls:0.16%
cases:0.64%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.17%
controls:0.03%
cases:0.62%
controls:0.18%
cases:1.28%
controls:0.91%
29
151
4661
46584
42
75
4648
46660
30
11
4660
46724
8
0
4682
46735
8
12
4665
46655
28
81
4493
45717
50
369
3862
40395
electrolytes in combination with other drugs
B05XA31 [21601214]
2.2e+00
—
—
—
—
—
6.0e+00
cases:0.17%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
cases:6.57%
controls:0.02%
8
9
4682
46726
—
—
—
—
—
257
7
3655
40757
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
5.5e-01
1.3e+00
2.0e+00
—
2.5e+00
1.2e+00
6.5e-01
cases:1.30%
controls:0.76%
cases:0.90%
controls:0.24%
cases:0.23%
controls:0.03%
—
—
cases:0.39%
controls:0.03%
cases:0.82%
controls:0.25%
cases:1.71%
controls:0.90%
61
354
4629
46381
42
114
4648
46621
11
15
4679
46720
—
18
15
4655
46652
37
113
4484
45685
67
368
3845
40396
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
4.7e-01
1.5e+00
2.4e+00
—
2.2e+00
9.6e-01
6.7e-01
cases:2.39%
controls:1.51%
cases:2.24%
controls:0.52%
cases:0.96%
controls:0.09%
—
—
cases:0.73%
controls:0.08%
cases:1.39%
controls:0.54%
cases:4.42%
controls:2.31%
112
707
4578
46028
105
243
4585
46492
45
41
4645
46694
—
34
39
4639
46628
63
246
4458
45552
173
941
3739
39823
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
2.7e-01
1.2e+00
2.2e+00
1.0e+50
2.6e+00
1.5e+00
6.8e-01
cases:0.53%
controls:0.41%
cases:0.38%
controls:0.12%
cases:0.15%
controls:0.02%
cases:0.11%
controls:0.00%
cases:0.19%
controls:0.01%
cases:0.64%
controls:0.14%
cases:1.10%
controls:0.56%
25
190
4665
46545
18
56
4672
46679
7
8
4683
46727
5
0
4685
46735
9
7
4664
46660
29
63
4492
45735
43
229
3869
40535
Base excess in Arterial blood by calculation
1925-7 [3003396]
4.8e-01
1.1e+00
2.9e+00
—
2.2e+00
9.2e-01
4.3e-01
cases:1.47%
controls:0.91%
cases:1.49%
controls:0.48%
cases:1.04%
controls:0.06%
—
—
cases:0.47%
controls:0.05%
cases:1.17%
controls:0.47%
cases:2.99%
controls:1.97%
69
426
4621
46309
70
224
4620
46511
49
26
4641
46709
—
22
25
4651
46642
53
216
4468
45582
117
802
3795
39962
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
9.9e-01
1.0e+00
2.1e+00
—
1.9e+00
1.7e+00
1.3e+00
cases:0.49%
controls:0.18%
cases:0.26%
controls:0.09%
cases:0.23%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.53%
controls:0.09%
cases:1.25%
controls:0.36%
23
85
4667
46650
12
44
4678
46691
11
13
4679
46722
—
9
13
4664
46654
24
43
4497
45755
49
146
3863
40618
General Surgery
2 [38004447]
3.7e-01
8.3e-01
1.5e+00
2.8e+00
1.4e+00
7.5e-01
4.2e-01
cases:27.87%
controls:21.01%
cases:14.31%
controls:6.78%
cases:4.35%
controls:1.05%
cases:0.60%
controls:0.04%
cases:3.89%
controls:0.98%
cases:13.07%
controls:6.62%
cases:27.40%
controls:19.94%
1307
9821
3383
36914
671
3168
4019
43567
204
493
4486
46242
28
17
4662
46718
182
456
4491
46211
591
3030
3930
42768
1072
8127
2840
32637
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
4.8e-01
1.2e+00
2.9e+00
—
2.1e+00
9.1e-01
4.2e-01
cases:1.47%
controls:0.91%
cases:1.49%
controls:0.48%
cases:1.07%
controls:0.06%
—
—
cases:0.43%
controls:0.05%
cases:1.19%
controls:0.48%
cases:2.91%
controls:1.93%
69
426
4621
46309
70
222
4620
46513
50
27
4640
46708
—
20
24
4653
46643
54
221
4467
45577
114
787
3798
39977
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
4.9e-01
1.2e+00
2.9e+00
—
2.1e+00
9.1e-01
4.1e-01
cases:1.47%
controls:0.91%
cases:1.49%
controls:0.48%
cases:1.07%
controls:0.06%
—
—
cases:0.43%
controls:0.05%
cases:1.19%
controls:0.48%
cases:2.89%
controls:1.93%
69
424
4621
46311
70
222
4620
46513
50
27
4640
46708
—
20
24
4653
46643
54
222
4467
45576
113
787
3799
39977
Case Management Agency
251B00000X [38004193]
1.7e-01
2.4e-01
7.4e-01
5.6e+00
8.9e-01
3.6e-01
9.4e-02
cases:49.79%
controls:45.54%
cases:43.54%
controls:37.68%
cases:26.65%
controls:14.73%
cases:71.73%
controls:0.94%
cases:29.34%
controls:14.60%
cases:48.86%
controls:39.88%
cases:59.99%
controls:57.71%
2335
21281
2355
25454
2042
17611
2648
29124
1250
6885
3440
39850
3364
441
1326
46294
1371
6812
3302
39855
2209
18264
2312
27534
2347
23526
1565
17238
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
7.0e-01
7.6e-01
2.6e+00
—
2.3e+00
1.3e+00
1.0e+00
cases:0.92%
controls:0.46%
cases:0.49%
controls:0.23%
cases:0.36%
controls:0.03%
—
—
cases:0.36%
controls:0.04%
cases:0.64%
controls:0.17%
cases:1.74%
controls:0.63%
43
213
4647
46522
23
107
4667
46628
17
13
4673
46722
—
17
17
4656
46650
29
78
4492
45720
68
255
3844
40509
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
2.4e-01
1.0e+00
2.6e+00
—
2.7e+00
1.4e+00
1.1e+00
cases:0.30%
controls:0.24%
cases:0.23%
controls:0.08%
cases:0.15%
controls:0.01%
—
—
cases:0.19%
controls:0.01%
cases:0.33%
controls:0.08%
cases:0.97%
controls:0.31%
14
110
4676
46625
11
39
4679
46696
7
5
4683
46730
—
9
6
4664
46661
15
36
4506
45762
38
128
3874
40636
Immunofixation for Serum or Plasma
25700-6 [3037756]
1.1e+00
1.5e+00
2.6e+00
—
—
1.7e+00
1.0e+00
cases:0.51%
controls:0.17%
cases:0.34%
controls:0.07%
cases:0.17%
controls:0.01%
—
—
—
—
cases:0.38%
controls:0.07%
cases:0.82%
controls:0.29%
24
81
4666
46654
16
35
4674
46700
8
6
4682
46729
—
—
17
33
4504
45765
32
119
3880
40645
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
1.6e-01
1.1e+00
2.1e+00
—
2.6e+00
9.8e-01
9.9e-01
cases:0.41%
controls:0.34%
cases:0.41%
controls:0.13%
cases:0.13%
controls:0.01%
—
—
cases:0.24%
controls:0.02%
cases:0.35%
controls:0.13%
cases:1.25%
controls:0.47%
19
161
4671
46574
19
62
4671
46673
6
7
4684
46728
—
11
8
4662
46659
16
61
4505
45737
49
191
3863
40573
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.3e-01
4.6e-01
1.5e+00
3.3e+00
1.4e+00
5.7e-01
3.8e-01
cases:5.57%
controls:4.45%
cases:5.76%
controls:3.72%
cases:3.58%
controls:0.81%
cases:1.17%
controls:0.04%
cases:3.42%
controls:0.87%
cases:6.79%
controls:3.97%
cases:11.71%
controls:8.28%
261
2082
4429
44653
270
1737
4420
44998
168
377
4522
46358
55
21
4635
46714
160
404
4513
46263
307
1819
4214
43979
458
3377
3454
37387
PET-CT of upper body metabolism
JN5DR [2001310926]
—
2.9e+00
—
—
—
2.9e+00
2.1e+00
—
—
cases:0.55%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.41%
controls:0.05%
—
26
15
4664
46720
—
—
—
16
9
4505
45789
16
21
3896
40743
Bacteria identified in Urine by Culture
630-4 [3026008]
2.8e-01
4.3e-01
1.2e+00
3.7e+00
1.3e+00
4.9e-01
3.3e-01
cases:4.31%
controls:3.29%
cases:3.05%
controls:2.00%
cases:0.98%
controls:0.30%
cases:0.45%
controls:0.01%
cases:1.20%
controls:0.31%
cases:3.52%
controls:2.18%
cases:9.00%
controls:6.62%
202
1538
4488
45197
143
934
4547
45801
46
139
4644
46596
21
5
4669
46730
56
147
4617
46520
159
998
4362
44800
352
2697
3560
38067
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.2e-01
6.2e-01
1.5e+00
3.6e+00
1.3e+00
4.8e-01
2.8e-01
cases:11.39%
controls:10.19%
cases:9.87%
controls:5.55%
cases:3.43%
controls:0.76%
cases:0.68%
controls:0.02%
cases:2.70%
controls:0.75%
cases:9.02%
controls:5.80%
cases:20.27%
controls:16.17%
534
4762
4156
41973
463
2592
4227
44143
161
355
4529
46380
32
9
4658
46726
126
348
4547
46319
408
2655
4113
43143
793
6590
3119
34174
Infectious Disease
44 [38004484]
5.8e-01
1.1e+00
2.1e+00
—
2.0e+00
1.3e+00
6.5e-01
cases:1.77%
controls:1.00%
cases:1.15%
controls:0.40%
cases:0.43%
controls:0.05%
—
—
cases:0.53%
controls:0.07%
cases:1.59%
controls:0.42%
cases:2.51%
controls:1.32%
83
466
4607
46269
54
187
4636
46548
20
24
4670
46711
—
25
34
4648
46633
72
192
4449
45606
98
539
3814
40225
General anaesthesia
WX402 [2001310806]
5.5e-01
1.0e+00
3.0e+00
—
1.6e+00
1.0e+00
5.0e-01
cases:1.56%
controls:0.90%
cases:1.28%
controls:0.46%
cases:1.13%
controls:0.06%
—
—
cases:0.30%
controls:0.06%
cases:1.24%
controls:0.45%
cases:3.09%
controls:1.89%
73
422
4617
46313
60
216
4630
46519
53
27
4637
46708
—
14
27
4659
46640
56
207
4465
45591
121
771
3791
39993
enoxaparin; parenteral
B01AB05 [21600976]
4.5e-01
1.0e+00
2.7e+00
—
2.1e+00
1.1e+00
4.3e-01
cases:5.39%
controls:3.50%
cases:3.20%
controls:1.17%
cases:2.26%
controls:0.16%
—
—
cases:1.24%
controls:0.16%
cases:2.88%
controls:1.02%
cases:6.11%
controls:4.05%
253
1635
4437
45100
150
545
4540
46190
106
75
4584
46660
—
58
74
4615
46593
130
465
4391
45333
239
1652
3673
39112
Short blood count panel - Blood
55429-5 [40758558]
3.5e-01
6.2e-01
1.4e+00
2.7e+00
1.4e+00
7.5e-01
4.6e-01
cases:3.86%
controls:2.76%
cases:3.05%
controls:1.66%
cases:1.54%
controls:0.37%
cases:0.32%
controls:0.02%
cases:1.39%
controls:0.35%
cases:3.56%
controls:1.71%
cases:6.75%
controls:4.38%
181
1289
4509
45446
143
775
4547
45960
72
173
4618
46562
15
10
4675
46725
65
165
4608
46502
161
783
4360
45015
264
1784
3648
38980
Family history of malignant neoplasm of digestive organs
Z80.0 [45542462]
2.5e+00
2.7e+00
—
—
—
—
2.4e+00
cases:0.21%
controls:0.02%
cases:0.26%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.03%
10
8
4680
46727
12
8
4678
46727
—
—
—
—
12
11
3900
40753
Cathetrisation of artery
TPH07 [2001309747]
6.0e-01
1.5e+00
3.6e+00
—
1.3e+00
1.2e+00
7.1e-01
cases:1.39%
controls:0.77%
cases:1.32%
controls:0.29%
cases:1.17%
controls:0.03%
—
—
cases:0.13%
controls:0.03%
cases:0.84%
controls:0.25%
cases:2.02%
controls:1.00%
65
359
4625
46376
62
135
4628
46600
55
15
4635
46720
—
6
16
4667
46651
38
116
4483
45682
79
408
3833
40356
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
5.6e-01
9.5e-01
2.7e+00
—
2.3e+00
1.1e+00
6.2e-01
cases:0.60%
controls:0.34%
cases:0.58%
controls:0.22%
cases:0.47%
controls:0.03%
—
—
cases:0.17%
controls:0.02%
cases:0.58%
controls:0.20%
cases:1.43%
controls:0.77%
28
159
4662
46576
27
104
4663
46631
22
15
4668
46720
—
8
8
4665
46659
26
91
4495
45707
56
315
3856
40449
Other specified special examinations
Z01.8 [45581003]
5.6e-01
1.2e+00
2.2e+00
1.0e+50
1.9e+00
1.1e+00
5.9e-01
cases:3.37%
controls:1.95%
cases:2.24%
controls:0.65%
cases:0.72%
controls:0.08%
cases:0.17%
controls:0.00%
cases:0.43%
controls:0.06%
cases:1.84%
controls:0.62%
cases:4.55%
controls:2.58%
158
911
4532
45824
105
306
4585
46429
34
37
4656
46698
8
0
4682
46735
20
30
4653
46637
83
283
4438
45515
178
1051
3734
39713
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.0e-01
5.6e-01
1.3e+00
3.8e+00
1.2e+00
4.6e-01
2.7e-01
cases:9.70%
controls:8.82%
cases:8.59%
controls:5.12%
cases:2.81%
controls:0.79%
cases:1.39%
controls:0.03%
cases:2.70%
controls:0.84%
cases:8.38%
controls:5.47%
cases:17.82%
controls:14.20%
455
4124
4235
42611
403
2391
4287
44344
132
369
4558
46366
65
14
4625
46721
126
393
4547
46274
379
2506
4142
43292
697
5790
3215
34974
Psychiatry
26 [38004469]
4.5e-01
7.0e-01
9.7e-01
2.7e+00
1.2e+00
1.0e+00
6.2e-01
cases:4.75%
controls:3.09%
cases:2.84%
controls:1.43%
cases:1.32%
controls:0.50%
cases:0.43%
controls:0.03%
cases:1.56%
controls:0.49%
cases:3.74%
controls:1.38%
cases:6.08%
controls:3.37%
223
1442
4467
45293
133
668
4557
46067
62
235
4628
46500
20
14
4670
46721
73
228
4600
46439
169
631
4352
45167
238
1372
3674
39392
Primary adrenocortical insufficiency
E27.1 [45537966]
—
2.8e+00
—
1.0e+50
—
2.5e+00
2.3e+00
—
—
cases:0.17%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.24%
controls:0.02%
cases:0.28%
controls:0.03%
—
8
5
4682
46730
—
6
0
4684
46735
—
11
9
4510
45789
11
12
3901
40752
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.2e-01
1.0e+00
2.6e+00
—
1.9e+00
1.0e+00
6.7e-01
cases:4.29%
controls:3.14%
cases:3.88%
controls:1.45%
cases:2.60%
controls:0.20%
—
—
cases:1.31%
controls:0.19%
cases:3.52%
controls:1.28%
cases:8.41%
controls:4.49%
201
1468
4489
45267
182
677
4508
46058
122
94
4568
46641
—
61
90
4612
46577
159
584
4362
45214
329
1832
3583
38932
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
2.6e-01
1.0e+00
2.7e+00
—
2.0e+00
1.1e+00
7.0e-01
cases:2.73%
controls:2.12%
cases:2.67%
controls:0.98%
cases:2.13%
controls:0.14%
—
—
cases:1.03%
controls:0.15%
cases:2.70%
controls:0.89%
cases:6.19%
controls:3.17%
128
991
4562
45744
125
456
4565
46279
100
66
4590
46669
—
48
68
4625
46599
122
408
4399
45390
242
1291
3670
39473
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
1.5e-01
7.0e-01
1.7e+00
2.8e+00
1.5e+00
4.7e-01
3.3e-01
cases:8.36%
controls:7.26%
cases:6.89%
controls:3.53%
cases:2.30%
controls:0.44%
cases:0.47%
controls:0.03%
cases:2.14%
controls:0.47%
cases:5.86%
controls:3.75%
cases:15.16%
controls:11.40%
392
3395
4298
43340
323
1649
4367
45086
108
206
4582
46529
22
13
4668
46722
100
218
4573
46449
265
1718
4256
44080
593
4647
3319
36117
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.9e-01
4.5e-01
1.6e+00
3.4e+00
1.4e+00
4.8e-01
1.1e-01
cases:15.12%
controls:12.86%
cases:16.67%
controls:11.29%
cases:11.47%
controls:2.58%
cases:5.10%
controls:0.18%
cases:9.91%
controls:2.63%
cases:18.43%
controls:12.23%
cases:24.57%
controls:22.52%
709
6012
3981
40723
782
5276
3908
41459
538
1207
4152
45528
239
83
4451
46652
463
1228
4210
45439
833
5601
3688
40197
961
9179
2951
31585
Fever, unspecified
R50.9 [45582716]
5.8e-01
1.1e+00
2.2e+00
—
1.6e+00
1.2e+00
8.1e-01
cases:1.73%
controls:0.98%
cases:1.15%
controls:0.40%
cases:0.28%
controls:0.03%
—
—
cases:0.24%
controls:0.05%
cases:1.35%
controls:0.40%
cases:3.20%
controls:1.44%
81
456
4609
46279
54
185
4636
46550
13
14
4677
46721
—
11
23
4662
46644
61
182
4460
45616
125
588
3787
40176
Malignant neoplasm: Lower third of oesophagus
C15.5 [45547480]
1.4e+00
2.6e+00
3.1e+00
1.0e+50
—
1.8e+00
—
cases:0.11%
controls:0.03%
cases:0.38%
controls:0.03%
cases:0.28%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
cases:0.22%
controls:0.03%
—
—
5
12
4685
46723
18
14
4672
46721
13
6
4677
46729
5
0
4685
46735
—
10
16
4511
45782
—
Bone marrow biopsy
XW000 [2001310618]
6.2e-01
1.8e+00
—
—
2.6e+00
2.3e+00
8.0e-01
cases:0.45%
controls:0.24%
cases:0.55%
controls:0.09%
—
—
—
—
cases:0.26%
controls:0.02%
cases:0.64%
controls:0.07%
cases:0.72%
controls:0.32%
21
113
4669
46622
26
42
4664
46693
—
—
12
9
4661
46658
29
31
4492
45767
28
132
3884
40632
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
5.9e-01
6.5e-01
2.6e+00
—
2.1e+00
1.1e+00
1.0e+00
cases:1.09%
controls:0.60%
cases:0.60%
controls:0.31%
cases:0.55%
controls:0.04%
—
—
cases:0.49%
controls:0.06%
cases:0.91%
controls:0.30%
cases:2.38%
controls:0.87%
51
282
4639
46453
28
146
4662
46589
26
19
4664
46716
—
23
28
4650
46639
41
138
4480
45660
93
355
3819
40409
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.4e-01
1.1e+00
2.1e+00
—
2.3e+00
9.5e-01
6.3e-01
cases:1.86%
controls:1.20%
cases:1.49%
controls:0.53%
cases:0.60%
controls:0.07%
—
—
cases:0.51%
controls:0.05%
cases:1.50%
controls:0.59%
cases:3.58%
controls:1.94%
87
563
4603
46172
70
246
4620
46489
28
34
4662
46701
—
24
25
4649
46642
68
269
4453
45529
140
791
3772
39973
Melaena
K92.1 [45533624]
6.0e-01
2.2e+00
1.9e+00
—
2.3e+00
1.1e+00
5.1e-01
cases:0.70%
controls:0.39%
cases:1.04%
controls:0.12%
cases:0.17%
controls:0.03%
—
—
cases:0.15%
controls:0.01%
cases:0.40%
controls:0.14%
cases:0.89%
controls:0.54%
33
181
4657
46554
49
57
4641
46678
8
12
4682
46723
—
7
7
4666
46660
18
62
4503
45736
35
219
3877
40545
Endoscopic dilatation of oesophagus
JCA55 [2001304612]
1.1e+00
2.5e+00
—
—
—
3.0e+00
1.9e+00
cases:0.13%
controls:0.04%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.53%
controls:0.03%
cases:0.36%
controls:0.06%
6
20
4684
46715
10
8
4680
46727
—
—
—
24
12
4497
45786
14
23
3898
40741
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
4.3e-01
1.3e+00
3.2e+00
1.0e+50
2.1e+00
8.2e-01
3.0e-01
cases:0.87%
controls:0.57%
cases:0.96%
controls:0.26%
cases:0.62%
controls:0.03%
cases:0.15%
controls:0.00%
cases:0.32%
controls:0.04%
cases:0.66%
controls:0.29%
cases:1.69%
controls:1.26%
41
267
4649
46468
45
123
4645
46612
29
12
4661
46723
7
0
4683
46735
15
19
4658
46648
30
135
4491
45663
66
514
3846
40250
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
4.5e-01
1.2e+00
2.5e+00
—
2.2e+00
8.5e-01
6.2e-01
cases:0.90%
controls:0.57%
cases:1.07%
controls:0.34%
cases:0.62%
controls:0.05%
—
—
cases:0.32%
controls:0.03%
cases:0.84%
controls:0.36%
cases:2.66%
controls:1.44%
42
268
4648
46467
50
158
4640
46577
29
24
4661
46711
—
15
16
4658
46651
38
165
4483
45633
104
588
3808
40176
Atherosclerotic heart disease
I25.1 [45596196]
1.3e-01
4.1e-01
8.1e-01
4.6e+00
1.1e+00
4.4e-01
1.9e-01
cases:5.25%
controls:4.65%
cases:3.60%
controls:2.43%
cases:1.00%
controls:0.45%
cases:1.86%
controls:0.02%
cases:1.43%
controls:0.48%
cases:4.16%
controls:2.72%
cases:7.90%
controls:6.64%
246
2174
4444
44561
169
1134
4521
45601
47
209
4643
46526
87
9
4603
46726
67
225
4606
46442
188
1246
4333
44552
309
2705
3603
38059
Blood transfusion
WW500 [2001310603]
6.9e-01
2.2e+00
—
1.0e+50
2.4e+00
1.4e+00
1.3e+00
cases:0.28%
controls:0.14%
cases:0.51%
controls:0.06%
—
—
cases:0.21%
controls:0.00%
cases:0.19%
controls:0.02%
cases:0.40%
controls:0.10%
cases:0.95%
controls:0.25%
13
65
4677
46670
24
27
4666
46708
—
10
0
4680
46735
9
8
4664
46659
18
45
4503
45753
37
103
3875
40661
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
5.2e-01
1.0e+00
2.0e+00
—
2.3e+00
9.1e-01
5.4e-01
cases:1.17%
controls:0.70%
cases:1.15%
controls:0.42%
cases:0.53%
controls:0.07%
—
—
cases:0.45%
controls:0.04%
cases:1.37%
controls:0.56%
cases:3.45%
controls:2.05%
55
326
4635
46409
54
194
4636
46541
25
33
4665
46702
—
21
21
4652
46646
62
256
4459
45542
135
834
3777
39930
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
4.1e-01
9.2e-01
1.8e+00
—
1.9e+00
1.3e+00
1.4e+00
cases:1.54%
controls:1.02%
cases:0.72%
controls:0.29%
cases:0.17%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.88%
controls:0.25%
cases:2.17%
controls:0.56%
72
478
4618
46257
34
135
4656
46600
8
13
4682
46722
—
9
13
4664
46654
40
115
4481
45683
85
230
3827
40534
FEV1 percent change
69983-5 [42868472]
4.1e-01
9.2e-01
1.8e+00
—
1.9e+00
1.3e+00
1.4e+00
cases:1.54%
controls:1.02%
cases:0.72%
controls:0.29%
cases:0.17%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.88%
controls:0.25%
cases:2.17%
controls:0.56%
72
478
4618
46257
34
135
4656
46600
8
13
4682
46722
—
9
13
4664
46654
40
115
4481
45683
85
230
3827
40534
FEV1 --post bronchodilation
20155-8 [3023550]
4.1e-01
9.2e-01
1.8e+00
—
1.9e+00
1.3e+00
1.4e+00
cases:1.54%
controls:1.02%
cases:0.72%
controls:0.29%
cases:0.17%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.88%
controls:0.25%
cases:2.17%
controls:0.56%
72
478
4618
46257
34
135
4656
46600
8
13
4682
46722
—
9
13
4664
46654
40
115
4481
45683
85
230
3827
40534
FEV1/FVC --post bronchodilation
69970-2 [42868459]
4.1e-01
9.2e-01
1.8e+00
—
1.9e+00
1.3e+00
1.4e+00
cases:1.54%
controls:1.02%
cases:0.72%
controls:0.29%
cases:0.17%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.88%
controls:0.25%
cases:2.17%
controls:0.56%
72
478
4618
46257
34
135
4656
46600
8
13
4682
46722
—
9
13
4664
46654
40
115
4481
45683
85
230
3827
40534
FVC percent change Respiratory system
69982-7 [42868471]
4.1e-01
9.2e-01
1.8e+00
—
1.9e+00
1.3e+00
1.4e+00
cases:1.54%
controls:1.02%
cases:0.72%
controls:0.29%
cases:0.17%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.88%
controls:0.25%
cases:2.17%
controls:0.56%
72
478
4618
46257
34
135
4656
46600
8
13
4682
46722
—
9
13
4664
46654
40
115
4481
45683
85
230
3827
40534
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
5.7e-01
9.6e-01
2.4e+00
—
2.1e+00
1.0e+00
7.5e-01
cases:0.36%
controls:0.21%
cases:0.55%
controls:0.21%
cases:0.30%
controls:0.03%
—
—
cases:0.26%
controls:0.03%
cases:0.69%
controls:0.25%
cases:1.89%
controls:0.90%
17
96
4673
46639
26
100
4664
46635
14
13
4676
46722
—
12
14
4661
46653
31
114
4490
45684
74
368
3838
40396
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.2e-01
1.1e+00
2.7e+00
—
2.4e+00
1.1e+00
4.9e-01
cases:0.30%
controls:0.27%
cases:0.38%
controls:0.13%
cases:0.21%
controls:0.01%
—
—
cases:0.24%
controls:0.02%
cases:0.49%
controls:0.16%
cases:1.15%
controls:0.71%
14
124
4676
46611
18
61
4672
46674
10
7
4680
46728
—
11
10
4662
46657
22
75
4499
45723
45
289
3867
40475
Metastasis to retroperitoneum
OMOP5031838 [35226284]
—
2.5e+00
2.5e+00
—
—
2.3e+00
9.6e-01
—
—
cases:0.15%
controls:0.01%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.18%
controls:0.07%
—
7
6
4683
46729
7
6
4683
46729
—
—
12
12
4509
45786
7
28
3905
40736
Metastasis to peritoneum
OMOP5031802 [35226253]
—
2.5e+00
2.5e+00
—
—
2.3e+00
9.6e-01
—
—
cases:0.15%
controls:0.01%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.18%
controls:0.07%
—
7
6
4683
46729
7
6
4683
46729
—
—
12
12
4509
45786
7
28
3905
40736
Secondary malignant neoplasm of retroperitoneum and peritoneum
C78.6 [45547522]
—
2.5e+00
2.5e+00
—
—
2.3e+00
9.6e-01
—
—
cases:0.15%
controls:0.01%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.18%
controls:0.07%
—
7
6
4683
46729
7
6
4683
46729
—
—
12
12
4509
45786
7
28
3905
40736
ferrous sulfate; oral
B03AA07 [21601086]
—
1.9e+00
1.9e+00
—
2.4e+00
1.8e+00
1.1e+00
—
—
cases:0.34%
controls:0.05%
cases:0.13%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.29%
controls:0.05%
cases:0.38%
controls:0.13%
—
16
24
4674
46711
6
9
4684
46726
—
8
7
4665
46660
13
22
4508
45776
15
53
3897
40711
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
3.9e-01
9.6e-01
2.1e+00
—
2.2e+00
1.2e+00
7.0e-01
cases:1.45%
controls:0.98%
cases:1.30%
controls:0.50%
cases:0.64%
controls:0.08%
—
—
cases:0.41%
controls:0.04%
cases:1.57%
controls:0.47%
cases:3.22%
controls:1.63%
68
460
4622
46275
61
234
4629
46501
30
36
4660
46699
—
19
21
4654
46646
71
215
4450
45583
126
664
3786
40100
Physiotherapist
Z3226 [2001311560]
5.3e-01
1.4e+00
2.2e+00
—
1.3e+00
1.1e+00
7.9e-01
cases:3.26%
controls:1.95%
cases:2.00%
controls:0.53%
cases:0.85%
controls:0.10%
—
—
cases:0.30%
controls:0.08%
cases:1.53%
controls:0.53%
cases:3.35%
controls:1.54%
153
913
4537
45822
94
246
4596
46489
40
45
4650
46690
—
14
39
4659
46628
69
245
4452
45553
131
628
3781
40136
Gas panel - Venous blood
24339-4 [3000991]
3.9e-01
1.0e+00
2.3e+00
—
2.0e+00
1.1e+00
6.8e-01
cases:0.85%
controls:0.58%
cases:1.02%
controls:0.38%
cases:0.70%
controls:0.07%
—
—
cases:0.41%
controls:0.05%
cases:1.15%
controls:0.38%
cases:2.61%
controls:1.33%
40
271
4650
46464
48
176
4642
46559
33
32
4657
46703
—
19
25
4654
46642
52
173
4469
45625
102
543
3810
40221
INR in Blood by Coagulation assay
34714-6 [3032080]
2.7e-01
7.7e-01
1.2e+00
2.6e+00
1.0e+00
7.8e-01
5.3e-01
cases:7.97%
controls:6.22%
cases:8.42%
controls:4.08%
cases:5.18%
controls:1.56%
cases:1.60%
controls:0.13%
cases:4.07%
controls:1.49%
cases:8.67%
controls:4.17%
cases:16.05%
controls:10.10%
374
2905
4316
43830
395
1909
4295
44826
243
727
4447
46008
75
59
4615
46676
190
694
4483
45973
392
1910
4129
43888
628
4117
3284
36647
Iron deficiency anaemia
D50 [45571628]
1.9e+00
1.9e+00
—
—
—
1.8e+00
1.6e+00
cases:0.34%
controls:0.05%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
cases:0.18%
controls:0.03%
cases:0.46%
controls:0.09%
16
23
4674
46712
11
17
4679
46718
—
—
—
8
14
4513
45784
18
38
3894
40726
Immunohistochemistry procedure
117617002 [4035726]
2.7e-01
1.7e+00
2.9e+00
—
—
1.5e+00
9.9e-01
cases:0.98%
controls:0.75%
cases:1.49%
controls:0.27%
cases:0.60%
controls:0.03%
—
—
—
—
cases:0.93%
controls:0.21%
cases:1.74%
controls:0.65%
46
350
4644
46385
70
125
4620
46610
28
15
4662
46720
—
—
42
95
4479
45703
68
265
3844
40499
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
8.5e-02
4.0e-01
1.5e+00
3.5e+00
1.3e+00
3.5e-01
1.3e-01
cases:20.11%
controls:18.78%
cases:22.09%
controls:16.02%
cases:12.37%
controls:3.12%
cases:6.06%
controls:0.20%
cases:11.15%
controls:3.19%
cases:22.67%
controls:17.17%
cases:34.10%
controls:31.34%
943
8776
3747
37959
1036
7488
3654
39247
580
1458
4110
45277
284
94
4406
46641
521
1490
4152
45177
1025
7862
3496
37936
1334
12774
2578
27990
Colonoscopy Study observation
28023-0 [3022145]
3.8e-01
1.1e+00
2.2e+00
1.0e+50
2.0e+00
1.2e+00
6.3e-01
cases:1.32%
controls:0.91%
cases:1.07%
controls:0.36%
cases:0.21%
controls:0.02%
cases:0.19%
controls:0.00%
cases:0.21%
controls:0.03%
cases:1.11%
controls:0.35%
cases:2.71%
controls:1.45%
62
424
4628
46311
50
168
4640
46567
10
11
4680
46724
9
0
4681
46735
10
13
4663
46654
50
160
4471
45638
106
593
3806
40171
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
8.9e-02
4.0e-01
1.5e+00
3.5e+00
1.3e+00
3.4e-01
1.3e-01
cases:20.32%
controls:18.92%
cases:22.32%
controls:16.19%
cases:12.45%
controls:3.21%
cases:6.03%
controls:0.20%
cases:11.23%
controls:3.25%
cases:22.85%
controls:17.38%
cases:34.30%
controls:31.49%
953
8841
3737
37894
1047
7565
3643
39170
584
1498
4106
45237
283
95
4407
46640
525
1515
4148
45152
1033
7960
3488
37838
1342
12835
2570
27929
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
8.5e-02
3.9e-01
1.4e+00
3.4e+00
1.3e+00
3.9e-01
1.9e-01
cases:13.86%
controls:12.88%
cases:16.29%
controls:11.64%
cases:9.32%
controls:2.55%
cases:4.37%
controls:0.15%
cases:8.67%
controls:2.52%
cases:17.52%
controls:12.61%
cases:26.89%
controls:23.38%
650
6018
4040
40717
764
5438
3926
41297
437
1194
4253
45541
205
69
4485
46666
405
1175
4268
45492
792
5773
3729
40025
1052
9530
2860
31234
Reticulocyte production index
31111-8 [3000012]
4.5e-01
1.9e+00
—
—
3.4e+00
1.7e+00
8.8e-01
cases:0.17%
controls:0.11%
cases:0.32%
controls:0.05%
—
—
—
—
cases:0.32%
controls:0.01%
cases:0.31%
controls:0.05%
cases:0.46%
controls:0.19%
8
51
4682
46684
15
22
4675
46713
—
—
15
5
4658
46662
14
25
4507
45773
18
78
3894
40686
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
8.7e-01
1.3e+00
2.3e+00
—
—
1.5e+00
1.1e+00
cases:1.39%
controls:0.59%
cases:0.70%
controls:0.19%
cases:0.17%
controls:0.02%
—
—
—
—
cases:0.71%
controls:0.16%
cases:1.74%
controls:0.61%
65
274
4625
46461
33
89
4657
46646
8
8
4682
46727
—
—
32
72
4489
45726
68
249
3844
40515
Alpha tocopherol [Moles/volume] in Serum or Plasma
14590-4 [3000208]
2.1e+00
—
—
—
—
2.6e+00
2.3e+00
cases:0.13%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.18%
controls:0.01%
cases:0.43%
controls:0.04%
6
7
4684
46728
—
—
—
—
8
6
4513
45792
17
18
3895
40746
Other and unspecified intestinal obstruction
K56.6 [45562499]
1.3e+00
2.6e+00
—
—
—
2.2e+00
9.8e-01
cases:0.72%
controls:0.20%
cases:0.68%
controls:0.05%
—
—
—
—
—
—
cases:0.66%
controls:0.07%
cases:0.84%
controls:0.32%
34
92
4656
46643
32
25
4658
46710
—
—
—
30
34
4491
45764
33
130
3879
40634
Laparotomy
JAH00 [2001304474]
1.3e+00
2.6e+00
—
—
—
2.0e+00
1.1e+00
cases:0.47%
controls:0.12%
cases:0.58%
controls:0.04%
—
—
—
—
—
—
cases:0.31%
controls:0.04%
cases:0.59%
controls:0.20%
22
58
4668
46677
27
20
4663
46715
—
—
—
14
19
4507
45779
23
82
3889
40682
Oncology Clinic/Center
261QX0200X [38004268]
1.1e-01
1.9e+00
2.6e+00
—
1.9e+00
5.4e-01
8.6e-02
cases:5.67%
controls:5.11%
cases:9.89%
controls:1.58%
cases:1.92%
controls:0.14%
—
—
cases:0.92%
controls:0.13%
cases:2.54%
controls:1.50%
cases:6.67%
controls:6.16%
266
2390
4424
44345
464
739
4226
45996
90
66
4600
46669
—
43
63
4630
46604
115
686
4406
45112
261
2510
3651
38254
Passage examination of small bowell with X-ray
JF1AB [2001304810]
1.4e+00
1.9e+00
—
—
—
2.3e+00
1.4e+00
cases:0.28%
controls:0.07%
cases:0.19%
controls:0.03%
—
—
—
—
—
—
cases:0.22%
controls:0.02%
cases:0.38%
controls:0.10%
13
33
4677
46702
9
13
4681
46722
—
—
—
10
10
4511
45788
15
39
3897
40725
Examination and observation for other specified reasons
Z04.8 [45552063]
4.3e-01
1.2e+00
1.7e+00
—
2.1e+00
1.4e+00
5.6e-01
cases:1.43%
controls:0.94%
cases:0.83%
controls:0.25%
cases:0.19%
controls:0.03%
—
—
cases:0.30%
controls:0.04%
cases:1.17%
controls:0.29%
cases:2.17%
controls:1.26%
67
438
4623
46297
39
116
4651
46619
9
16
4681
46719
—
14
17
4659
46650
53
135
4468
45663
85
512
3827
40252
Abnormal weight loss
R63.4 [45568144]
8.2e-01
1.8e+00
2.6e+00
1.0e+50
—
1.8e+00
2.9e-01
cases:0.47%
controls:0.21%
cases:0.41%
controls:0.07%
cases:0.19%
controls:0.01%
cases:0.17%
controls:0.00%
—
—
cases:0.38%
controls:0.06%
cases:0.54%
controls:0.40%
22
97
4668
46638
19
31
4671
46704
9
7
4681
46728
8
0
4682
46735
—
17
29
4504
45769
21
164
3891
40600
Cardiology
6 [38004451]
1.3e-01
3.1e-01
5.7e-01
4.4e+00
9.6e-01
4.8e-01
2.6e-01
cases:9.45%
controls:8.42%
cases:5.54%
controls:4.11%
cases:1.11%
controls:0.63%
cases:1.32%
controls:0.02%
cases:1.56%
controls:0.60%
cases:6.55%
controls:4.16%
cases:12.76%
controls:10.14%
443
3935
4247
42800
260
1923
4430
44812
52
293
4638
46442
62
8
4628
46727
73
281
4600
46386
296
1905
4225
43893
499
4132
3413
36632
Systemic arterial pressure
364090009 [4238447]
8.8e-01
1.4e+00
3.4e+00
—
—
1.0e+00
1.2e+00
cases:0.43%
controls:0.18%
cases:0.23%
controls:0.06%
cases:0.32%
controls:0.01%
—
—
—
—
cases:0.20%
controls:0.07%
cases:0.66%
controls:0.19%
20
83
4670
46652
11
28
4679
46707
15
5
4675
46730
—
—
9
32
4512
45766
26
78
3886
40686
Atrial fibrillation and flutter
I48 [45596206]
1.4e-01
4.1e-01
1.1e+00
3.9e+00
1.1e+00
4.3e-01
1.5e-01
cases:6.42%
controls:5.65%
cases:4.69%
controls:3.18%
cases:1.86%
controls:0.65%
cases:2.32%
controls:0.05%
cases:1.82%
controls:0.63%
cases:5.20%
controls:3.44%
cases:8.69%
controls:7.59%
301
2642
4389
44093
220
1484
4470
45251
87
302
4603
46433
109
22
4581
46713
85
295
4588
46372
235
1577
4286
44221
340
3094
3572
37670
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
6.5e-01
1.0e+00
3.0e+00
—
2.8e+00
8.0e-01
4.9e-01
cases:0.53%
controls:0.28%
cases:0.34%
controls:0.12%
cases:0.26%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.29%
controls:0.13%
cases:0.72%
controls:0.44%
25
130
4665
46605
16
57
4674
46678
12
6
4678
46729
—
12
7
4661
46660
13
59
4508
45739
28
179
3884
40585
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
1.7e-02
4.0e-01
1.1e+00
4.1e+00
1.1e+00
2.6e-01
2.1e-01
cases:3.99%
controls:3.92%
cases:3.35%
controls:2.26%
cases:0.96%
controls:0.31%
cases:0.62%
controls:0.01%
cases:1.01%
controls:0.35%
cases:3.03%
controls:2.36%
cases:10.02%
controls:8.31%
187
1833
4503
44902
157
1058
4533
45677
45
147
4645
46588
29
5
4661
46730
47
162
4626
46505
137
1082
4384
44716
392
3386
3520
37378
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.3e-01
3.7e-01
1.5e+00
3.3e+00
1.3e+00
3.7e-01
-2.9e-02
cases:17.23%
controls:15.51%
cases:18.19%
controls:13.32%
cases:11.66%
controls:2.94%
cases:4.97%
controls:0.18%
cases:9.99%
controls:2.96%
cases:19.49%
controls:14.27%
cases:25.51%
controls:26.06%
808
7247
3882
39488
853
6225
3837
40510
547
1372
4143
45363
233
86
4457
46649
467
1383
4206
45284
881
6534
3640
39264
998
10622
2914
30142
Gas panel - Arterial blood
24336-0 [3019060]
3.3e-01
1.2e+00
3.2e+00
—
2.0e+00
5.6e-01
4.9e-01
cases:0.83%
controls:0.60%
cases:0.85%
controls:0.26%
cases:0.45%
controls:0.02%
—
—
cases:0.24%
controls:0.03%
cases:0.49%
controls:0.28%
cases:1.84%
controls:1.13%
39
281
4651
46454
40
120
4650
46615
21
9
4669
46726
—
11
15
4662
46652
22
128
4499
45670
72
462
3840
40302
Ulcerative colitis, unspecified
K51.9 [45605941]
9.0e-01
1.1e+00
2.1e+00
—
1.4e+00
1.4e+00
1.3e+00
cases:0.51%
controls:0.21%
cases:0.32%
controls:0.10%
cases:0.17%
controls:0.02%
—
—
cases:0.11%
controls:0.03%
cases:0.40%
controls:0.10%
cases:0.89%
controls:0.24%
24
98
4666
46637
15
49
4675
46686
8
10
4682
46725
—
5
12
4668
46655
18
45
4503
45753
35
96
3877
40668
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
7.8e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.6e-02
cases:22.49%
controls:21.17%
cases:25.48%
controls:19.26%
cases:16.80%
controls:4.29%
cases:6.61%
controls:0.26%
cases:14.15%
controls:4.36%
cases:27.76%
controls:20.59%
cases:36.73%
controls:34.76%
1055
9894
3635
36841
1195
9000
3495
37735
788
2006
3902
44729
310
123
4380
46612
661
2037
4012
44630
1255
9428
3266
36370
1437
14171
2475
26593
Weakness/tiredness general
A04 [2002000145]
2.9e-01
6.5e-01
1.1e+00
2.2e+00
1.4e+00
7.9e-01
6.8e-01
cases:1.34%
controls:1.01%
cases:0.96%
controls:0.50%
cases:0.30%
controls:0.10%
cases:0.19%
controls:0.02%
cases:0.41%
controls:0.10%
cases:1.28%
controls:0.59%
cases:3.89%
controls:2.00%
63
471
4627
46264
45
236
4645
46499
14
47
4676
46688
9
10
4681
46725
19
46
4654
46621
58
268
4463
45530
152
817
3760
39947
Platelets [#/volume] in Blood
26515-7 [3007461]
7.3e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.3e-02
cases:22.37%
controls:21.12%
cases:25.44%
controls:19.20%
cases:16.74%
controls:4.28%
cases:6.57%
controls:0.26%
cases:14.12%
controls:4.35%
cases:27.67%
controls:20.53%
cases:36.61%
controls:34.71%
1049
9870
3641
36865
1193
8975
3497
37760
785
1999
3905
44736
308
123
4382
46612
660
2031
4013
44636
1251
9403
3270
36395
1432
14149
2480
26615
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
7.5e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.5e-02
cases:22.45%
controls:21.17%
cases:25.46%
controls:19.25%
cases:16.74%
controls:4.29%
cases:6.57%
controls:0.26%
cases:14.12%
controls:4.35%
cases:27.67%
controls:20.57%
cases:36.71%
controls:34.76%
1053
9896
3637
36839
1194
8998
3496
37737
785
2005
3905
44730
308
123
4382
46612
660
2031
4013
44636
1251
9421
3270
36377
1436
14170
2476
26594
MCH [Entitic mass]
28539-5 [3035941]
7.5e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.3e-02
cases:22.43%
controls:21.15%
cases:25.46%
controls:19.23%
cases:16.70%
controls:4.29%
cases:6.57%
controls:0.26%
cases:14.12%
controls:4.35%
cases:27.67%
controls:20.57%
cases:36.66%
controls:34.75%
1052
9885
3638
36850
1194
8988
3496
37747
783
2006
3907
44729
308
123
4382
46612
660
2030
4013
44637
1251
9419
3270
36379
1434
14164
2478
26600
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.4e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.3e-02
cases:22.43%
controls:21.17%
cases:25.46%
controls:19.26%
cases:16.74%
controls:4.29%
cases:6.57%
controls:0.26%
cases:14.12%
controls:4.36%
cases:27.69%
controls:20.59%
cases:36.68%
controls:34.77%
1052
9895
3638
36840
1194
9001
3496
37734
785
2006
3905
44729
308
123
4382
46612
660
2034
4013
44633
1252
9429
3269
36369
1435
14174
2477
26590
Ulcerative colitis and Crohn's disease
208 [2001600206]
2.3e+00
2.2e+00
—
1.0e+50
—
2.4e+00
6.8e-01
cases:1.43%
controls:0.15%
cases:0.28%
controls:0.03%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.35%
controls:0.03%
cases:0.26%
controls:0.13%
67
70
4623
46665
13
15
4677
46720
—
17
0
4673
46735
—
16
15
4505
45783
10
53
3902
40711
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
7.5e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.3e-02
cases:22.47%
controls:21.20%
cases:25.50%
controls:19.28%
cases:16.80%
controls:4.30%
cases:6.57%
controls:0.27%
cases:14.15%
controls:4.37%
cases:27.72%
controls:20.62%
cases:36.71%
controls:34.80%
1054
9907
3636
36828
1196
9011
3494
37724
788
2009
3902
44726
308
125
4382
46610
661
2040
4012
44627
1253
9444
3268
36354
1436
14184
2476
26580
Leukocytes [#/volume] in Blood
26464-8 [3010813]
7.7e-02
3.6e-01
1.5e+00
3.3e+00
1.3e+00
3.9e-01
8.9e-02
cases:22.49%
controls:21.18%
cases:25.52%
controls:19.26%
cases:16.74%
controls:4.29%
cases:6.57%
controls:0.27%
cases:14.12%
controls:4.37%
cases:27.72%
controls:20.60%
cases:36.81%
controls:34.78%
1055
9899
3635
36836
1197
9001
3493
37734
785
2005
3905
44730
308
125
4382
46610
660
2039
4013
44628
1253
9436
3268
36362
1440
14176
2472
26588
Supplier / Service Provider
OMOP5117446 [33004]
-1.0e+00
-6.1e-01
-4.4e-02
—
2.6e+00
2.7e+00
3.2e+00
cases:10.94%
controls:25.69%
cases:4.80%
controls:8.52%
cases:0.90%
controls:0.94%
—
—
cases:0.66%
controls:0.05%
cases:4.29%
controls:0.31%
cases:13.96%
controls:0.66%
513
12007
4177
34728
225
3984
4465
42751
42
437
4648
46298
—
31
24
4642
46643
194
140
4327
45658
546
268
3366
40496
Cardia
C16.00 [2000500510]
—
—
1.0e+50
—
1.0e+50
3.8e+00
2.9e+00
—
—
—
—
cases:0.49%
controls:0.00%
—
—
cases:0.28%
controls:0.00%
cases:0.51%
controls:0.01%
cases:0.54%
controls:0.03%
—
—
23
0
4667
46735
—
13
0
4660
46667
23
5
4498
45793
21
12
3891
40752
Hypothyroidism caused by autoimmune thyroiditis
E03.80 [2000501406]
1.4e+00
2.0e+00
—
1.0e+50
—
1.8e+00
1.5e+00
cases:0.53%
controls:0.13%
cases:0.38%
controls:0.05%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.44%
controls:0.07%
cases:0.74%
controls:0.17%
25
59
4665
46676
18
25
4672
46710
—
9
0
4681
46735
—
20
32
4501
45766
29
69
3883
40695
CBC panel - Blood by Automated count
58410-2 [40761511]
5.7e-02
3.5e-01
1.5e+00
3.1e+00
1.3e+00
3.9e-01
1.3e-01
cases:18.81%
controls:17.95%
cases:18.06%
controls:13.44%
cases:10.11%
controls:2.54%
cases:3.67%
controls:0.16%
cases:8.67%
controls:2.59%
cases:19.42%
controls:13.99%
cases:30.70%
controls:28.01%
882
8388
3808
38347
847
6282
3843
40453
474
1186
4216
45549
172
77
4518
46658
405
1211
4268
45456
878
6408
3643
39390
1201
11417
2711
29347
Malignant tumour
130 [2001600128]
4.7e-01
2.6e+00
1.5e+00
1.0e+50
3.1e+00
1.1e+00
3.8e-01
cases:0.55%
controls:0.35%
cases:2.73%
controls:0.22%
cases:0.13%
controls:0.03%
cases:2.56%
controls:0.00%
cases:0.36%
controls:0.02%
cases:0.71%
controls:0.23%
cases:1.10%
controls:0.76%
26
162
4664
46573
128
101
4562
46634
6
14
4684
46721
120
0
4570
46735
17
8
4656
46659
32
106
4489
45692
43
309
3869
40455
Malignant neoplasm: Stomach, unspecified
C16.9 [45571490]
2.8e+00
—
1.0e+50
1.0e+50
—
—
4.0e+00
cases:0.17%
controls:0.01%
—
—
cases:1.56%
controls:0.00%
cases:0.62%
controls:0.00%
—
—
—
—
cases:1.41%
controls:0.03%
8
5
4682
46730
—
73
0
4617
46735
29
0
4661
46735
—
—
55
11
3857
40753
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
5.1e-01
1.1e+00
1.9e+00
—
1.9e+00
6.9e-01
7.2e-01
cases:2.39%
controls:1.45%
cases:1.26%
controls:0.44%
cases:0.26%
controls:0.04%
—
—
cases:0.19%
controls:0.03%
cases:0.95%
controls:0.48%
cases:3.83%
controls:1.90%
112
679
4578
46056
59
205
4631
46530
12
18
4678
46717
—
9
14
4664
46653
43
220
4478
45578
150
775
3762
39989
Bacterial infection, unspecified
A49.9 [45590816]
5.3e-01
9.4e-01
1.8e+00
—
1.7e+00
1.0e+00
6.6e-01
cases:1.30%
controls:0.77%
cases:0.79%
controls:0.31%
cases:0.28%
controls:0.04%
—
—
cases:0.28%
controls:0.05%
cases:1.02%
controls:0.36%
cases:2.63%
controls:1.38%
61
360
4629
46375
37
145
4653
46590
13
21
4677
46714
—
13
23
4660
46644
46
166
4475
45632
103
561
3809
40203
ursodeoxycholic acid; oral
A05AA02 [21600513]
1.2e+00
1.4e+00
1.8e+00
—
1.2e+00
1.2e+00
1.2e+00
cases:0.36%
controls:0.11%
cases:0.36%
controls:0.09%
cases:0.15%
controls:0.03%
—
—
cases:0.15%
controls:0.05%
cases:0.31%
controls:0.09%
cases:0.46%
controls:0.14%
17
52
4673
46683
17
41
4673
46694
7
12
4683
46723
—
7
22
4666
46645
14
43
4507
45755
18
59
3894
40705
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
4.8e-01
1.0e+00
2.1e+00
—
2.2e+00
8.6e-01
5.5e-01
cases:1.17%
controls:0.73%
cases:1.15%
controls:0.41%
cases:0.53%
controls:0.07%
—
—
cases:0.43%
controls:0.05%
cases:1.31%
controls:0.56%
cases:3.32%
controls:1.95%
55
342
4635
46393
54
190
4636
46545
25
32
4665
46703
—
20
22
4653
46645
59
256
4462
45542
130
796
3782
39968
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.2e-01
4.9e-01
1.2e+00
3.2e+00
1.1e+00
4.2e-01
2.6e-01
cases:10.49%
controls:9.38%
cases:8.42%
controls:5.33%
cases:2.62%
controls:0.79%
cases:0.79%
controls:0.03%
cases:2.42%
controls:0.81%
cases:8.16%
controls:5.49%
cases:18.40%
controls:14.77%
492
4383
4198
42352
395
2491
4295
44244
123
370
4567
46365
37
15
4653
46720
113
378
4560
46289
369
2516
4152
43282
720
6022
3192
34742
Catheterisation of bladder
TKC20 [2001306020]
4.0e-01
1.1e+00
2.5e+00
—
2.3e+00
5.8e-01
8.4e-01
cases:0.79%
controls:0.53%
cases:0.53%
controls:0.18%
cases:0.23%
controls:0.02%
—
—
cases:0.13%
controls:0.01%
cases:0.38%
controls:0.21%
cases:1.64%
controls:0.71%
37
247
4653
46488
25
86
4665
46649
11
9
4679
46726
—
6
6
4667
46661
17
97
4504
45701
64
290
3848
40474
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
4.5e-01
7.7e-01
2.1e+00
—
2.0e+00
7.6e-01
5.8e-01
cases:1.96%
controls:1.26%
cases:1.17%
controls:0.55%
cases:0.66%
controls:0.08%
—
—
cases:0.62%
controls:0.08%
cases:1.19%
controls:0.56%
cases:2.74%
controls:1.55%
92
589
4598
46146
55
256
4635
46479
31
37
4659
46698
—
29
39
4644
46628
54
257
4467
45541
107
631
3805
40133
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
6.1e-02
9.5e-01
2.9e+00
—
2.6e+00
1.2e+00
5.1e-01
cases:0.17%
controls:0.16%
cases:0.28%
controls:0.11%
cases:0.19%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.33%
controls:0.10%
cases:0.69%
controls:0.42%
8
75
4682
46660
13
50
4677
46685
9
5
4681
46730
—
8
6
4665
46661
15
46
4506
45752
27
170
3885
40594
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
5.0e-01
1.2e+00
1.7e+00
—
2.1e+00
9.1e-01
8.6e-01
cases:0.58%
controls:0.35%
cases:0.70%
controls:0.22%
cases:0.23%
controls:0.04%
—
—
cases:0.32%
controls:0.04%
cases:0.71%
controls:0.29%
cases:1.81%
controls:0.78%
27
163
4663
46572
33
102
4657
46633
11
21
4679
46714
—
15
19
4658
46648
32
131
4489
45667
71
316
3841
40448
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
1.4e+00
2.5e+00
—
—
—
1.3e+00
1.4e+00
cases:0.49%
controls:0.12%
cases:0.45%
controls:0.04%
—
—
—
—
—
—
cases:0.24%
controls:0.07%
cases:0.59%
controls:0.14%
23
55
4667
46680
21
17
4669
46718
—
—
—
11
31
4510
45767
23
57
3889
40707
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
3.8e-01
1.1e+00
2.6e+00
—
2.0e+00
9.3e-01
3.2e-01
cases:0.60%
controls:0.41%
cases:0.58%
controls:0.20%
cases:0.45%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.55%
controls:0.22%
cases:1.41%
controls:1.02%
28
191
4662
46544
27
94
4663
46641
21
15
4669
46720
—
9
12
4664
46655
25
100
4496
45698
55
416
3857
40348
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
5.6e-01
8.9e-01
1.7e+00
—
1.9e+00
1.1e+00
5.5e-01
cases:3.03%
controls:1.75%
cases:1.49%
controls:0.62%
cases:0.47%
controls:0.09%
—
—
cases:0.53%
controls:0.08%
cases:1.68%
controls:0.59%
cases:4.29%
controls:2.51%
142
817
4548
45918
70
289
4620
46446
22
40
4668
46695
—
25
39
4648
46628
76
271
4445
45527
168
1024
3744
39740
fludrocortisone; oral
H02AA02 [21602726]
1.3e+00
1.8e+00
—
—
1.4e+00
1.9e+00
1.6e+00
cases:0.26%
controls:0.07%
cases:0.43%
controls:0.07%
—
—
—
—
cases:0.11%
controls:0.03%
cases:0.46%
controls:0.07%
cases:0.56%
controls:0.12%
12
32
4678
46703
20
32
4670
46703
—
—
5
12
4668
46655
21
33
4500
45765
22
47
3890
40717
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
7.9e-02
3.5e-01
1.4e+00
3.3e+00
1.3e+00
3.1e-01
1.0e-01
cases:21.32%
controls:20.03%
cases:23.75%
controls:17.99%
cases:13.82%
controls:3.89%
cases:6.08%
controls:0.24%
cases:12.43%
controls:3.89%
cases:24.55%
controls:19.27%
cases:35.51%
controls:33.24%
1000
9359
3690
37376
1114
8407
3576
38328
648
1816
4042
44919
285
110
4405
46625
581
1816
4092
44851
1110
8825
3411
36973
1389
13549
2523
27215
cisapride; oral, rectal
A03FA02 [21600485]
7.7e-01
1.5e+00
1.9e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:1.34%
controls:0.63%
cases:0.96%
controls:0.21%
cases:0.28%
controls:0.04%
—
—
cases:0.13%
controls:0.03%
cases:0.71%
controls:0.21%
cases:1.76%
controls:0.53%
63
293
4627
46442
45
100
4645
46635
13
20
4677
46715
—
6
13
4667
46654
32
95
4489
45703
69
215
3843
40549
Thiamine [Moles/volume] in Blood
32554-8 [3006653]
1.4e+00
2.7e+00
1.0e+50
—
—
2.2e+00
1.8e+00
cases:0.15%
controls:0.04%
cases:0.21%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.38%
controls:0.07%
7
17
4683
46718
10
7
4680
46728
5
0
4685
46735
—
—
13
15
4508
45783
15
27
3897
40737
General anesthesia, balanced
WX408 [2001310808]
2.5e-01
1.4e+00
3.0e+00
—
1.1e+00
1.2e+00
9.8e-01
cases:3.30%
controls:2.60%
cases:2.92%
controls:0.71%
cases:1.34%
controls:0.07%
—
—
cases:0.17%
controls:0.06%
cases:1.81%
controls:0.55%
cases:4.70%
controls:1.82%
155
1216
4535
45519
137
331
4553
46404
63
33
4627
46702
—
8
27
4665
46640
82
253
4439
45545
184
742
3728
40022
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
3.9e-01
1.0e+00
2.8e+00
—
1.9e+00
8.6e-01
4.4e-01
cases:0.60%
controls:0.41%
cases:0.58%
controls:0.21%
cases:0.47%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.51%
controls:0.22%
cases:1.51%
controls:0.98%
28
190
4662
46545
27
97
4663
46638
22
14
4668
46721
—
9
13
4664
46654
23
99
4498
45699
59
399
3853
40365
dexamethasone; oral, parenteral
H02AB02 [21602730]
2.9e-01
1.4e+00
1.3e+00
—
2.2e+00
1.3e+00
3.4e-01
cases:2.05%
controls:1.53%
cases:2.75%
controls:0.67%
cases:0.36%
controls:0.10%
—
—
cases:0.64%
controls:0.07%
cases:2.26%
controls:0.63%
cases:3.40%
controls:2.44%
96
716
4594
46019
129
315
4561
46420
17
47
4673
46688
—
30
33
4643
46634
102
289
4419
45509
133
993
3779
39771
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
4.0e-01
1.0e+00
2.7e+00
—
1.9e+00
9.1e-01
3.4e-01
cases:0.60%
controls:0.40%
cases:0.55%
controls:0.21%
cases:0.45%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.55%
controls:0.22%
cases:1.46%
controls:1.05%
28
187
4662
46548
26
96
4664
46639
21
14
4669
46721
—
9
13
4664
46654
25
102
4496
45696
57
426
3855
40338
tinzaparin; parenteral
B01AB10 [21600981]
6.3e-01
9.3e-01
2.1e+00
—
1.6e+00
1.3e+00
1.7e-01
cases:0.83%
controls:0.45%
cases:0.68%
controls:0.27%
cases:0.45%
controls:0.06%
—
—
cases:0.36%
controls:0.07%
cases:0.91%
controls:0.25%
cases:1.07%
controls:0.91%
39
208
4651
46527
32
126
4658
46609
21
27
4669
46708
—
17
33
4656
46634
41
115
4480
45683
42
370
3870
40394
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
6.4e-01
1.4e+00
1.4e+00
—
1.8e+00
2.2e+00
1.0e+00
cases:0.34%
controls:0.18%
cases:0.49%
controls:0.12%
cases:0.13%
controls:0.03%
—
—
cases:0.28%
controls:0.04%
cases:0.93%
controls:0.10%
cases:0.82%
controls:0.29%
16
84
4674
46651
23
54
4667
46681
6
15
4684
46720
—
13
21
4660
46646
42
46
4479
45752
32
120
3880
40644
Other iron deficiency anaemias
D50.8 [45571629]
3.3e+00
—
—
1.0e+50
—
—
3.2e+00
cases:0.30%
controls:0.01%
—
—
—
—
cases:0.32%
controls:0.00%
—
—
—
—
cases:0.72%
controls:0.03%
14
5
4676
46730
—
—
15
0
4675
46735
—
—
28
12
3884
40752
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
5.4e-01
1.4e+00
2.3e+00
—
2.8e+00
5.8e-01
2.3e-01
cases:0.72%
controls:0.42%
cases:0.51%
controls:0.13%
cases:0.13%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.22%
controls:0.12%
cases:0.69%
controls:0.55%
34
198
4656
46537
24
59
4666
46676
6
6
4684
46729
—
8
5
4665
46662
10
57
4511
45741
27
224
3885
40540
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.9e-01
9.6e-01
1.7e+00
—
2.2e+00
9.0e-01
6.9e-01
cases:1.36%
controls:1.14%
cases:1.07%
controls:0.41%
cases:0.30%
controls:0.05%
—
—
cases:0.36%
controls:0.04%
cases:0.97%
controls:0.40%
cases:2.91%
controls:1.48%
64
531
4626
46204
50
192
4640
46543
14
25
4676
46710
—
17
19
4656
46648
44
182
4477
45616
114
602
3798
40162
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
8.2e-01
8.6e-01
6.6e-01
1.4e+00
7.5e-01
9.4e-01
1.0e+00
cases:14.63%
controls:7.02%
cases:15.31%
controls:7.12%
cases:4.01%
controls:2.11%
cases:0.30%
controls:0.07%
cases:4.45%
controls:2.15%
cases:17.21%
controls:7.49%
cases:21.91%
controls:9.07%
686
3281
4004
43454
718
3327
3972
43408
188
988
4502
45747
14
35
4676
46700
208
1002
4465
45665
778
3432
3743
42366
857
3697
3055
37067
palonosetron, combinations
A04AA55 [45893275]
1.2e+00
2.2e+00
—
—
2.0e+00
2.2e+00
2.9e-01
cases:0.23%
controls:0.07%
cases:0.41%
controls:0.04%
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.40%
controls:0.04%
cases:0.13%
controls:0.10%
11
34
4679
46701
19
21
4671
46714
—
—
6
8
4667
46659
18
20
4503
45778
5
39
3907
40725

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2309
11057
3.09
315.88
3.4
2.1
3.07
2.77
mg/l
5.65
2079
9334
1295
4927
3.23
255.75
1.5
1.2
—
—
—
0
0
1593
6923
2.94
247.73
3.3
2.4
11.64
12.77
umol/l
7.38
1493
6366
1513
6474
2.95
241.11
3.1
2.4
2.33
2.24
g/l
7.69
1419
5901
1387
5948
2.87
216.88
3.2
2.5
20.70
22.80
%
4.91
1299
5452
1677
8193
2.61
200.15
2.0
1.8
1123.60
1154.56
nmol/l
0.69
1326
6076
2977
18925
2.50
200.05
3.5
2.2
79.49
94.74
pmol/l
48.12
1907
9899
2723
16899
2.41
188.85
5.1
2.8
128.50
144.71
ug/l
1.29
2559
15443
1153
5046
2.69
167.99
2.8
2.4
1.84
1.75
%
1.66
1020
4429
2103
12656
2.17
144.26
2.2
1.7
20.35
20.24
nmol/l
0.12
1874
10607
1646
9009
2.26
142.86
2.4
1.7
13711420.36
28158829.04
pmol/l
0.70
1342
7298
885
3888
2.56
124.27
2.7
2.4
70.28
66.92
e9/l
0.81
680
2833
1100
5597
2.25
109.54
6.0
5.4
1.04
1.04
mmol/l
0.14
1036
5148
517
1940
2.86
97.76
1.9
1.7
1.45
1.54
g/l
1.17
434
1657
2656
19097
1.87
95.53
7.7
4.7
33.88
34.90
g/l
16.60
2518
17733
801
3916
2.25
85.84
3.2
2.1
0.19
0.20
g/l
2.46
747
3614
1217
7044
1.97
83.00
3.7
3.0
0.80
0.82
mmol/l
9.40
1153
6553
2470
17948
1.77
80.07
8.2
6.1
9.10
9.03
%
0.56
2339
16668
2459
17914
1.76
78.37
8.1
6.0
2.89
2.81
%
0.79
2324
16651
1940
13212
1.78
78.04
7.6
5.8
—
—
—
0
0
2491
18228
1.76
78.03
8.3
6.1
25.36
26.42
%
4.97
2383
17147
2456
17909
1.76
77.80
8.2
6.1
0.65
0.65
%
0.26
2322
16624
2851
21698
1.77
77.66
9.8
7.0
1.21
1.21
mmol/l
4.79
2510
18594
2610
19444
1.75
75.91
8.4
6.2
1.21
1.21
mmol/l
2.36
2435
17791
2437
17843
1.74
75.09
3.6
2.4
76.28
79.34
nmol/l
6.11
2233
15779
99
122
8.26
74.75
2.7
1.4
2.04
1.94
umol/l
0.41
92
110
2436
17870
1.73
74.21
8.1
5.9
58.74
58.35
%
0.85
2339
16942
2596
19407
1.73
73.66
8.1
5.8
0.04
0.04
e9/l
1.98
2249
16382
2583
19328
1.73
72.62
8.1
5.8
0.60
0.61
e9/l
1.25
2236
16302
2620
19757
1.71
70.91
8.2
5.9
1.71
1.86
e9/l
7.17
2324
17077
2642
19995
1.71
70.31
8.4
6.0
0.20
0.19
e9/l
0.19
2322
17139
345
1238
2.92
70.17
1.6
1.4
244.54
273.18
ug/g
1.80
230
740
2775
21408
1.70
67.61
8.7
6.2
12.30
12.31
umol/l
0.01
2657
20360
1223
7524
1.84
67.00
1.4
1.3
2.09
1.50
u/ml
0.55
271
1934
1825
12778
1.69
62.63
5.1
4.2
—
—
—
0
0
2804
22035
1.65
60.50
12.1
9.0
4.22
4.29
e9/l
0.63
2465
18922
1823
12890
1.67
59.42
3.4
2.6
73.38
67.13
u/l
0.19
1704
11856
821
4622
1.94
58.35
5.0
3.9
43.00
22.52
ug/l
0.30
707
3813
2620
20451
1.62
56.24
17.5
18.2
1.31
1.34
inr
2.45
2258
17214
1056
6524
1.79
55.58
1.6
1.5
2.75
2.51
g/l
1.57
602
3827
373
1600
2.44
52.87
4.5
3.2
1038.94
3765.31
u/ml
0.82
322
1372
1815
13149
1.61
51.71
5.4
4.0
7.40
7.40
ph
1.20
1361
9486
787
4559
1.87
50.62
3.5
2.5
8.33
9.45
umol/l
1.01
697
4013
88
150
5.96
49.37
2.9
1.3
28.28
29.52
umol/l
0.41
83
140
724
4140
1.88
48.32
1.5
1.3
—
—
—
0
0
727
4179
1.87
47.68
4.1
2.1
220.54
147.86
ug/g
4.38
620
3297
1674
12220
1.57
44.39
4.1
3.1
35.90
37.14
u/l
0.18
1591
11454
684
3939
1.86
44.37
7.0
6.4
10.81
11.00
mmol/l
0.26
657
3736
3496
30127
1.58
42.36
12.2
8.0
89.08
81.87
u/l
8.35
3348
28361
1739
12927
1.54
41.88
3.4
2.4
—
—
—
0
0
600
3423
1.86
39.83
4.4
3.6
105.00
90.84
ng/l
2.39
502
2877
607
3489
1.85
39.32
2.2
2.2
382.16
386.88
nmol/l
0.21
555
3205
2890
24167
1.49
37.82
7.0
4.9
7.17
6.81
mmol/l
9.90
2796
22994
1816
14060
1.47
33.90
4.3
3.6
—
—
—
0
0
2242
18070
1.45
33.88
3.5
2.8
—
—
estimate
—
0
0
218
907
2.47
32.86
4.1
3.2
249.29
942.89
u/ml
1.29
196
832
53
84
6.37
32.01
1.5
1.2
16.53
16.51
umol/l
0.01
48
70
1367
10134
1.49
31.21
5.3
3.9
84.38
85.84
%
1.27
1341
9901
627
3882
1.71
31.03
2.5
2.6
65.42
65.96
g/l
0.95
573
3509
462
2620
1.84
30.92
1.2
1.2
—
—
—
0
0
730
4716
1.65
30.70
5.2
3.4
7.37
7.38
ph
1.01
442
2744
473
2732
1.81
29.78
3.1
2.8
10.77
10.70
g/l
0.10
434
2505
1867
14844
1.42
28.83
3.9
3.4
2.33
2.35
mmol/l
11.91
1703
13352
715
4682
1.62
28.30
5.2
3.4
5.75
5.81
kpa
0.85
698
4558
697
4547
1.62
27.99
5.2
3.4
1.45
1.82
mmol/l
1.65
596
3941
848
5798
1.56
27.89
2.4
2.0
—
—
—
0
0
602
3814
1.66
27.10
3.7
2.4
38.32
52.12
u/l
0.52
509
3183
77
196
3.98
26.97
1.4
1.2
125.95
138.54
nmol/l
1.70
77
196
3212
28257
1.41
26.37
5.6
4.4
16.35
13.69
mm/h
14.65
3027
26113
779
5302
1.56
25.97
7.5
6.6
0.82
1.00
mmol/l
0.49
615
4312
780
5314
1.56
25.89
7.6
6.7
7.41
7.42
ph
1.15
433
2937
712
4755
1.58
25.77
1.4
1.3
591.34
481.22
titre
0.77
194
1081
381
2151
1.84
25.74
2.0
1.9
1.40
1.41
g/l
0.02
343
1952
128
466
2.79
25.29
3.9
3.2
6.30
17.66
nmol/l
0.48
122
455
711
4780
1.57
24.95
7.8
6.8
94.91
95.30
%
0.66
681
4595
776
5342
1.54
24.46
7.6
6.7
5.03
5.07
kpa
0.53
737
5101
3041
26656
1.38
24.45
6.6
5.3
4506.98
2468.57
e6/l
0.60
54
433
299
1588
1.94
24.38
3.0
3.4
39.33
59.61
mg/l
1.22
260
1365
775
5341
1.54
24.29
7.6
6.7
11.94
11.99
kpa
0.10
739
5098
299
1592
1.94
24.20
3.0
3.4
55.91
62.38
mg/l
0.45
261
1365
511
3201
1.67
23.89
1.6
1.5
—
—
—
0
0
421
2505
1.75
23.79
9.9
8.8
15.21
15.90
%
6.60
409
2410
617
4057
1.60
23.73
7.9
6.4
1.41
1.36
mmol/l
0.51
603
3964
656
4377
1.58
23.70
8.2
7.4
113.92
120.84
g/l
15.91
642
4273
430
2583
1.73
23.48
6.2
3.4
23.61
24.19
mmol/l
3.20
425
2543
586
3833
1.60
23.00
9.8
7.5
—
—
—
0
0
652
4373
1.57
22.98
1.7
1.6
—
—
—
0
0
271
1422
1.96
22.89
2.9
3.3
1.99
4.77
ratio
2.34
173
850
334
1890
1.82
22.35
2.1
2.4
3.60
3.70
g/l
0.71
303
1710
334
1893
1.82
22.24
2.1
2.4
4.16
4.17
g/l
0.05
305
1713
334
1893
1.82
22.24
2.1
2.4
7.39
7.44
g/l
0.17
305
1711
2640
22845
1.34
21.74
4.0
3.2
58.88
52.65
u/l
1.71
2470
21020
686
4708
1.53
21.73
2.1
1.7
—
—
—
0
0
298
1645
1.86
21.59
2.2
2.4
10.42
10.33
g/l
0.12
264
1450
1651
13325
1.36
21.50
2.3
2.2
189.15
225.91
u/l
0.82
1570
12515
1725
14047
1.35
21.10
4.4
3.5
91.45
89.91
e6/l
0.02
1357
10861
583
3884
1.57
21.06
1.6
1.5
—
—
—
0
0
899
6559
1.46
21.00
2.1
1.9
29.97
29.92
s
0.09
878
6366
296
1646
1.85
20.95
1.1
1.1
2.56
1.29
u/ml
—
5
19
590
3950
1.56
20.85
4.3
2.9
4.41
4.42
kpa
0.05
576
3833
39
70
5.61
20.82
3.8
2.9
7.57
7.06
mg/l
0.18
32
57
365
2189
1.72
19.99
2.6
2.4
—
—
—
0
0
1118
8554
1.40
19.91
3.7
3.0
526.30
530.65
mosm/kgh2o
0.31
991
7504
307
1755
1.80
19.85
2.2
2.4
3.02
2.93
g/l
0.83
279
1575
454
2904
1.62
19.41
4.0
3.6
5.12
5.16
kpa
0.34
422
2747
1036
7855
1.41
19.38
6.0
4.6
—
—
—
0
0
443
2827
1.62
19.11
3.9
3.6
7.41
7.42
ph
2.53
371
2344
1426
11429
1.35
18.85
4.1
3.3
0.00
38.06
estimate
—
7
67
172
821
2.14
18.85
2.3
2.3
34.05
32.44
umol/l
0.30
148
721
661
4632
1.49
18.78
3.5
3.2
4.51
4.66
e9/l
0.19
578
3907
1115
8622
1.38
18.42
4.9
4.2
346.11
472.33
ng/l
0.42
943
7299
163
770
2.16
18.35
1.1
1.1
11.01
8.44
eliau/ml
0.18
16
74
526
3538
1.55
18.09
4.7
4.2
1.13
0.98
%
0.43
212
1081
3139
28243
1.32
17.76
6.0
4.4
15.15
14.99
pmol/l
2.90
2881
25501
341
2086
1.68
17.33
5.8
4.7
1.60
1.55
%
0.38
329
1975
1858
15612
1.31
17.29
5.4
4.1
135.78
114.80
e6/l
0.42
1387
11258
318
1913
1.71
17.20
5.9
4.9
0.86
0.87
%
0.09
307
1806
2419
21078
1.30
17.03
5.1
4.3
2.68
0.08
estimate
0.65
489
4334
2402
20929
1.29
16.84
5.1
4.3
5.22
3.03
estimate
0.25
527
4616
28
45
6.25
16.72
1.7
1.8
202.31
32.63
pmol/l
2.72
21
39
252
1435
1.80
16.52
1.1
1.1
540.00
151.06
titre
—
6
34
1477
12083
1.32
16.49
4.2
3.4
0.60
0.49
e6/l
0.84
1118
9045
910
6917
1.39
16.45
4.1
3.3
3.39
2.43
e6/l
1.52
471
3490
230
1280
1.84
16.26
5.9
5.8
1.38
1.33
mmol/l
0.35
210
1133
2369
20661
1.29
16.25
5.1
4.2
0.00
0.00
estimate
0.23
503
4446
201
1073
1.91
16.17
1.8
1.4
12.10
15.14
iu/ml
0.17
13
20
1956
16671
1.29
15.95
16.4
11.7
0.00
0.00
e9/l
0.46
1581
13509
1237
9908
1.33
15.89
3.3
2.8
5.44
5.31
e6/l
0.13
1131
9020
342
2147
1.64
15.72
3.3
3.4
4.15
4.42
pmol/l
5.71
302
1887
492
3364
1.51
15.61
4.6
4.1
0.70
0.73
%
0.16
199
1018
1728
14523
1.30
15.59
3.4
3.2
2132.54
1740.63
ng/l
2.72
1541
12641
29
52
5.60
15.53
1.3
1.2
58.28
64.48
ug/l
0.95
29
52
173
892
1.97
15.43
1.8
1.3
59.80
61.40
mmol/l
0.21
143
727
629
4527
1.45
15.42
1.6
1.4
—
—
—
0
0
1943
16629
1.28
15.06
4.4
3.7
6.23
6.27
ph
0.88
1043
9128
179
942
1.93
15.05
1.3
1.2
104.17
97.43
titre
0.10
12
70
1438
11841
1.31
15.00
8.7
6.1
—
—
—
0
0
218
1225
1.82
14.95
1.6
1.6
19.94
21.04
u/ml
0.06
31
239
1661
13950
1.29
14.88
4.9
4.1
10.86
8.93
mg/mmol
0.86
1111
8626
1661
13975
1.29
14.61
4.0
3.3
6.90
7.13
mmol/l
1.57
1421
11651
489
3393
1.49
14.42
4.8
4.3
0.14
0.13
%
0.05
176
941
130
623
2.12
14.18
2.5
1.9
0.85
0.89
%
0.39
94
413
428
2901
1.52
14.12
4.3
3.0
118.71
128.70
g/l
15.65
414
2825
554
3958
1.45
14.06
3.5
3.0
273.54
237.42
ng/l
0.73
509
3618
182
997
1.86
13.57
2.5
2.2
3.56
3.65
g/l
0.33
170
952
484
3392
1.47
13.56
5.0
4.4
0.10
0.23
%
0.70
168
881
298
1876
1.63
13.55
1.4
1.3
—
—
—
0
0
1280
10513
1.30
13.30
3.3
2.8
352.19
351.26
umol/l
0.10
1095
9052
195
1104
1.80
13.08
4.1
2.8
57.87
59.61
%
0.49
185
1060
89
381
2.36
12.79
1.2
1.1
—
—
—
0
0
1050
8437
1.31
12.76
1.8
1.7
1.63
1.43
mg/l
0.66
845
6619
183
1026
1.81
12.69
1.9
1.5
0.23
0.24
g/l
0.77
170
975
949
7525
1.33
12.67
3.9
3.1
1.44
1.16
e6/l
0.99
508
4099
96
427
2.27
12.64
1.5
1.6
54.17
30.64
ng/l
0.88
96
427
138
707
1.98
12.60
2.5
1.6
0.76
0.84
nmol/l
0.38
120
591
1607
13654
1.27
12.56
4.2
3.4
59.64
48.67
mg/l
0.70
1119
8708
187
1061
1.79
12.47
1.8
1.5
1.15
1.18
g/l
0.69
175
1009
74
296
2.52
12.33
1.6
1.1
30.57
34.80
mmol/l
0.69
67
251
394
2702
1.50
12.27
9.1
8.1
23.71
24.28
mmol/l
2.56
379
2622
1904
16551
1.25
12.08
4.8
4.2
52.22
74.62
ng/l
0.96
1505
12652
264
1663
1.62
11.99
1.5
1.6
13.56
21.53
iu/ml
—
10
44
414
2884
1.48
11.93
6.8
6.3
24.27
24.51
mmol/l
0.53
394
2757
253
1579
1.64
11.93
3.2
3.0
24.24
24.92
mmol/l
1.57
244
1551
108
517
2.11
11.88
1.9
1.6
0.81
0.83
g/l
0.08
92
400
178
1010
1.79
11.88
1.8
1.5
—
—
—
0
0
141
747
1.91
11.70
1.5
1.5
—
—
—
0
0
298
1950
1.56
11.53
4.2
3.8
—
—
—
0
0
162
902
1.82
11.52
6.8
6.7
11.34
11.23
mmol/l
0.15
152
799
162
903
1.82
11.48
6.8
6.7
105.14
104.91
mmol/l
0.26
152
801
21
37
5.70
11.46
1.0
1.1
86.48
71.20
ug/l
0.65
13
28
229
1409
1.66
11.43
1.3
1.2
—
—
—
0
0
3845
36282
1.30
11.33
28.3
18.1
28.61
26.73
mg/l
2.68
3442
30694
82
362
2.29
11.04
1.1
1.2
—
—
—
0
0
1270
10638
1.26
10.87
3.9
3.3
0.28
0.06
1.24
29
387
170
980
1.76
10.78
1.4
1.3
5.64
6.73
u/ml
0.18
31
157
188
1117
1.71
10.72
3.3
3.0
8.00
7.82
kpa
0.80
182
1090
186
1104
1.71
10.65
2.8
2.7
1.75
1.68
mg/l
0.45
169
971
105
521
2.04
10.55
2.1
1.4
73.02
43.55
mu/l
0.70
92
467
312
2105
1.52
10.52
1.4
1.4
—
—
—
0
0
168
977
1.75
10.35
3.2
2.9
88.88
88.79
%
0.04
162
950
1101
9112
1.27
10.35
3.9
3.0
2.46
2.46
mmol/l
0.45
989
8147
287
1912
1.53
10.27
2.0
1.9
3.51
2.25
ug/l
0.76
258
1646
53
199
2.68
10.09
1.9
1.4
1.01
1.12
nmol/l
0.38
47
144
61
246
2.50
10.06
1.7
1.4
—
—
—
0
0
134
739
1.84
9.88
3.9
3.2
60.07
58.76
%
0.53
134
739
479
3547
1.39
9.85
1.5
1.4
—
—
—
0
0
166
977
1.72
9.82
1.4
1.2
4.57
3.15
u/ml
0.55
23
86
552
4188
1.36
9.76
5.6
4.4
7.37
7.36
ph
0.89
424
2932
53
204
2.62
9.63
1.1
1.1
—
—
—
0
0
232
1497
1.58
9.58
4.2
3.8
24.41
24.82
mmol/l
1.22
211
1344
38
124
3.08
9.34
2.5
2.3
0.60
0.62
mmol/l
0.63
38
124
3573
33670
1.24
9.15
7.4
5.5
2.06
2.00
mu/l
0.90
3297
30633
178
1090
1.66
9.11
2.3
2.2
122.31
129.30
g/l
2.86
140
845
804
6496
1.29
9.05
1.3
1.3
33.91
33.50
iu/ml
0.03
239
1992
170
1035
1.67
8.91
1.4
1.2
11.88
43.29
u/ml
1.88
13
59
91
457
2.01
8.91
1.2
1.2
—
—
—
0
0
123
685
1.82
8.83
3.1
3.8
1.61
1.75
%
0.14
110
596
15
13
11.57
8.56
1.1
1.1
41.00
—
titre
—
5
0
484
3687
1.35
8.31
3.2
2.5
0.39
0.52
e6/l
0.81
473
3549
114
633
1.82
8.29
1.3
1.2
—
—
—
0
0
342
2469
1.41
8.16
1.2
1.3
—
—
—
0
0
87
445
1.97
8.13
1.1
1.1
1.51
1.54
g/l
0.25
78
400
14
12
11.70
8.06
1.1
1.1
359.86
278.42
nmol/l
0.52
14
12
134
787
1.72
8.06
1.3
1.2
—
—
—
0
0
988
11666
0.81
8.03
3.6
3.4
—
—
—
0
0
201
1309
1.56
8.03
2.0
1.8
21.80
21.08
s
0.47
188
1182
160
987
1.64
8.01
3.9
3.7
—
—
—
0
0
1245
10717
1.22
7.85
4.7
3.7
1.29
0.34
estimate
0.56
411
3438
215
1430
1.53
7.81
3.1
3.1
2734.09
375.42
mg/l
0.89
109
583
296
2105
1.43
7.69
1.2
1.2
210.13
131.39
u/ml
2.17
116
767
385
2865
1.37
7.68
9.9
8.3
0.66
0.64
%
0.58
380
2846
153
945
1.64
7.64
1.6
1.9
14.79
12.65
mg/l
0.73
135
870
40
151
2.66
7.62
1.8
2.1
55.80
131.85
umol/l
2.04
25
88
47
193
2.45
7.55
2.0
2.2
212.54
209.71
e6/l
0.03
41
167
75
378
2.00
7.34
1.3
1.2
343.15
331.17
nmol/l
0.13
69
306
211
1419
1.51
7.30
2.1
1.7
17.68
7.36
iu/ml
2.04
53
335
150
933
1.63
7.30
2.3
2.3
75.58
106.83
ug/min
0.67
94
543
40
155
2.59
7.26
3.2
2.8
88.44
66.86
mg/l
0.51
32
105
25
74
3.39
7.23
1.2
1.1
—
—
—
0
0
3913
37511
1.23
7.06
33.1
22.0
139.29
139.60
mmol/l
9.76
3836
36700
113
659
1.73
7.02
1.7
1.8
3.53
4.61
mmol/24h
3.91
96
571
1355
11876
1.20
6.91
5.2
4.4
0.00
0.00
estimate
1.54
448
3998
3915
37559
1.23
6.86
33.5
22.2
3.99
3.99
mmol/l
0.37
3834
36689
100
567
1.78
6.86
5.9
5.8
12.40
12.45
mg/l
0.04
89
521
181
1195
1.53
6.85
1.6
1.5
0.40
0.33
mg/l
0.66
89
505
390
2975
1.34
6.65
9.8
8.0
1.15
1.29
%
3.14
383
2955
86
472
1.84
6.58
1.3
1.3
0.21
0.23
nmol/l
0.24
68
373
93
523
1.79
6.57
1.4
1.2
289.36
275.78
u/ml
0.17
53
316
98
560
1.77
6.56
1.0
1.0
—
—
—
0
0
122
742
1.66
6.52
1.4
1.2
47.77
43.19
u/ml
0.11
16
81
1084
9359
1.20
6.45
5.2
4.6
1.02
1.18
kg/l
0.50
772
6358
298
2191
1.38
6.43
4.7
3.2
24.78
25.17
mmol/l
1.07
290
2123
25
80
3.14
6.43
1.6
1.3
—
—
—
0
0
83
454
1.84
6.42
1.4
1.2
—
—
—
0
0
158
1030
1.55
6.36
1.3
1.2
—
—
—
0
0
69
357
1.95
6.33
1.1
1.1
3.24
2.82
eliau/ml
0.10
18
134
93
530
1.77
6.30
1.0
1.1
—
—
—
0
0
25
81
3.10
6.30
1.0
1.1
289.86
273.31
pmol/l
0.09
14
59
50
231
2.18
6.20
1.2
1.1
—
—
—
0
0
226
1594
1.44
6.20
1.8
2.1
448.07
714.75
ug/l
0.94
214
1511
446
3504
1.30
6.17
4.8
3.7
1.21
1.23
mmol/l
3.95
388
2991
178
1199
1.50
6.17
4.3
3.3
3.29
1.82
index
0.45
93
616
54
259
2.10
6.10
1.1
1.0
292.82
290.75
mg/l
0.06
45
231
88
501
1.77
6.00
1.2
1.1
117.98
79.06
iu/ml
0.39
14
94
44
196
2.26
5.97
2.1
2.1
399.08
480.64
e6/l
0.61
37
158
1721
15547
1.17
5.91
5.3
4.3
2.67
0.22
estimate
0.82
418
3630
52
253
2.07
5.69
1.2
1.1
—
—
—
0
0
94
555
1.71
5.67
1.4
1.3
0.51
0.30
nmol/l
—
8
39
1696
15391
1.16
5.35
2.4
2.3
—
—
—
0
0
89
529
1.70
5.27
7.1
5.9
8.24
7.44
mmol/l
0.87
70
441
58
303
1.93
5.24
2.3
2.2
980.16
1061.14
e6/l
0.42
51
270
174
2455
0.70
5.15
2.0
2.0
3.25
3.40
ratio
1.00
145
1944
70
393
1.79
5.07
1.6
1.3
1.27
1.48
nmol/l
0.81
61
352
712
6040
1.21
5.01
1.3
1.3
18.19
11.68
u/ml
1.00
247
2219
77
447
1.73
4.98
1.8
2.1
—
—
—
0
0
1111
9807
1.17
4.97
4.7
4.1
0.00
0.49
—
5
150
49
246
2.00
4.97
1.4
1.2
—
—
—
0
0
59
316
1.88
4.96
1.1
1.2
—
—
—
0
0
51
261
1.96
4.91
1.3
1.2
92.50
138.64
titre
0.50
12
44
59
318
1.87
4.88
1.3
1.4
3.32
2.98
g/l
0.60
47
233
59
318
1.87
4.88
1.3
1.4
0.43
0.43
g/l
0.03
47
232
59
318
1.87
4.88
1.3
1.4
7.80
6.85
g/l
0.53
47
233
24
89
2.70
4.83
1.8
1.6
3680.00
5120.00
titre
—
6
12
3058
29052
1.14
4.71
36.1
22.3
14.48
13.79
%
91.60
3028
28611
29
120
2.42
4.70
1.4
1.2
145.63
127.17
nmol/l
0.16
19
86
45
224
2.02
4.69
1.8
1.4
—
—
—
0
0
19
64
2.98
4.55
4.8
5.7
—
—
—
0
0
27
110
2.46
4.53
2.4
1.6
—
—
—
0
0
97
618
1.58
4.43
1.6
1.3
—
—
—
0
0
83
509
1.64
4.43
1.6
1.3
—
—
—
0
0
83
509
1.64
4.43
1.6
1.3
—
—
—
0
0
83
509
1.64
4.43
1.6
1.3
—
—
—
0
0
83
509
1.64
4.43
1.6
1.3
—
—
—
0
0
3781
36539
1.16
4.31
25.5
16.2
—
—
—
0
0
72
429
1.69
4.29
1.3
1.2
9.25
58.31
u/ml
—
6
23
61
347
1.77
4.28
3.0
3.0
32.02
33.11
mg/l
0.02
44
264
76
461
1.66
4.24
1.3
1.3
—
—
nmol/l
—
0
0
123
1776
0.68
4.19
1.7
1.8
3.09
3.43
mmol/l
2.48
88
1260
140
979
1.44
4.14
2.2
1.9
4.35
10.34
iu/l
0.46
58
370
51
278
1.84
4.13
3.4
1.7
8.83
8.10
mmol/l
0.57
51
278
79
490
1.62
4.06
1.3
1.3
434.95
295.93
pmol/l
0.40
63
410
46
246
1.88
3.96
2.1
1.3
1.16
1.09
promille
0.12
38
194
16
53
3.03
3.96
1.7
1.4
—
—
—
0
0
399
3270
1.24
3.95
3.7
3.0
6.03
6.07
ph
0.53
292
2322
56
319
1.76
3.94
1.2
1.3
—
—
—
0
0
19
70
2.72
3.91
1.8
1.4
—
—
—
0
0
82
519
1.59
3.90
1.7
1.4
—
—
—
0
0
48
262
1.84
3.89
1.2
1.3
—
—
—
0
0
260
2031
1.30
3.85
2.4
2.0
—
—
—
0
0
77
482
1.61
3.84
1.8
1.4
—
—
—
0
0
3938
38263
1.16
3.80
36.4
24.2
85.66
81.68
umol/l
6.05
3870
37662
127
889
1.44
3.77
5.0
4.2
2.65
2.61
mmol/l
0.06
91
616
39
201
1.95
3.76
1.8
1.9
509.82
489.14
min
0.67
28
142
77
486
1.59
3.72
4.0
2.9
11.06
10.56
mmol/l
0.59
77
480
73
456
1.61
3.68
3.3
3.6
61.25
57.61
%
0.79
65
380
55
319
1.73
3.67
1.2
1.2
—
—
—
0
0
50
282
1.78
3.66
1.8
1.7
97.04
112.70
ng/l
0.68
50
282
81
520
1.57
3.65
1.7
1.4
—
—
—
0
0
81
523
1.56
3.57
1.7
1.4
—
—
—
0
0
83
539
1.55
3.57
1.6
1.3
161.53
155.44
au/ml
0.23
33
166
80
516
1.56
3.54
2.3
2.2
0.83
1.20
g/24h
1.05
46
294
30
145
2.08
3.46
1.4
1.4
2.47
3.34
mmol/l
2.10
30
133
46
259
1.78
3.41
1.4
1.3
9.67
9.33
mmol/l
0.15
41
246
3867
37597
1.14
3.40
17.7
12.5
23.55
25.01
u/l
4.14
3753
36239
54
320
1.70
3.36
1.1
1.2
123.28
109.57
pmol/l
0.69
54
320
197
1513
1.31
3.35
4.1
3.5
1.50
1.40
mmol/l
0.36
190
1485
108
753
1.44
3.32
1.3
1.2
110.98
31.64
u/l
1.49
98
644
249
1975
1.27
3.31
2.7
2.1
0.00
0.45
estimate
0.53
67
579
47
269
1.75
3.31
1.1
1.2
—
—
—
0
0
470
3992
1.20
3.29
2.5
2.2
0.01
0.01
estimate
0.17
85
767
73
470
1.56
3.28
1.2
1.3
—
—
—
0
0
78
512
1.53
3.23
1.8
1.4
—
—
—
0
0
158
1184
1.35
3.19
3.4
3.4
0.87
0.82
nmol/l
0.64
116
952
52
310
1.68
3.19
2.1
2.3
—
—
—
0
0
73
475
1.54
3.15
1.1
1.1
31.10
19.39
au/ml
—
8
93
63
399
1.59
3.06
1.1
1.1
—
—
—
0
0
6
8
7.51
3.05
1.0
1.3
27.43
31.89
umol/24h
—
6
8
3535
34248
1.12
3.04
8.5
6.9
41.59
40.03
mmol/mol
14.93
3284
31537
18
74
2.44
3.04
1.0
1.1
1020.00
905.56
titre
—
5
18
16
62
2.59
3.04
1.1
1.1
—
—
—
0
0
78
520
1.51
3.03
1.6
1.4
—
—
—
0
0
9
21
4.29
2.99
1.9
1.3
497.67
349.38
umol/24h
—
9
21
21
94
2.24
2.96
1.0
1.1
—
—
—
0
0
20
88
2.28
2.93
1.3
1.5
—
—
—
0
0
22
101
2.18
2.92
1.7
2.1
33.00
29.96
%
0.34
22
91
23
108
2.13
2.90
1.5
1.6
14.05
15.06
pmol/l
0.50
17
89
14
52
2.70
2.88
7.7
15.0
4.07
5.24
mmol/l
1.54
14
52
16
64
2.50
2.86
1.0
1.0
—
—
—
0
0
6
9
6.67
2.86
1.3
1.3
—
—
—
0
0
228
1825
1.26
2.86
2.7
2.7
—
—
—
0
0
40
230
1.75
2.82
2.0
2.1
14.30
16.63
%
0.59
40
220
13
47
2.77
2.81
1.2
1.5
73.45
72.71
%
0.03
13
41
140
1056
1.34
2.76
1.7
1.6
10001.18
14012.87
e6/l
0.94
100
737
45
270
1.67
2.74
3.5
1.9
15.13
16.41
%
1.79
45
270
45
724
0.62
2.69
1.1
1.2
1.56
1.55
g/l
0.00
45
724
23
112
2.06
2.66
1.3
1.6
65.61
448.19
nmol/24h
0.85
23
112
42
250
1.69
2.64
1.1
1.1
—
—
—
0
0
27
140
1.93
2.64
1.3
1.3
178.33
163.28
mmol/24h
0.27
27
140
11
35
3.15
2.64
1.2
1.2
—
—
—
0
0
177
1390
1.28
2.62
1.3
1.2
2.32
1.08
u/ml
0.32
13
118
11
36
3.06
2.56
1.1
1.0
—
—
—
0
0
110
811
1.36
2.54
1.4
1.4
1015.41
1193.69
e6/l
0.11
94
647
63
421
1.50
2.48
4.7
3.3
13.26
11.93
index
0.31
38
218
39
232
1.69
2.48
2.3
1.7
25.49
8.64
umol/l
0.68
30
154
71
487
1.46
2.46
1.3
1.3
276.93
275.90
mosm/kgh2o
0.12
58
356
13
51
2.55
2.44
3.3
3.1
0.54
0.61
u/field
0.12
13
51
31
174
1.79
2.41
1.3
1.3
63.67
69.04
%
—
6
23
15
64
2.35
2.38
1.1
1.1
—
—
—
0
0
51
329
1.56
2.37
1.5
1.3
102.00
65.00
titre
—
5
26
3948
38650
1.12
2.34
42.9
27.2
6.88
6.90
e9/l
0.09
3847
37536
110
823
1.34
2.34
1.2
1.2
4.30
3.78
mmol/l
3.08
105
768
139
1780
0.77
2.33
1.3
1.4
—
—
—
0
0
3946
38636
1.12
2.31
42.9
27.2
248.87
243.98
e9/l
3.73
3854
37674
107
799
1.35
2.31
1.4
1.4
12.31
32.39
e6/l
0.97
85
599
66
453
1.46
2.30
1.6
1.5
56.00
61.37
%
0.52
46
280
17
78
2.18
2.30
1.4
1.3
88.13
56.94
mu/l
0.28
11
57
3946
38639
1.12
2.30
42.8
27.1
91.68
91.77
fl
0.47
3886
38052
3946
38640
1.12
2.29
42.7
27.1
30.17
30.46
pg
13.89
3885
38052
3946
38641
1.12
2.29
43.8
27.6
37.74
39.64
%
90.95
3884
38037
3946
38642
1.12
2.28
42.9
27.2
4.19
4.39
e12/l
94.72
3843
37534
47
301
1.57
2.26
1.1
1.1
—
—
—
0
0
3946
38649
1.12
2.25
43.3
27.4
124.75
132.81
g/l
185.41
3884
38086
361
3107
1.17
2.24
4.3
4.3
—
—
—
0
0
22
114
1.93
2.20
1.6
1.9
7258.67
9473.85
e6/l
—
9
60
33
196
1.69
2.15
2.1
2.5
36.00
40.01
%
0.69
20
103
51
340
1.51
2.08
1.5
1.4
226.67
422.26
titre
—
9
31
121
936
1.30
2.08
1.3
1.3
473.37
587.36
mg/l
3.19
113
886
46
300
1.54
2.07
1.4
1.3
29.94
31.57
u/l
0.12
38
250
17
82
2.08
2.06
2.6
2.3
5.00
505.62
ug/l
0.80
17
82
15
69
2.18
2.04
1.6
1.9
2.83
0.15
e9/l
—
7
23
73
525
1.40
2.02
2.2
1.8
88.15
89.31
%
0.58
73
519
54
367
1.48
2.02
1.1
1.1
—
—
—
0
0
86
638
1.35
1.98
1.6
1.4
1147.60
3950.82
e6/l
1.28
68
454
34
209
1.63
1.97
2.2
2.2
254.89
139.87
ug/min
—
9
53
221
1846
1.21
1.96
1.3
1.2
—
—
—
0
0
67
926
0.72
1.95
1.3
1.3
—
—
—
0
0
44
289
1.53
1.94
2.1
2.1
593.47
614.45
ml
0.16
32
176
11
45
2.45
1.92
1.4
1.6
—
—
—
0
0
21
113
1.86
1.91
1.2
1.1
—
—
—
0
0
452
4009
1.14
1.90
2.5
2.4
6.23
6.83
ug/l
0.26
369
3429
20
106
1.89
1.90
1.1
1.4
14.40
13.73
g/l
0.09
13
80
83
617
1.35
1.90
1.5
1.3
16.03
11.10
u/l
1.87
66
492
9
34
2.65
1.86
2.9
2.2
1.24
1.12
mg/l
—
9
25
65
467
1.40
1.84
1.2
1.3
—
—
—
0
0
76
563
1.36
1.80
1.7
1.4
9966.66
67611.11
e6/l
3.08
47
323
62
444
1.40
1.79
1.2
1.2
4.08
5.50
u/ml
0.41
38
198
21
116
1.81
1.78
1.6
1.4
6.25
7.62
mmol/l
0.93
21
116
30
472
0.63
1.74
1.4
1.7
—
—
—
0
0
24
140
1.72
1.71
1.2
1.1
1612.75
1601.75
miu/ml
0.02
24
140
17
89
1.91
1.69
1.6
1.9
—
—
—
0
0
731
7927
0.91
1.64
3.3
3.5
0.85
0.83
ug/l
0.13
519
5664
130
1050
1.24
1.64
1.4
1.3
35.04
31.73
iu/l
0.40
108
907
23
135
1.71
1.62
2.0
2.1
669.46
6810.46
e6/l
0.52
13
91
63
463
1.37
1.60
3.1
2.6
—
—
—
0
0
8
32
2.50
1.59
1.3
1.1
0.05
0.03
u/ml
—
8
32
241
2076
1.17
1.56
1.3
1.3
327.57
218.21
u/ml
0.41
229
1915
91
709
1.29
1.56
2.0
1.7
343.61
305.19
mu/l
0.43
83
655
15
78
1.93
1.54
1.3
1.5
—
—
—
0
0
35
232
1.51
1.54
2.8
1.8
2.23
2.50
u/field
0.09
30
161
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
74
563
1.32
1.51
2.1
2.1
37.62
23.81
mg/l
1.41
34
187
33
217
1.52
1.51
1.9
1.6
—
—
—
0
0
15
80
1.88
1.44
1.0
1.1
—
—
—
0
0
36
247
1.46
1.37
1.4
1.2
3.91
1.18
u/ml
0.61
22
148
2968
28950
1.07
1.37
37.7
23.7
328.48
331.32
g/l
47.38
2943
28705
92
733
1.26
1.36
1.6
1.5
30.17
30.89
g/l
0.20
83
662
32
216
1.48
1.32
2.2
2.2
17.38
26.64
umol/l
—
9
17
55
410
1.35
1.32
1.2
1.2
—
—
—
0
0
17
98
1.74
1.30
1.1
1.3
1.59
1.50
mmol/l
0.10
12
67
6
24
2.50
1.30
1.2
1.1
—
—
—
0
0
6
24
2.50
1.30
1.2
1.1
—
—
—
0
0
213
1851
1.16
1.28
4.3
3.9
77.42
84.17
u/ml
0.08
207
1780
38
269
1.42
1.25
1.3
1.3
7.46
7.40
ph
2.03
32
184
35
244
1.44
1.25
1.1
1.1
1.48
7.63
nmol/l
—
9
58
19
115
1.65
1.24
1.4
1.9
—
—
—
0
0
57
433
1.32
1.23
2.0
2.1
—
—
—
0
0
55
416
1.33
1.22
2.6
2.1
2.50
1.55
u/field
0.99
44
221
13
71
1.83
1.19
36.2
9.6
5.22
5.34
kpa
0.07
13
71
108
893
1.21
1.17
1.3
1.1
—
—
—
0
0
42
307
1.37
1.17
2.0
2.8
21.41
32.14
mg/l
2.18
32
228
260
2314
1.13
1.13
4.8
3.7
1.02
1.02
ratio
0.57
240
2090
139
1185
1.18
1.10
5.9
4.5
—
—
—
0
0
32
226
1.42
1.09
1.5
1.8
475.60
322.95
mu/l
0.61
25
178
25
168
1.49
1.09
1.2
1.1
27.58
17.88
u/ml
—
6
69
580
5393
1.09
1.09
1.4
1.4
—
—
—
0
0
68
541
1.26
1.07
1.5
1.6
—
—
—
0
0
1027
9761
1.07
1.06
1.4
1.3
—
—
—
0
0
12
67
1.79
1.04
1.0
1.1
0.46
0.63
u/ml
—
7
28
52
402
1.30
1.03
1.2
1.2
—
—
—
0
0
51
395
1.29
1.00
1.3
1.3
258265.09
99173.10
e6/l
0.53
34
266
18
116
1.55
0.96
1.5
1.2
25.50
14.87
%
—
6
15
13
77
1.69
0.95
1.2
1.1
0.62
0.68
umol/24h
—
7
39
45
346
1.30
0.94
1.8
1.8
—
—
—
0
0
80
661
1.21
0.93
1.1
1.3
242.24
213.98
miu/ml
0.23
25
271
6
28
2.14
0.91
1.0
1.5
—
—
—
0
0
34
253
1.35
0.90
3.2
3.0
—
—
—
0
0
191
1702
1.13
0.87
1.9
1.6
—
—
—
0
0
32
425
0.75
0.86
1.4
1.1
—
—
—
0
0
22
153
1.44
0.85
1.0
1.1
8.00
477.40
ng/l
—
6
40
32
424
0.75
0.85
1.4
1.1
—
—
—
0
0
63
515
1.23
0.83
3.0
4.7
313.25
344.33
umol/l
0.98
53
449
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
0.06
—
0
19
20
139
1.44
0.79
2.5
2.2
29.70
30.03
%
0.03
20
139
3539
34942
1.05
0.75
5.9
5.6
6.18
6.03
mmol/l
7.46
3227
31463
5
24
2.08
0.74
1.2
1.0
—
—
—
0
0
49
396
1.24
0.74
1.5
1.3
—
—
—
0
0
36
280
1.29
0.74
2.3
1.9
7.68
6.84
mmol/l
0.65
25
187
5
25
2.00
0.72
1.2
1.6
—
—
—
0
0
513
4836
1.07
0.72
5.3
5.2
34.74
33.39
%
1.89
375
3074
7
39
1.80
0.72
2.0
2.5
16.99
18.59
umol/l
—
7
39
7
40
1.75
0.71
1.1
1.1
1.28
1.70
umol/24h
—
7
40
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
13
85
1.53
0.68
36.7
8.9
5.74
5.96
kpa
0.59
13
71
5
27
1.85
0.68
1.2
1.0
—
—
—
0
0
17
121
1.41
0.62
1.2
1.2
8.39
11.79
pmol/l
—
8
44
41
501
0.82
0.61
1.6
1.6
994.79
1018.58
mu/l
0.06
32
404
42
343
1.23
0.61
1.5
1.4
—
—
—
0
0
63
536
1.18
0.60
2.6
2.0
440.05
4320.26
u/l
3.15
30
218
194
2113
0.91
0.59
1.3
1.4
—
—
—
0
0
103
914
1.13
0.57
4.2
3.6
33.95
28.85
mg/l
0.73
76
660
23
177
1.30
0.54
1.7
1.4
1.60
4.69
%
—
5
35
8
125
0.64
0.54
1.8
2.0
0.00
0.05
estimate
—
8
125
25
197
1.27
0.50
4.9
3.7
—
—
—
0
0
27
215
1.26
0.50
4.6
3.6
—
—
—
0
0
36
298
1.21
0.49
1.1
1.0
253.79
313.84
ng/l
0.96
24
194
36
298
1.21
0.49
1.1
1.0
755.13
660.89
ng/l
0.58
24
188
18
234
0.77
0.48
1.7
1.5
—
—
—
0
0
17
129
1.32
0.45
1.1
1.0
—
—
—
0
0
17
129
1.32
0.45
1.1
1.0
—
—
—
0
0
17
129
1.32
0.45
1.1
1.0
—
—
—
0
0
20
156
1.28
0.45
1.2
1.2
—
—
—
0
0
45
386
1.17
0.43
1.5
1.8
—
—
—
0
0
5
31
1.61
0.43
1.0
1.1
—
22.44
—
0
9
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
14
105
1.33
0.41
1.5
2.2
—
—
—
0
0
12
88
1.36
0.40
1.2
1.3
28.17
28.54
s
0.04
12
88
61
540
1.13
0.39
1.6
1.5
—
—
—
0
0
23
187
1.23
0.38
1.0
1.6
5.76
13.53
ug/l
1.05
23
164
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
1064
10884
0.97
0.37
4.7
5.0
21.86
22.31
%
0.43
506
5844
53
598
0.88
0.36
2.2
1.8
177.25
196.32
pmol/l
0.86
48
559
29
244
1.19
0.36
1.3
1.2
—
—
—
0
0
33
385
0.86
0.35
1.1
1.1
0.18
1.23
u/ml
2.13
17
155
3451
34756
0.97
0.34
5.4
5.3
4.22
4.51
mmol/l
51.60
3209
31873
18
222
0.81
0.34
1.6
1.5
—
—
—
0
0
86
940
0.91
0.34
1.2
1.2
—
—
—
0
0
6
45
1.33
0.33
2.2
1.6
—
—
—
0
0
6
46
1.30
0.33
3.3
1.8
7.57
8.77
mmol/l
—
6
27
26
219
1.19
0.33
1.8
1.6
—
—
—
0
0
34
392
0.87
0.32
1.3
1.3
7.29
7.70
mmol/l
0.26
26
333
18
220
0.82
0.32
1.6
1.4
1.35
1.26
mm
0.32
12
156
17
209
0.81
0.32
5.4
7.0
24.67
108.90
ug/l
—
7
130
16
198
0.81
0.32
1.3
1.5
59.55
68.25
%
0.70
11
162
3276
32998
0.98
0.31
4.5
4.4
1.30
1.26
mmol/l
1.83
2980
29652
65
589
1.10
0.31
2.6
2.2
—
—
—
0
0
41
361
1.14
0.31
1.7
1.5
29.53
27.56
%
0.12
28
230
7
57
1.23
0.29
1.6
1.3
—
—
—
0
0
11
85
1.29
0.28
6.4
6.0
9.99
8.80
mmol/l
0.67
11
85
113
1204
0.94
0.26
11.8
11.7
—
—
—
0
0
35
394
0.89
0.26
1.1
1.1
1.67
4.06
u/ml
1.74
18
189
116
1233
0.94
0.26
1.1
1.1
—
—
—
0
0
3426
34452
0.98
0.25
5.3
5.2
1.42
1.46
mmol/l
8.80
3153
31349
38
340
1.12
0.24
1.5
1.4
0.23
0.32
nmol/l
0.85
31
251
66
609
1.08
0.24
3.2
2.6
—
—
—
0
0
229
2204
1.04
0.22
1.3
1.3
37.85
55.14
au/ml
0.76
13
154
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
11.91
—
0
7
79
741
1.07
0.20
1.4
1.4
238.04
214.89
pmol/l
0.07
79
717
0
14
0.00
0.20
0.0
1.0
—
0.11
—
0
9
9
115
0.78
0.20
1.0
1.2
17.56
12.26
mm/h
—
9
115
44
479
0.92
0.19
1.2
1.1
0.80
1.69
u/ml
0.95
29
259
97
918
1.06
0.19
1.0
1.1
—
—
—
0
0
41
375
1.09
0.19
1.1
1.2
—
—
—
0
0
3540
35545
0.98
0.19
6.3
6.1
2.35
2.59
mmol/l
38.32
3281
32474
22
194
1.13
0.18
1.2
1.2
—
—
—
0
0
42
387
1.09
0.17
1.5
1.3
8.94
12.46
u/l
1.95
34
354
13
152
0.85
0.17
1.3
1.4
156.02
214.54
pmol/l
0.43
13
152
72
760
0.95
0.15
1.9
1.8
57.71
44.88
nmol/l
2.82
72
730
15
130
1.15
0.15
1.1
1.0
0.41
1.02
u/ml
—
9
44
23
207
1.11
0.15
1.0
1.0
—
—
—
0
0
250
2440
1.03
0.13
2.5
2.4
20.64
23.21
au/ml
0.14
18
196
33
305
1.08
0.13
3.2
5.5
50.29
52.73
u/ml
—
8
96
17
152
1.12
0.12
1.4
1.7
2.55
5.28
ug/l
0.74
12
116
20
182
1.10
0.11
1.0
1.7
39.42
39.58
g/l
0.04
20
182
29
270
1.07
0.10
1.0
1.0
0.04
0.23
u/ml
1.41
15
100
1361
13519
1.01
0.10
5.5
6.1
3.41
4.01
ug/l
0.50
1198
12076
5
48
1.04
0.09
1.4
1.1
6.46
119.24
ng/l
—
5
31
14
126
1.11
0.09
1.1
1.1
—
—
—
0
0
102
991
1.03
0.09
1.1
1.1
—
—
—
0
0
5
60
0.83
0.08
1.8
1.3
15.34
9.33
mg/l
—
5
54
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
13
118
1.10
0.07
1.1
1.1
0.44
0.43
u/ml
—
6
27
9
88
1.02
0.07
1.0
1.0
—
—
—
0
0
14
128
1.09
0.06
1.2
1.2
46.50
39.10
g/l
—
8
55
38
365
1.04
0.05
2.9
2.5
—
—
—
0
0
30
288
1.04
0.04
1.0
1.1
0.47
3.82
u/ml
2.93
18
125
114
1157
0.98
0.04
1.9
1.8
—
—
—
0
0
23
240
0.96
0.03
1.7
1.7
88.39
89.47
umol/l
0.05
23
240
32
310
1.03
0.03
1.0
1.1
0.46
2.90
u/ml
2.67
20
152
1471
14736
1.00
0.02
2.1
1.9
1.32
1.31
mmol/l
0.06
1235
12211
36
351
1.03
0.02
1.1
1.1
0.39
1.40
u/ml
1.74
22
183
259
2602
0.99
0.01
2.2
2.2
13.46
12.26
nmol/l
0.73
236
2277
17
176
0.97
0.00
1.3
1.2
0.59
0.52
ratio
0.55
12
102
11
107
1.03
0.00
1.5
1.1
—
—
—
0
0
17
174
0.98
0.00
1.2
1.3
6.87
6.09
mmol/l
0.81
17
165
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3260.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.95
-0.00
1.9
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_ANAEMIA_B12_DEF and mortality.

Females

Parameter HR [95% CI] p-value
D3_ANAEMIA_B12_DEF 1.482 [1.37, 1.6] < 0.001
Birth year 0.992 [0.98, 1.0] 0.055

During the follow-up period (1.1.1998 — 31.12.2019), 7706 out of 16915 females with D3_ANAEMIA_B12_DEF died.

Males

Parameter HR [95% CI] p-value
D3_ANAEMIA_B12_DEF 1.604 [1.46, 1.76] < 0.001
Birth year 0.989 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 6887 out of 13361 males with D3_ANAEMIA_B12_DEF died.

Mortality risk

Mortality risk for people of age

years, who have D3_ANAEMIA_B12_DEF.

N-year risk Females Males
1 0.147% 0.38%
5 0.848% 2.113%
10 2.174% 5.004%
15 4.043% 9.139%
20 6.83% 15.193%

Relationships between endpoints

↥

Index endpoint: D3_ANAEMIA_B12_DEF – Vitamin B12 deficiency anaemia

GWS hits: 14

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data